Ohio State Navbar

Directory

Abraham, William MD


Staff photo

473 W 12th Ave
Columbus, OH 43210

Phone: (614) 292-9560

Email: abraham.61@osu.edu

 

Current OSU Appointments

Professor, Cardiovascular Medicine

Professor, SBS-Physiology & Cell Biology

Physician, FGP-Cardiovascular Medicine

 

Academic Advising

2010 - 2011 Subha Raman The Ohio State University. Junior Faculty
 

Books

William T Abraham, Henry Krum. Heart Failure. New York, NY, US|USA: McGraw Hill, January 2007.

William T. Abraham, Ragavendra R. Baliga. Cardiac Resynchronization Therapy in Heart Failure. Philadelphia, PA, US|USA: Lippincott Williams & Wilkins, January 2010.

 

Certifications

1987 - present Diplomate: National Board of Medical Examiners
1988 - present Medical Licensure: Colorado Medical Board
1989 - present Diplomate: American Board of Internal Medicine
1997 - present Medical Licensure: Ohio State Medical Association
1998 - present Medical Licensure: Kentucky Board of Medical Licensure
2010 - present Diplomate: American Board of Internal Medicine
1995 - 2005 Diplomate: American Board of Internal Medicine
2005 - 2015 Diplomate: American Board of Internal Medicine
 

Chapters in Books

Abraham WT. "Eosinophilic pneumonia." In University of Colorado Health Sciences Center Department of Medicine Syllabus. Edited by Schrier RW. 211-214. Denver, CO: University Press, January 1988.

Schrier RW, Abraham WT, Hensen J. "Disorders of sodium and water metabolism." In Proceedings of The International Workshop on Renal Diseases. -. Beijing, CN|CHN: The International Workshop on Renal Diseases, January 1988.

Abraham WT. "Hepatorenal syndrome: a need for a novel treatment." In University of Colorado Health Sciences Center Department of Medicine Syllabus. Edited by Schrier RW. 1-4. Denver, CO: University Press, January 1989.

Schrier RW, Abraham WT, Hensen J. "Strategies in the management of acute renal failure in the intensive therapy unit." In Acute Renal Failure in the Intensive Therapy Unit. Edited by Bihari D, Neild G. 193-214. London: Springer-Verlag, January 1990.

Abraham WT. "Valvular heart disease." In University of Colorado Health Sciences Center Department of Medicine Casebook. 82-90. Denver, CO: University Press, January 1991.

Abraham WT, Schrier RW. "Body fluid volume regulation in heart disease, cirrhosis, and pregnancy." In Proceedings of the Fifth Asian Pacific Congress of Nephrology. -. New Delhi, IN|IND: the Fifth Asian Pacific Congress of Nephrology, January 1992.

Abraham WT, Schrier RW. "Use of furosemide in the treatment of congestive heart failure." In Aspects of Diuretic Therapy with Furosemide: An Update. International Clinical Practice Series. 23-33. Kent, OH: Wells Medical Ltd., January 1993.

Abraham WT, Schrier RW. "Body fluid volume regulation in health and disease." In Advances in Internal Medicine. Vol. 39. Edited by Schrier RW, Abboud FM, Baxter JD, Fauci AS. 23-47. Chicago, IL: Mosby Year Book, January 1994.

Lowes BD, Abraham WT, Bristow MR. "Role of beta blockers in the treatment of heart failure." In Heart Disease: A Texbook of Cardiovascular Medicine - Update Summer 1994. Edited by Braunwald E. 1-10. Philadelphia: W.B. Saunders Company, January 1994.

Abraham WT, Schrier RW. "Renal function in congestive heart failure." In National Kidney Foundation Nephrology Primer. Edited by Cheung AK, Coffman TM, Falk RJ, Greenberg A, Jennette JC. 213-217. San Diego, CA: Academic Press, Inc., January 1994.

Abraham WT, Schrier RW. "Renal salt and water handling in congestive heart failure." In Congestive Heart Failure: Pathophysiology, Diagnosis, and Comprehensive Approach to Management. Edited by Hosenpud JD, Greenberg BH. 161-173. New York, NY: Springer-Verlag, January 1994.

Abraham WT. "Specific patient problems in cardiology: valvular heart disease." In The Intenal Medicine Casebook: Real Patients, Real Answers. Edited by Schrier RW. 47-54. Boston, MA: Little, Brown & Company, January 1994.

Abraham WT, Schrier RW. "Cardiac failure, liver disease, and the nephrotic syndrome." In Diseases of the Kidney. 6th ed. Edited by Schrier RW, Gottschalk CW. 2353-2392. Boston, MA: Little, Brown & Company, January 1996.

Abraham WT, Port JD, Bristow MR. "Neurohormonal receptors in the failing heart." In Heart Failure. Edited by Poole-Wilson PA, Chatterjee K, Coats AJS, Colucci WS, Massie. 127-141. New York, NY: Churchill Livingstone, January 1997.

Cohn JN, Abraham WT, Colucci WS, Fowler MB, Francis GS, Leier CV, Massie BM, Packer M. "A New Era In Heart Failure: Translating Mechanism Into Management." In A Highlights Bulletin. 1-16. Springfield: Scientific Therapeutics Information, Inc, January 1997.

Abraham WT, Schrier RW. "Renal sodium excretion, edematous disorders, and diuretic use." In Renal and Electrolyte Disorders. 5th ed. Edited by Schrier RW. 72-129. Boston, MA: Little, Brown & Company, January 1997.

Abraham WT, Colucci WS. "The Learning Partnership and On-Site Insights Subcommittees of the Advisory Council to Improve Outcomes Nationwide in Heart Failure." In Optimal Management of Heart Failure: A CME Study Guide. 1-50. Greenwich: Cliggott Communications, January 1998.

Abraham WT, Schrier RW. "Renal function in congestive heart failure." In National Kidney Foundation Nephrology Primer. 2nd ed. Edited by Greenberg A, Cheung AK, Coffman TM, Falk RJ, Jennette JC. 183-187. San Diego, CA: Academic Press, Inc, January 1998.

Abraham WT. "Impact of heart failure and ventricular conduction abnormalities." In Cardiac Resynchronization for Heart Failure: The Role of Biventricular Pacing. Edited by Abraham WT, Hayes DL. 3-5. New York, NY: Accel Healthcare Communications, January 1999.

Abraham WT. "The MIRACLE Study: The InSync clinical trial program." In Cardiac Resynchronization for Heart Failure: The Role of Biventricular Pacing. 24-27. New York, NY: Accel Healthcare Communications, January 1999.

Abraham WT, Mehra M, Piepho RW, Solomon SD. "Controversies in Care." In Treatment of the Post MI Patient. 1-36. Waltham: ICPRx, January 1999.

Abraham WT, Basile J. "Chapter 1." In The role of the primary care physician in the management of heart failure. 1-13. New York: Accel Healthcare Communications, January 1999.

Abraham WT, Schrier RW. "Extracellular fluid volume homeostasis." In The Liver and the Kidney. Edited by Arroyo V, Rodés J, Ginès P, Schrier RW. 129-142. Boston, MA: Blackwell Science, January 1999.

Stevenson LW, Abraham WT, Colucci WS, Cody RJ, Silver MA, Massie M. "Management of Decompensated Heart Failure." In New Options, New Goals. 1-12. South Plainfield: Catalyst Communications, Inc., January 1999.

Abraham WT, Schrier RW. "Renal salt and water handling in congestive heart failure." In Congestive Heart Failure: Pathophysiology, Diagnosis, and Comprehensive Approach to Management. 2nd ed. Edited by Hosenpud JD, Greenberg BH. 253-266. Philadelphia: Lippincott Williams & Wilkins, January 2000.

Abraham WT. "Heart failure as a progressive disease: current perspectives." In Improving Outcomes in Heart Failure: From Theory to Practice. Edited by Abraham WT, Dalton RP, Hansen K, Karunarante HB, Milunski MR, Nocero MA, Young WD. 6-. New York, NY: Accel Healthcare Communications, January 2000.

Abraham WT. "Consensus recommendations for the management of chronic heart failure: putting them into practice." In Improving Outcomes in Heart Failure: From Theory to Practice. Edited by Abraham WT, Dalton RP, Hansen K, Karunarante HB, Milunski MR, Nocero MA, Young WD. 7-12. New York, NY: Accel Healthcare Communications, January 2000.

Packer M, Abraham WT. "Chapter 1." In Treatment and cost-effective management of congestive heart failure within managed care organizations. 1-12. Totowa, NJ: Emron, January 2001.

Baas LS, Trupp RJ, Abraham WT. "Supportive resources for the patient with heart failure." In Improving Outcomes in Heart Failure: An Interdisciplinary Approach. Edited by Moser DK, Riegel B. 201-218. Gaithersburg, MD: Aspen Publishers, Inc, January 2001.

Abraham WT, Cadnapaphornchai MA, Schrier RW. "Cardiac failure, liver disease, and the nephrotic syndrome." In Diseases of the Kidney. 7th ed. Edited by Schrier RW, Gottschalk CW. -. Boston, MA: Little, Brown & Company (in press), January 2001.

Greenberg BH, Abraham WT. "An expanding role for beta-blockers in heart failure." In results of the COPERNICUS study. 1-8. Montreal, CA|CAN: Snell Medical Communications, Inc, January 2001.

Abraham WT. "Anti-adrenergic therapy in hypertensive patients with concomitant disease." In Prevention of Disease Progression Throughout the Cardiovascular Continuum. Edited by Ryden L. 16-28. Heidelberg, DE|DEU: Springer-Verlag, January 2001.

Lamba S, Abraham WT, Lowes BD, Lindenfeld J. "Chapter 37: Heart Transplantation." In Cardiology Secrets. 2nd ed. Edited by Adair OV. 192-196. Philadelphia: Hanley & Belfus, January 2001.

Trupp RJ, Abraham WT. "Congestive heart failure." In Conn’s Current Therapy 2002. Edited by Rakel RE, Bope ET. 306-313. Philadelphia: W.B. Saunders Company, January 2002.

Abraham WT. "Value of biventricular pacing in advanced heart failure." In Cardiology Exploration: Management and Treatment Strategies in Late-Stage Heart Failure (Monograph Series). 4-16. New York, NY: Wishbone, January 2002.

Abraham WT. "The era of devices? Biventricular pacing and ICDs." In Heart Failure Therapy Annual 2003. Edited by Pfeffer MA, McMurray J. -. London: Martin Dunitz Ltd, January 2003.

Singh BK, Abraham WT. "Angiotensin converting enzyme inhibitors and oxidative stress." In Oxidative Stress and Cardiac Failure. Edited by Kukin ML, Fuster V. 183-196. Armonk, NY: Futura Publishing, January 2003.

Abraham WT. "Best practices for post-myocardial infarction with left ventricular dysfunction." In update on treatment options. 1-4. Hampton, NH: Millennium Medical Communications, Inc, January 2004.

Abraham WT. "Acute Decompensated Heart Failure National Registry (ADHERE)." In Management of the Cardiorenal Syndrome. 1-8. New York, NY: McMahon Publishing Group, January 2004.

Abraham WT. "New approaches in the prevention of heart failure." In Textbook of Cardiovascular Medicine – Update Series. Edited by E Topol. 8:1-12. Philadelphia: Lippincott Williams & Wilkins, January 2005.

Abraham WT. "Chapter 18: Cardiac Resynchronization Therapy." In Heart Failure: A Comprehensive Guide to Diagnosis and Treatment. Edited by GW Dec, TG DiSalvo, RJ Hajjar, M Semigran. 381-394. New York, NY: Marcel Dekker, January 2005.

Iyengar S, Abraham WT. "Neutral endopeptidase inhibitors and endothelin antagonists: why did the clinical trials not demonstrate beneficial effects?." In Heart Failure Clinics. Edited by Fonarow GC, Narula J, Young JB. 95-102. Philadelphia: W.B. Saunders Company, January 2005.

Poole BD, Abraham WT, Schrier RW. "Extracellular fluid volume homeostasis." In Ascites & Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Edited by Ginès P, Arroyo V, Rodés J, Schrier RW. 3-14. Malden, MA: Blackwell Publishing Ltd, January 2005.

Haas GJ, Abraham WT. "Comprehensive pharmacologic management strategies for heart failure." In Cardiac Resynchronization Therapy. Edited by Yu CM, Hayes DL, Auricchio A. 13-31. Oxford: Blackwell Publishing, January 2006.

Hayes DL, Abraham WT. "Clinical trials: an overview." In Cardiac Resynchronization Therapy. Edited by Yu CM, Hayes DL, Auricchio A. 239-256. Oxford: Blackwell Publishing, January 2006.

Abraham WT. "Biventricular pacing in congestive heart failure." In Congestive Heart Failure. 3rd ed. Edited by Hosenpud JD, Greenberg BH. 647-654. Philadelphia: Lippincott Williams & Wilkins, January 2007.

Abraham WT. "Implantable devices for the management of heart failure." In Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease. 3rd ed. Edited by Antman EM, Givertz MM, Josephson ME, de Lemos J, Oparil S, Sacks FM. 363-372. Philadelphia: Saunders Elsevier, January 2007.

Sugumaran RK, Haas GJ, Abraham WT. "Summary of all large randomized trials." In Cardiac Resynchronization Therapy. Edited by St. John Sutton M, Bax JJ, Jessup M, Brugada J, Schalij M. 43-54. London: Informa Healthcare, January 2007.

Abraham WT, Hasan A, Poole-Wilson P. "Diagnosis and management of heart failure." In Hurst’s The Heart. 12th ed. Edited by Fuster V, O’Rourke RA, Walsh RA, Poole-Wilson P. 724-760. New York, NY: McGraw Hill, January 2008.

Hayes DL, Abraham WT. "Clinical trials supporting current indications for CRT." In Cardiac Resynchronization Therapy. 2nd ed. Edited by Yu CM, Hayes DL, Auricchio A. 261-276. Oxford: Blackwell Publishing, January 2008.

Haas GJ, Abraham WT. "Comprehensive pharmacologic management strategies for heart failure." In Cardiac Resynchronization Therapy. 2nd ed. Edited by Yu CM, Hayes DL, Auricchio A. 15-34. Oxford: Blackwell Publishing, January 2008.

 

Conferences

Abraham WT. "Neurohormonal activation in heart failure: pathophysiological and therapeutic implications." Proceedings of the 17th Annual Veterinary Medical Forum. (January 1999). .

Abraham WT. "Cardiac resynchronization for heart failure." Proceedings of the 17th Annual Veterinary Medical Forum. (January 1999). .

 

Degrees

1982 B.A., University of Pittsburgh

1986 M.D., Harvard Medical School

 

Edited Books

"Heart Failure in Our Community: A Call for Improved Standards of Care." Edited by Abraham WT (ed.). Greenwich: Cliggott Communications, January 1998.

"Heart Failure: A Practical Approach to Therapy." Edited by Abraham WT, Krum H, eds.. New York, NY, US|USA: McGraw-Hill, January 2007.

 

Editorial Activities

present European Heart Journal
present Congestive Heart Failure
present Expert Review of Cardiovasular Therapy
present Current Heart Failure Reports
present Current Cardiology Reviews
present The American Heart Hospital Journal
present The Journal of Heart Failure
present PACE - Pacing and Clinical Electrophysiology
present Journal Watch Cardiology
 

Honors

1978 - 1982 University Honors Scholarship. University of Pittsburgh.
1979 Phi Eta Sigma Freshman Honor Society. University of Pittsburgh.
1980 Order of Omega. University of Pittsburgh.
1980 Druids Sophomore/Junior Honor Society. University of Pittsburgh.
1980 Delta Tau Delta Scholarship Award. University of Pittsburgh.
1980 Alpha Epsilon Delta Honor Society. University of Pittsburgh.
1981 Omicron Delta Kappa Honor Society. University of Pittsburgh.
1981 Nominee, Rhodes Scholarship. University of Pittsburgh.
1982 Speaker, University Honors Convocation. University of Pittsburgh.
1982 Outstanding Young Men of America. University of Pittsburgh.
1982 Class Marshal University of Pittsburgh Commencement Exercises. University of Pittsburgh.
1985 Outstanding Young Men of America. Harvard University Commencement Excercises.
1986 Class Marshal, Commencement Exercises. Class Marshal, Commencement Exercises.
1989 First Place Winner, Research Papers Presentation Competition. Annual Associates Meeting of the Colorado Chapter of the American College of Physicians, Denver, CO.
1989 First Place Winner, Clinical Poster Competition. Annual Associates Meeting of the Colorado Chapter of the American College of Physicians, Denver, CO.
1989 Finalist, National Clinical Poster Competition. 70th Annual Session of the American College of Physicians, San Francisco, CA.
1989 Physician's Recognition Award. American Medical Association, Denver, CO.
1990 Who's Who in Health and Medical Services.
1992 - 1993 Outstanding Research Fellow. Division of Cardiology.
1992 - 1993 Merck Fellow of the American College of Cardiology.
1993 American College of Cardiology/Bristol Laboratories Affiliate Travel Award Winner.
2000 Nominee, Cincinnati Business Courier's Health Care Heroes Award. Cincinnati Business Courier's Health Care.
2002 Jan J. Kellerman Memorial Award in Cardiovascular Disease Prevention.
2003 - 2004 The Best Doctors in America. Best Doctors.
2004 - 2005 Guide to America's Top Physicians.
2005 Strathmore's Who's Who - Lifetime Membership.
2005 - 2006 The Best Doctors in America. Best Doctors.
2005 - 2006 Guide to America's Top Cardiologists.
2007 WBNS TV-10 (Columbus, OH), Docs Rate Docs, 2007. WBNS TV-10.
2007 Guide to America's Top Cardiologists.
2007 - 2008 The Best Doctors in America. Best Doctors.
2008 The Guide to America's Top Cardiologists.
2009 America's Best Doctors. U.S. News & World Report.
2009 - 2010 The Best Doctors in America. Best Doctors.
2011 - 2012 The Best Doctors in America. Best Doctors.
 

Journal Articles

Abraham, WT, Schrier RW. "The hepatorenal syndrome: altered diuretic responsiveness with increased effective arterial blood volume." Cardiovasc Rev & Rep. Vol. 9, (January 1988.): 63-65.

Abraham,W,T; Hensen,J; Schrier,R,W. "ELEVATED PLASMA NORADRENALINE CONCENTRATIONS IN PATIENTS WITH LOW-OUTPUT CARDIAC-FAILURE - DEPENDENCE ON INCREASED NORADRENALINE SECRETION RATES." CLINICAL SCIENCE. Vol. 79, no. 5. (November 1990.): 429-435.

Hensen,J; Abraham,W,T; Durr,J,A; Schrier,R,W. "ALDOSTERONE IN CONGESTIVE-HEART-FAILURE - ANALYSIS OF DETERMINANTS AND ROLE IN SODIUM RETENTION." American Journal Of Nephrology. Vol. 11, no. 6. (November 1991.): 441-446.

Rahman SN, Abraham WT, Schrier RW. "Peripheral arterial vasodilation hypothesis in cirrhosis." Gastroenterology Int. no. 5. (January 1992.): 192-195.

Hensen,J; Abraham,W,T; Lesnefsky,E,J; Levenson,B; Groves,B,M; Schroder,K; Schrier,R,W; Durr,J. "ATRIAL-NATRIURETIC-PEPTIDE KINETIC-STUDIES IN PATIENTS WITH CARDIAC DYSFUNCTION." Kidney International. Vol. 41, no. 5. (May 1992.): 1333-1339.

Abraham,W,T; Hensen,J; Kim,J,K; Durr,J; Lesnefsky,E,J; Groves,B,M; Schrier,R,W. "ATRIAL-NATRIURETIC-PEPTIDE AND URINARY CYCLIC GUANOSINE-MONOPHOSPHATE IN PATIENTS WITH CHRONIC HEART-FAILURE." JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. Vol. 2, no. 12. (June 1992.): 1697-.

Rahman,S,N; Abraham,W,T; VANPUTTEN,V,J; Hasbargen,J,A; Schrier,R,W. "INCREASED NOREPINEPHRINE SECRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME AND NORMAL GLOMERULAR-FILTRATION RATES - EVIDENCE FOR PRIMARY SYMPATHETIC ACTIVATION." American Journal Of Nephrology. Vol. 13, no. 4. (July 1993.): 266-270.

Abraham,W,T; Schrier,R,W. "Edematous disorders: pathophysiology of renal sodium and water retention and treatment with diuretics.." Current Opinion In Nephrology And Hypertension. Vol. 2, no. 5. (September 1993.): 798-805.

Abraham WT, Schrier RW. "Pathogenesis of sodium and water retention in congestive heart failure: therapeutic implications." Am J Geriatric Cardiol. no. 2. (January 1993.): 11-13.

Raynolds,M,V; Bristow,M,R; Bush,E,W; Abraham,W,T; Lowes,B,D; Zisman,L,S; Taft,C,S; PERRYMAN,M,B. "ANGIOTENSIN-CONVERTING ENZYME-DD GENOTYPE IN PATIENTS WITH ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY." Lancet. Vol. 342, no. 8879. (October 1993.): 1073-1075.

Abraham,W,T; Schrier,R,W. "BODY-FLUID VOLUME REGULATION IN HEALTH AND DISEASE." ADVANCES IN INTERNAL MEDICINE, VOL 39. Vol. 39, (January 1994.): 23-47.

Abraham,W,T. "NEW NEUROHORMONAL ANTAGONISTS AND ATRIAL-NATRIURETIC-PEPTIDE IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE." Coronary Artery Disease. Vol. 5, no. 2. (February 1994.): 127-136.

Abraham WT; Lowes BD; White M; Ferguson DA; Scheffel CA; Wolfel EE; Lindenfeld J; Bristow MR. "Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.." Journal Of Cardiac Failure. Vol. 1, no. 1. (October 1994.): 57-.

Abraham,W,T; Lowes,B,D; White,M; Ferguson,D,A; Scheffel,C,A; Wolfel,E,E; Lindenfeld,J; Bristow,M,R. "Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.." Journal of cardiac failure. Vol. 1, no. 1. (October 1994.): 57-62.

Gines,P; Abraham,W,T; Schrier,R,W. "VASOPRESSIN IN PATHOPHYSIOLOGICAL STATES." Seminars In Nephrology. Vol. 14, no. 4. (July 1994.): 384-397.

Zisman,L,S; Abraham,W,T; Meixell,G,E; VAMVAKIAS,B,N; Quaife,R,A; Lowes,B,D; Roden,R,L; Peacock,S,J; Groves,B,M; Raynolds,M,V; Bristow,M,R; PERRYMAN,M,B. "ANGIOTENSIN-II FORMATION IN THE INTACT HUMAN HEART - PREDOMINANCE OF THE ANGIOTENSIN-CONVERTING ENZYME PATHWAY." JOURNAL OF CLINICAL INVESTIGATION. Vol. 96, no. 3. (September 1995.): 1490-1498.

Abraham,W,T; LAUWAARS,M,E; Kim,J,K; PENA,R,L; Schrier,R,W. "REVERSAL OF ATRIAL-NATRIURETIC-PEPTIDE RESISTANCE BY INCREASING DISTAL TUBULAR SODIUM DELIVERY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS." HEPATOLOGY. Vol. 22, no. 3. (September 1995.): 737-743.

Bristow,M,R; Abraham,W,T. "Anti-adrenergic effects of angiotensin converting enzyme inhibitors." European Heart Journal. Vol. 16, (November 1995.): 37-41.

White,M; Yanowitz,F; Gilbert,E,M; Larrabee,P; OCONNELL,J,B; Anderson,J,L; Renlund,D; MEALEY,P; Abraham,W,T; Bristow,M,R. "ROLE OF BETA-ADRENERGIC-RECEPTOR DOWN-REGULATION IN THE PEAK EXERCISE RESPONSE IN PATIENTS WITH HEART-FAILURE DUE TO IDIOPATHIC DILATED CARDIOMYOPATHY." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 76, no. 17. (December 1995.): 1271-1276.

Abraham WT; Raynolds MV; Gottschall B; Badesch DB; Wynne KM; Groves BM; Lowes BD; Bristow MR; Perryman MB; Voelkel NF. "Importance of angiotensin-converting enzyme in pulmonary hypertension.." Cardiology. Vol. 86 Suppl 1, (January 1995.): 9-.

White,M; Wiechmann,R,J; Roden,R,L; Hagan,M,B; WOLLMERING,M,M; Port,J,D; Hammond,E; Abraham,W,T; Wolfel,E,E; Lindenfeld,J; Fullerton,D; Bristow,M,R. "CARDIAC BETA-ADRENERGIC NEUROEFFECTOR SYSTEMS IN ACUTE MYOCARDIAL DYSFUNCTION RELATED TO BRAIN INJURY - EVIDENCE FOR CATECHOLAMINE-MEDIATED MYOCARDIAL DAMAGE." Circulation. Vol. 92, no. 8. (October 1995.): 2183-2189.

Abraham WT, Guest Editor. "Natriuretic peptides in heart failure." Heart Failure. no. 12. (January 1996.): 34-36.

Abraham WT. "Physiology and therapeutic implications of natriuretic peptides in chronic heart failure." Heart Failure. no. 12. (January 1996.): 55-72.

Bristow,M,R; Gilbert,E,M; Abraham,W,T; Adams,K,F; Fowler,M,B; Hershberger,R,E; Kubo,S,H; Narahara,K,A; INGERSOLL,H; Krueger,S; Young,S; Shusterman,N. "Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure." Circulation. Vol. 94, no. 11. (December 1996.): 2807-.

Gilbert,E,M; Abraham,W,T; Olsen,S; Hattler,B; White,M; Mealy,P; Larrabee,P; Bristow,M,R. "Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart." Circulation. Vol. 94, no. 11. (December 1996.): 2817-2825.

Bristow MR; Abraham WT; Yoshikawa T; White M; Hattler BG; Crisman TS; Lowes BD; Robertson AD; Larrabee P; Gilbert EM. "Second- and third-generation beta-blocking drugs in chronic heart failure.." Cardiovascular Drugs And Therapy / Sponsored By The International Society Of Cardiovascular Pharmacotherapy. Vol. 11 Suppl 1, (May 1997.): 291-.

Abraham WT; Bristow MR. "Specialized centers for heart failure management.." Circulation. Vol. 96, no. 9. (November 1997.): 2755-.

Lowes,B,D; Minobe,W; Abraham,W,T; Rizeq,M,N; BOHLMEYER,T,J; Quaife,R,A; Roden,R,L; Dutcher,D,L; Robertson,A,D; Voelkel,N,F; Badesch,D,B; Groves,B,M; Gilbert,E,M; Bristow,M,R. "Changes in gene expression in the intact human heart - Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium." JOURNAL OF CLINICAL INVESTIGATION. Vol. 100, no. 9. (November 1997.): 2315-2324.

Bristow,M,R; Gilbert,E,M; Abraham,W,T; Robertson,A,D. "Carvedilol and dose-related improvements in left ventricular function - Response." CIRCULATION. Vol. 96, no. 8. (October 1997.): 2743-2744.

Asano,K; Dutcher,D,L; Port,J,D; Minobe,W,A; Tremmel,K,D; Roden,R,L; BOHLMEYER,T,J; Bush,E,W; JENKIN,M,J; Abraham,W,T; Raynolds,M,V; Zisman,L,S; PERRYMAN,M,B; Bristow,M,R. "Selective downregulation of the angiotensin II AT(1)-receptor subtype in failing human ventricular myocardium." Circulation. Vol. 95, no. 5. (March 1997.): 1193-1200.

Chapman,A,B; Zamudio,S; Woodmansee,W; Merouani,A; Osorio,F; Johnson,A; Moore,L,G; Dahms,T; Coffin,C; Abraham,W,T; Schrier,R,W. "Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy." AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. Vol. 273, no. 5. (November 1997.): F777-F782.

Gerdes,A,M; Onodera,T; Tamura,T; Said,S; BOHLMEYER,T,J; Abraham,W,T; Bristow,M,R. "New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material.." Journal Of Cardiac Failure. Vol. 4, no. 4. (December 1998.): 343-348.

Havranek EP, Abraham WT. "The healthcare economics heart failure." Heart Failure. no. 14. (January 1998.): 10-18.

Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F, DeMets DL,, White BG, for the Vesnarinone Trial Investigators. "A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure." New England Journal of Medicine. no. 4. (January 1998.): 343-348.

Bristow MR; Zisman LS; Lowes BD; Abraham WT; Badesch DB; Groves BM; Voelkel NF; Lynch DM; Quaife RA. "The pressure-overloaded right ventricle in pulmonary hypertension.." Chest. Vol. 114, no. 1 Suppl. (July 1998.): 101S-.

Boland DG, Abraham WT. "Natriuretic peptides in heart failure." CHF. no. 4. (January 1998.): 23-33.

Abraham,W,T; Lowes,B,D; Ferguson,D,A; Odom,J; Kim,J,K; Robertson,A,D; Bristow,M,R; Schrier,R,W. "Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.." Journal Of Cardiac Failure. Vol. 4, no. 1. (March 1998.): 37-44.

Shakar,S,F; Abraham,W,T; Gilbert,E,M; Robertson,A,D; Lowes,B,D; Zisman,L,S; Ferguson,D,A; Bristow,M,R. "Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure." Journal Of The American College Of Cardiology. Vol. 31, no. 6. (May 1998.): 1336-1340.

Abraham WT. "Systolic versus diastolic heart failure: therapeutic considerations." Cardiovasc Rev & Rep. no. 19. (January 1998.): 59-68.

Abraham WT. "Pharmacologic management of chronic heart failure: a review." Sem Cardiothoracic Vascular Anesthes. no. 2. (January 1998.): 168-190.

Abraham WT. "Management of systolic heart failure: application of clinical guidelines." Cardiology Rev. no. 15(suppl.). (January 1998.): 11-13.

Chapman AB; Abraham WT; Zamudio S; Coffin C; Merouani A; Young D; Johnson A; Osorio F; Goldberg C; Moore LG; Dahms T; Schrier RW. "Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.." Kidney International. Vol. 54, no. 6. (December 1998.): 2056-.

Abraham WT. "Preceptorships: a practical approach to education in heart failure.." Journal Of Cardiac Failure. Vol. 5, no. 3. (September 1999.): 265-.

Schrier,R,W; Abraham,W,T. "Hormones and hemodynamics in heart failure.." New England journal of medicine. Vol. 341, no. 8. (August 1999.): 577-585.

Abraham WT. "Looking to the future: new possibilities in the management of heart failure." Heart Failure Forum. no. 1. (January 1999.): 10-.

Abraham,W,T. "Preceptorships: a practical approach to education in heart failure.." Journal of cardiac failure. Vol. 5, no. 3. (September 1999.): 265-268.

Martin,P,Y; Abraham,W,T; Xu,L,M; Olson,B,R; Oren,R,M; Ohara,M; Schrier,R,W. "Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure." JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. Vol. 10, no. 10. (October 1999.): 2165-2170.

Lowes,B,D; Gill,E,A; Abraham,W,T; Larrain,J,R; Robertson,A,D; Bristow,M,R; Gilbert,E,M. "Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 83, no. 8. (April 1999.): 1201-1205.

Havranek,E,P; McGovern,K,M; Weinberger,J; Brocato,A; Lowes,B,D; Abraham,W,T. "Patient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure." Journal Of Cardiac Failure. Vol. 5, no. 2. (June 1999.): 85-91.

Packer M, Cohn JN, on behalf of the Steering Committee (Packer M, Cohn JN, Abraham WT, Colucci WS, Fowler MB, Greenberg BH, Leier CV, Massie BM, Young JB) and Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure. "Consensus recommendations for the management of heart failure." Am J Cardiol. no. 83(suppl.2A). (January 1999.): 1A-38A.

Trupp RJ, Abraham WT. "Considerations in managing advanced heart failure." Cardiology Rev. no. 16. (January 1999.): 17-18.

Mills RM, LeJemtel TH, Horton DP, Liang C-s, Lang R, Silver MA, Lui C, Chatterjee K, on behalf of the Natecor Study Group. "Sustained hemodynamic effects of an infusion of nesiritide (human B-type natriuretic peptide) in heart failure: a randomized double-blind, blacebo-controlled trial." J Am Coll Cardiol. no. 34. (January 1999.): 155-162.

Lamba S, Abraham WT. "Congestive heart failure in the elderly." Cardiovasc Rev & Rep. no. 20. (January 1999.): 656-660.

Abraham WT, Cleland JGF, Guest Eds. "Neurohormonal Antagonism in Heart Failure: Clinical Implications for Ischemic Versus Nonischemic Disease." J Cardiovasc Pharmacol. no. 33(Suppl.1). (January 1999.): S1-S41.

Abraham WT. "Heart failure: confronting the challenge." Heart Failure Forum. no. 1. (January 1999.): 3-4.

Abraham WT; Singh B. "Ischemic and nonischemic heart failure do not require different treatment strategies.." Journal Of Cardiovascular Pharmacology. Vol. 33 Suppl 3, (June 1999.): S1-.

Wagoner LE, Abraham WT. "The use of brain or B-type natriuretic peptide (Nesiritide or Natrecor) for the treatment of congestive heart failure." Today’s Therapeutic Trends. no. 17. (January 1999.): 113-131.

Cohn JN, Abraham WT, Levine TB, Piña IL, Silver M. "Heart failure: impact and evolving concepts." Cur Issues Heart Failure. no. 1(1). (January 1999.): 1-7.

Abraham WT. "Optimal care strategies for heart failure: patients with ischemia." Published on the World Wide Web at Medscape.com. (December 1999.): -.

Schrier,R,W; Abraham,W,T. "Mechanisms of disease - Hormones and hemodynamics in heart failure." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 341, no. 8. (August 1999.): 577-585.

Colucci,W,S; Elkayam,U; Horton,D,P; Abraham,W,T; Bourge,R,C; Johnson,A,D; Wagoner,L,E; Givertz,M,M; Liang,C,S; Neibaur,M; Haught,W,H; LeJemtel,T,H. "Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.." New England journal of medicine. Vol. 343, no. 4. (July 2000.): 246-253.

Cohn JN, Abraham WT, Levine TB, Piña IL, Silver M. "Clinical trials in heart failure, part 2: classes of drugs used in selected heart failure patients and investigational drugs and classes of drugs." Cur Issues Heart Failure. no. 1(2). (January 2000.): 1-8.

Vadlamani L; Abraham WT. "Insights into pathogenesis and treatment of cytokines in cardiomyopathy.." Current Cardiology Reports. Vol. 2, no. 2. (March 2000.): 120-.

Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH. "Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.." The New England Journal Of Medicine. Vol. 343, no. 4. (July 2000.): 246-.

Suresh DP; Lamba S; Abraham WT. "New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.." Journal Of Cardiac Failure. Vol. 6, no. 4. (December 2000.): 359-.

Vadlamani,L; Abraham,W,T. "Insights into pathogenesis and treatment of cytokines in cardiomyopathy.." Current cardiology reports. Vol. 2, no. 2. (March 2000.): 120-128.

Takeishi,Y; Jalili,T; Hoit,B,D; Kirkpatrick,D,L; Wagoner,L,E; Abraham,W,T; Walsh,R,A. "Alterations in Ca2+ cycling proteins and Gag signaling after left ventricular assist device support in failing human hearts." Cardiovascular Research. Vol. 45, no. 4. (March 2000.): 883-888.

Franciosa,J,A; Abraham,W,T; Fowler,M; Gilbert,E,M; Greenberg,B; Massie,B,M; Chen,T; Lukas,M,A; Nelson,J,J. "Rationale, design, and methods for a Coreg (Carvedilol) heart failure registry (COHERE)." Journal Of Cardiac Failure. Vol. 6, no. 3. (September 2000.): 264-271.

Lamba,S; Abraham,W,T. "Alterations in adrenergic receptor signaling in heart failure.." Heart Failure Reviews. Vol. 5, no. 1. (March 2000.): 7-16.

Wagoner,L,E; Craft,L,L; Singh,B; Suresh,D,P; Zengel,P,W; McGuire,N; Abraham,W,T; Chenier,T,C; Dorn,G,W; Liggett,S,B. "Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure." Circulation research. Vol. 86, no. 8. (April 2000.): 834-840.

Abraham,W,T. "beta-Blockers - The new standard of therapy for mild heart failure." Archives of internal medicine. Vol. 160, no. 9. (May 2000.): 1237-1247.

Suresh,D,P; Lamba,S; Abraham,W,T. "New developments in heart failure: Role of endothelin and the use of endothelin receptor antagonists." Journal of cardiac failure. Vol. 6, no. 4. (December 2000.): 359-368.

Abraham,W,T. "Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE)." Journal of cardiac failure. Vol. 6, no. 4. (December 2000.): 369-380.

Abraham WT. "Beta-blockers: the new standard of therapy for mild heart failure.." Archives Of Internal Medicine. Vol. 160, no. 9. (May 2000.): 1237-.

Abraham WT. "Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).." Journal Of Cardiac Failure. Vol. 6, no. 4. (December 2000.): 369-.

Abraham WT. "The cardiovascular disease continuum and the role of adrenergic blockade." Cardiology Rev. no. 17. (January 2000.): 4-9.

Abraham WT. "Consensus recommendations for the management of chronic heart failure: a review of the guidelines for pharmacologic therapy." Servier Cardiovasc Lit Ser (in press). (January 2000.): -.

Abraham WT. "Antithrombotic therapy in heart failure: controversies and recent developments." Cur Issues Heart Failure. no. 5. (January 2000.): 7-16.

Vadlamani L, Abraham WT. "Cytokines and cardiomyopathy: insights into pathogenesis and treatment." Cur Cardiol Rep. no. 2. (January 2000.): 120-128.

Wagoner LE; Craft LL; Singh B; Suresh DP; Zengel PW; McGuire N; Abraham WT; Chenier TC; Dorn GW 2nd; Liggett SB. "Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure.." Circulation Research. Vol. 86, no. 8. (April 2000.): 834-.

Schrier RW; Abdallah JG; Weinberger HH; Abraham WT. "Therapy of heart failure.." Kidney International. Vol. 57, no. 4. (April 2000.): 1418-.

Colucci,W,S; Elkayam,U; Horton,D,P; Abraham,W,T; Bourge,R,C; Johnson,A,D; Wagoner,L,E; Givertz,M,M; Liang,C,S; Neibaur,M; Haught,W,H. "Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 343, no. 4. (July 2000.): 246-253.

Kosowsky J, Abraham WT, Storrow A. "Evaluation and management of patients with acutely decompensated chronic heart failure in the emergency department." CHF. no. 7. (January 2001.): 124-136.

Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL, for the Carvedilol Prospective Randomized Cumulative Survival Study Group. "Effect of carvedilol on survival in severe chronic heart failure." New England Journal of Medicine. no. 344. (January 2001.): 1651-1658.

Shah,M; Ali,V; Lamba,S; Abraham,W,T. "Pathophysiology and clinical spectrum of acute congestive heart failure.." Reviews In Cardiovascular Medicine. Vol. 2, (January 2001.): S2-6.

Dash,R; Kadambi,V,J; Schmidt,A,G; Tepe,N,M; Biniakiewicz,D; Gerst,M,J; Canning,A,M; Abraham,W,T; Hoit,B,D; Liggett,S,B; Lorenz,J,N; Dorn,G,W; Kranias,E,G. "Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality." Circulation. Vol. 103, no. 6. (February 2001.): 889-896.

Schleman,K,A; Lindenfeld,J,A; Lowes,B,D; Bristow,M,R; Ferguson,D; Wolfel,E,E; Abraham,W,T; Zisman,L,S. "Predicting response to carvedilol for the treatment of heart failure: A multivariate retrospective analysis." Journal Of Cardiac Failure. Vol. 7, no. 1. (March 2001.): 4-12.

Abraham,W,T; Wagoner,L,E. "Medical management of mild-to-moderate heart failure before the advent of beta blockers.." American journal of medicine. Vol. 110, (May 2001.): 47S-62S.

Shah MR, for the ESCAPE Investigators. "Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: design and rationale." Am Heart J. no. 141. (January 2001.): 528-535.

Abraham WT. "Don’t undervalue contribution from any member of health care team (Letter)." Am Med News. (June 2001.): 23-24.

The Beta-Blocker Evaluation of Survival Investigators. "A Trial of the beta-blocker bucindolol in patients with advanced chronic heart failure." New England Journal of Medicine. no. 344. (January 2001.): 1659-1667.

Gerson,M,C; Craft,L,L; McGuire,N; Suresh,D,P; Abraham,W,T; Wagoner,L,E. "Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine." JOURNAL OF NUCLEAR CARDIOLOGY. Vol. 9, no. 6. (November 2002.): 608-615.

Young,J,B; Abraham,W,T; Stevenson,L,W; Horton,D,P; Elkayam,U; Bourge,R,C. "Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure - A randomized controlled trial." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 287, no. 12. (March 2002.): 1531-1540.

Lowes,B,D; Gilbert,E,M; Abraham,W,T; Minobe,W,A; Larrabee,P; Ferguson,D; Wolfel,E,E; Lindenfeld,J; Tsvetkova,T; Robertson,A,D; Quaife,R,A; Bristow,M,R. "Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 346, no. 18. (May 2002.): 1357-1365.

Singh,J; van Vlijmen,H; Liao,Y,S; Lee,W,C; Cornebise,M; Harris,M; Shu,I,H; Gill,A; Cuervo,J,H; Abraham,W,M; Adams,S,P. "Identification of potent and novel alpha 4 beta 1 antagonists using in silico screening." JOURNAL OF MEDICINAL CHEMISTRY. Vol. 45, no. 14. (July 2002.): 2988-2993.

Abraham,W,T. "Cardiac resynchronization therapy for heart failure: biventricular pacing and beyond." Current Opinion In Cardiology. Vol. 17, no. 4. (July 2002.): 346-.

Abraham,W,T. "Cardiac resynchronization therapy for heart failure - Reply." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 347, no. 22. (November 2002.): 1803-1804.

Abraham WT, Lewis D, Trupp RJ. "Changing algorithms for the management of acutely decompensated congestive heart failure." Previews in Cardiovasc Med. (January 2002.): 1-2.

Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon A, Loh E, Kocovic DZ, Packer M, Clabell AL, Hayes DL, Ellestad M, Messenger J, for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Investigators and Coordinators. "Randomized trial of cardiac resynchronization in heart failure." New England Journal of Medicine. no. 346. (January 2002.): 1845-1853.

Abraham,W,T; Gilbert,E,M; Lowes,B,D; Minobe,W,A; Larrabee,P; Roden,R,L; Dutcher,D; Sederberg,J; Lindenfeld,J,A; Wolfel,E,E; Shakar,S,F; Ferguson,D; Volkman,K; Linseman,J,V; Quaife,R,A; Robertson,A,D; Bristow,M,R. "Coordinate changes in myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype." MOLECULAR MEDICINE. Vol. 8, no. 11. (November 2002.): 750-760.

Abraham,W,T; Fisher,W,G; Smith,A,L; DeLurgio,D,B; Leon,A,R; Loh,E; Kocovic,D,Z; Packer,M; Clavell,A,L; Hayes,D,L; Ellestad,M; Messenger,J; Trupp,R,J; Underwood,J; Pickering,F; Truex,C; McAtee,P. "Cardiac resynchronization in chronic heart failure." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 346, no. 24. (June 2002.): 1845-1853.

Gottlieb,S,S; Abraham,W; Butler,J; Forman,D,E; Loh,E; Massie,B,M; O'Connor,C,M; Rich,M,W; Stevenson,L,W; Young,J; Krumholz,H,M. "The prognostic importance of different definitions of worsening renal function in congestive heart failure." JOURNAL OF CARDIAC FAILURE. Vol. 8, no. 3. (June 2002.): 136-141.

Abraham,William,T; Scarpinato,Len. "Higher expectations for management of heart failure: current recommendations.." journal of the American Board of Family Practice. Vol. 15, no. 1. (January 2002.): 39-49.

Maisel AS; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Clopton P; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA. "Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.." The New England Journal Of Medicine. Vol. 347, no. 3. (July 2002.): 161-.

Trupp RJ, Lewis DA, Taylor D, Warnott K, Abraham WT. "Nesiritide: a protocol for acutely decompensated heart failure patients." Cardiovasc Rev & Rep. no. 23. (January 2002.): 455-457.

Trupp RJ, Abraham WT. "Dilated cardiomyopathy: non-pharmacologic treatment." Cur Treatment Options Cardiovasc Med (in press). (January 2002.): -.

Gottlieb,S,S; Brater,D,C; Thomas,I; Havranek,E; Bourge,R; Goldman,S; Dyer,F; Gomez,M; Bennett,D; Ticho,B; Beckman,E; Abraham,W,T. "BG9719 (CVT-124), an A(1) adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy." Circulation. Vol. 105, no. 11. (March 2002.): 1348-1353.

McCullough,P,A; Nowak,R,M; McCord,J; Hollander,J,E; Herrmann,H,C; Steg,P,G; Due,P; Westheim,A; Omland,T; Knudsen,C,W; Storrow,A,B; Abraham,W,T; Lamba,S; Wu,A,HB; Perez,A; Clopton,P; Krishnaswamy,P; Kazanegra,R; Maisel,A,S. "B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure - Analysis from breathing not properly (BNP) multinational study." Circulation. Vol. 106, no. 4. (July 2002.): 416-422.

Lewis, Daniel, A; Gurram, Nandkishore, R; Abraham, William, T; Akers, Wendell S. "Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. Vol. 60 Suppl 4, (January 2003.): S16-20.

Abraham,W,T. "Electrophysiological aids in congestive heart failure: supporting and synchronizing systole." MEDICAL CLINICS OF NORTH AMERICA. Vol. 87, no. 2. (March 2003.): 509-?.

Costanzo,M,J; Yabut,S,C; Almond,H,R; Andrade-Gordon,P; Corcoran,T,W; de Garavilla,L; Kauffman,J,A; Abraham,W,M; Recacha,R; Chattopadhyay,D; Maryanoff,B,E. "Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone." JOURNAL OF MEDICINAL CHEMISTRY. Vol. 46, no. 18. (August 2003.): 3865-3876.

Prystowsky EN, Abraham WT, eds. "Cardiac resynchronization and defibrillation therapies: complementary approaches to the management of heart failure." Rev Cardiovasc Med. Vol. 4 (suppl.2), (January 2003.): -.

Fonarow GC; Abraham WT; Cannon CP; Gheorghiade M; Sackner-Bernstein JD; Udelson JE. "Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.." Reviews In Cardiovascular Medicine. Vol. 4 Suppl 3, (January 2003.): S54-.

Maisel AS; McCord J; Nowak RM; Hollander JE; Wu AH; Duc P; Omland T; Storrow AB; Krishnaswamy P; Abraham WT; Clopton P; Steg G; Aumont MC; Westheim A; Knudsen CW; Perez A; Kamin R; Kazanegra R; Herrmann HC; McCullough PA. "Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.." Journal Of The American College Of Cardiology. Vol. 41, no. 11. (June 2003.): 2010-.

Jaski BE; Ha J; Denys BG; Lamba S; Trupp RJ; Abraham WT. "Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.." Journal Of Cardiac Failure. Vol. 9, no. 3. (June 2003.): 227-.

Abraham WT. "Cardiac resynchronization therapy for the management of chronic heart failure.." The American Heart Hospital Journal. Vol. 1, no. 1. (December 2003.): 55-.

Sutton,M,GS; Plappert,T; Abraham,W,T; Smith,A,L; DeLurgio,D,B; Leon,A,R; Loh,E; Kocovic,D,Z; Fisher,W,G; Ellestad,M; Messenger,J; Kruger,K; Hilpisch,K,E; Hill,M,RS. "Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure." Circulation. Vol. 107, no. 15. (April 2003.): 1985-1990.

Young,J,B; Abraham,W,T; Smith,A,L; Leon,A,R; LIEBERMAN,R; Wilkoff,B; Canby,R,C; Schroeder,J,S; Liem,L,B; Hall,S; Wheelan,K. "Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure - The MIRACLE ICD Trial." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 289, no. 20. (May 2003.): 2685-2694.

Abraham,William,T. "Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.." Reviews in cardiovascular medicine. Vol. 4, (January 2003.): S30-6.

Huke,S; Liu,L,H; Biniakiewicz,D; Abraham,W,T; Periasamy,M. "Altered force-frequency response in non-failing hearts with decreased SERCA pump-level." Cardiovascular Research. Vol. 59, no. 3. (September 2003.): 668-677.

Dash,R; Schmidt,A,G; Pathak,A; Gerst,M,J; Biniakiewicz,D; Kadambi,V,J; Hoit,B,D; Abraham,W,T; Kranias,E,G. "Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy." Cardiovascular research. Vol. 57, no. 3. (March 2003.): 704-714.

Abraham,W,T; Hayes,D,L. "Cardiac resynchronization therapy for heart failure." Circulation. Vol. 108, no. 21. (November 2003.): 2596-2603.

Abraham,William,T. "Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient.." Reviews In Cardiovascular Medicine. Vol. 4, (January 2003.): S30-7.

Abraham,William,T. "Cardiac resynchronization therapy for the management of chronic heart failure.." The American heart hospital journal. Vol. 1, no. 1. (January 2003.): 55-61.

Abraham,William,T. "Switching between beta blockers in heart failure patients: rationale and practical considerations.." Congestive Heart Failure (Greenwich, Conn.). Vol. 9, no. 5. (September 2003.): 271-278.

Fonarow,Gregg,C; Abraham,William,T; Cannon,Christopher,P; Gheorghiade,Mihai; Sackner-Bernstein,Jonathan,D; Udelson,James,E. "Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.." Reviews in cardiovascular medicine. Vol. 4, (January 2003.): S54-9.

Trupp,Robin,J; Abraham,William,T. "Nonpharmacologic options for the management of heart failure.." Current Cardiology Reports. Vol. 5, no. 3. (May 2003.): 243-246.

Yancy,Clyde; Abraham,William,T. "Noninvasive hemodynamic monitoring in heart failure: utilization of impedance cardiography.." Congestive Heart Failure (Greenwich, Conn.). Vol. 9, no. 5. (September 2003.): 241-250.

Sutton,M,GSJ; Plappert,T; Abraham,W,T; Smith,A,L; DeLurgio,D,B; Leon,A,R; Loh,E; Kocovic,D,Z; Fisher,W,G; Ellestad,M; Messanger,J; Kruger,K; Hilpisch,K,E; Hill,M,RS. "Cardiac resynchronization therapy - Response." CIRCULATION. Vol. 108, no. 13. (September 2003.): E97-E97.

Fonarow,Gregg,C; Abraham,William,T; Gheorghiade,Mihai; Cannon,Christopher,P; Sackner-Bernstein,Jonathan,D; Udelson,James,E; Konstam,Marvin,A. "Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guideline.." Critical Pathways In Cardiology. Vol. 2, no. 4. (December 2003.): 239-246.

McCullough,Peter,A; Abraham,William,T. "Does quality of life evidence assist in the selection of patients for resynchronization therapy?." Cardiac Electrophysiology Review. Vol. 7, no. 1. (January 2003.): 71-76.

Baas,L,S; Beery,T,A; Allen,G,A; Ware,S; Lamba,S; Abraham,W,T. "Accuracy of the precordial V-quick((R)) patch in persons with cardiac or pulmonary disease." JOURNAL OF EMERGENCY MEDICINE. Vol. 24, no. 2. (February 2003.): 131-139.

McCullough,P,A; Hollander,J,E; Nowak,R,M; Storrow,A,B; Duc,P; Omland,T; McCord,J; Herrmann,H,C; Steg,P,G; Westheim,A; Knudsen,C,W; Abraham,W,T; Lamba,S; Wu,A,HB; Perez,A; Clopton,P; Krishnaswamy,P; Kazanegra,R; Maisel,A,S. "Uncovering heart failure in patients with a history of pulmonary disease: Rationale for the early use of B-type natriuretic peptide in the emergency department." ACADEMIC EMERGENCY MEDICINE. Vol. 10, no. 3. (March 2003.): 198-204.

McCullough,P,A; Duc,P; Omland,T; McCord,J; Nowak,R,M; Hollander,J,E; Herrmann,H,C; Steg,P,G; Westheim,A; Knudsen,C,W; Storrow,A,B; Abraham,W,T; Lamba,S; Wu,A,HB; Perez,A; Clopton,P; Krishnaswamy,P; Kazanegra,R; Maisel,A,S. "B-Type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the Breathing Not Properly Multinational Study." AMERICAN JOURNAL OF KIDNEY DISEASES. Vol. 41, no. 3. (March 2003.): 571-579.

Adamson,P,B; Kleckner,K,J; VanHout,W,L; Srinivasan,S; Abraham,W,T. "Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure." Circulation. Vol. 108, no. 3. (July 2003.): 266-269.

Trupp,Robin,J; Abraham,William,T; Lamba,Sumant. "Future therapies for heart failure.." Critical care nursing clinics of North America. Vol. 15, no. 4. (December 2003.): 525-?.

Reinlib,L; Abraham,W. "Recovery from heart failure with circulatory assist: A working group of the national, heart, lung, and blood institute." JOURNAL OF CARDIAC FAILURE. Vol. 9, no. 6. (December 2003.): 459-463.

Yancy, Clyde; Abraham, William T. "Noninvasive hemodynamic monitoring in heart failure: utilization of impedance cardiography.." Congest Heart Fail. Vol. 9, no. 5. (January 2003.): 241-50.

Trupp RJ, Abraham WT. "Non-pharmacologic options for the management of heart failure." Curr Cardiol Rep. no. 5. (January 2003.): 301-309.

Dash R; Schmidt AG; Pathak A; Gerst MJ; Biniakiewicz D; Kadambi VJ; Hoit BD; Abraham WT; Kranias EG. "Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy.." Cardiovascular Research. Vol. 57, no. 3. (March 2003.): 704-.

Lewis DA; Gurram NR; Abraham WT; Akers WS. "Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.." American Journal Of Health-System Pharmacy: AJHP: Official Journal Of The American Society Of Health-System Pharmacists. Vol. 60 Suppl 4, (August 2003.): S16-.

Trupp RJ; Abraham WT; Lamba S. "Future therapies for heart failure.." Critical Care Nursing Clinics Of North America. Vol. 15, no. 4. (December 2003.): 525-.

St John Sutton, Martin, G; Plappert, Ted; Abraham, William, T; Smith, Andrew, L; DeLurgio, David, B; Leon, Angel, R; Loh, Evan; Kocovic, Dusan, Z; Fisher, Westby, G; Ellestad, Myrvin; Messenger, John; Kruger, Kristin; Hilpisch, Kathryn, E; Hill, Michael R, S; Hill, Michael R S. "Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.." Circulation. Vol. 107, no. 15. (January 2003.): 1985-90.

McCullough, Peter, A; Duc, Philippe; Omland, Torbjorn; McCord, James; Nowak, Richard, M; Hollander, Judd, E; Herrmann, Howard, C; Steg, Philippe, G; Westheim, Arne; Knudsen, Cathrine Wold; Storrow, Alan, B; Abraham, William, T; Lamba, Sumant; Wu, Alan H, B; Perez, Alberto; Clopton, Paul; Krishnaswamy, Padma; Kazanegra, Radmila; Maisel, Alan, S; Maisel, Alan S. "B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.." American journal of kidney diseases : the official journal of the National Kidney Foundation. Vol. 41, no. 3. (January 2003.): 571-9.

Jaski, Brian, E; Ha, Jae; Denys, Bart, G; Lamba, Sumant; Trupp, Robin, J; Abraham, William T. "Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.." Journal of cardiac failure. Vol. 9, no. 3. (January 2003.): 227-31.

Adamson, Philip, B; Kleckner, Karen, J; VanHout, Warren, L; Srinivasan, Sriram; Abraham, William T. "Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure.." Circulation. Vol. 108, no. 3. (January 2003.): 266-9.

Adamson PB, Abraham WT. "Cardiac resynchronization for advanced heart failure." Curr Ther Options Cardiovasc Med. no. 5. (January 2003.): 301-309.

Abraham, William, T; Hayes, David L. "Cardiac resynchronization therapy for heart failure.." Circulation. Vol. 108, no. 21. (January 2003.): 2596-603.

Abraham WT, Raynolds MV, Badesch DB, Ynne KM, Groves BM, Roden RL, Robertson AD, Lowes BD, Zisman LS, Voelkel NF, Bristow MR, Perryman MB. "The Angiotensin converting enzyme DD genotype in patients with severe primary pulmonary hypertension: increased frequency and association with preserved hemodynamics." JRAAS. no. 4. (January 2003.): 27-30.

Abraham WT. "Electrophysiological aids in congestive heart failure: supporting and synchronizing systole." Med Clin N Am. no. 87. (January 2003.): 509-521.

Abraham WT. "Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.." Reviews In Cardiovascular Medicine. Vol. 4 Suppl 3, (January 2003.): S30-.

Abraham WT. "Cardiac resynchronization therapy: A review of clinical trials and criteria for identifying the appropriate patient." Rev Cardiovasc Med. no. 4(suppl.3). (January 2003.): S30-S36.

Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K. "Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.." JAMA: The Journal Of The American Medical Association. Vol. 289, no. 20. (May 2003.): 2685-.

Abraham,W,T; Raynolds,M,V; Badesch,D,B; Wynne,K,M; Groves,B,M; Roden,R,L; Robertson,A,D; Lowes,B,D; Zisman,L,S; Voelkel,N,F; Bristow,M,R; PERRYMAN,M,B. "Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics." JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. Vol. 4, no. 1. (March 2003.): 27-30.

Maisel,A,S; Clopton,P; Krishnaswamy,P; Nowak,R,M; McCord,J; Hollander,J,E; Duc,P; Omland,T; Storrow,A,B; Abraham,W,T; Wu,A,HB; Steg,G; Westheim,A; Knudsen,C,W; Perez,A; Kazanegra,R; Bhalla,V; Herrmann,H,C; Aumont,M,C; McCullough,P,A. "Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: Results from the Breathing Not Properly (BNP) multinational study." American Heart Journal. Vol. 147, no. 6. (June 2004.): 1078-1084.

Adamson,P,B; Smith,A,L; Abraham,W,T; Kleckner,K,J; Stadler,R,W; Shih,A; Rhodes,M,M. "Continuous autonomic assessment in patients with symptomatic heart failure - Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device." Circulation. Vol. 110, no. 16. (October 2004.): 2389-2394.

Iyengar S; Feldman DS; Trupp R; Abraham WT. "Nesiritide for the treatment of congestive heart failure.." Expert Opinion On Pharmacotherapy. Vol. 5, no. 4. (April 2004.): 901-.

Wang,X; Richardson,L; Krishnamurthy,S; Pennigton,K; Evans,J; Bruce,E; Abraham,W; Bhakta,D; Patwardhan,A. "Orthostatic modification of ventilatory dynamic response to carbon dioxide perturbations." AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL. Vol. 116, no. 1-2. (November 2004.): 76-83.

Javaheri,S; Abraham,W,T; Brown,C; Nishiyama,H; Giesting,R; Wagoner,L,E. "Prevalence of obstructive steep apnoea and periodic limb movement in 45 subjects with heart transplantation." European heart journal. Vol. 25, no. 3. (February 2004.): 260-266.

Wilkoff,B,L; Hess,M; Young,J; Abraham,W,T. "Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients." Journal of cardiovascular electrophysiology. Vol. 15, no. 9. (September 2004.): 1002-1009.

Trupp,Robin,J; Hardesty,Peggy; Osborne,Julia; Shelby,Shelly; Lamba,Sumant; Ali,Vaqar; Jansen,Donald,E; Kunik,Cherie,L; Abraham,William,T. "Prevalence of sleep disordered breathing in a heart failure program.." Congestive Heart Failure (Greenwich, Conn.). Vol. 10, no. 5. (September 2004.): 217-220.

McAlister,F,A; Ezekowitz,J,A; Wiebe,N; ROWE,B; Spooner,C; Crumley,E; Hartling,L; Klassen,T; Abraham,W. "Systematic review: cardiac resynchronization in patients with symptomatic heart failure." ANNALS OF INTERNAL MEDICINE. Vol. 141, no. 5. (September 2004.): 381-390.

Auricchio, Angelo; Abraham, William T. "Cardiac resynchronization therapy: current state of the art: cost versus benefit.." Circulation. Vol. 109, no. 3. (January 2004.): 300-7.

Javaheri S; Abraham WT; Brown C; Nishiyama H; Giesting R; Wagoner LE. "Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation.." European Heart Journal. Vol. 25, no. 3. (February 2004.): 260-.

Dulin B; Abraham WT. "Pharmacology of carvedilol.." The American Journal Of Cardiology. Vol. 93, no. 9A. (May 2004.): 3B-.

Abraham WT. "Beyond Pharmacotherapy for heart failure: the role of ICDs and CRT." Published online at www.medscape.com/viewarticle/484828. (August 2004.): -.

Wilkoff BL; Hess M; Young J; Abraham WT. "Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.." Journal Of Cardiovascular Electrophysiology. Vol. 15, no. 9. (September 2004.): 1002-.

Fonarow,G,C; Abraham,W,T; Albert,N,M; Gattis,W,A; Gheorghiade,M; Greenberg,B; O'Connor,C,M; Yancy,C,W; Young,J. "Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): Rationale and design." American Heart Journal. Vol. 148, no. 1. (July 2004.): 43-51.

Forman,D,E; Butler,J; Wang,Y,F; Abraham,W,T; O'Connor,C,M; Gottlieb,S,S; Loh,E; Massie,B,M; Rich,M,W; Stevenson,L,W; Young,J,B; Krumholz,H,M. "Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure." Journal of the American College of Cardiology. Vol. 43, no. 1. (January 2004.): 61-67.

Adamson PB; Abraham WT; Love C; Reynolds D. "The evolving challenge of chronic heart failure management: a call for a new curriculum for training heart failure specialists.." Journal Of The American College Of Cardiology. Vol. 44, no. 7. (October 2004.): 1354-.

Fonarow,G,C; Gheorghiade,M; Abraham,W,T. "Importance of in-hospital initiation of evidence-based medical therapies for heart failure - A review." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 94, no. 9. (November 2004.): 1155-1160.

Abraham,W,T; Young,J,B; Leon,A,R; Adler,S; Bank,A,J; Hall,S,A; LIEBERMAN,R; Liem,L,B; O'Connell,J,B; Schroeder,J,S; Wheelan,K,R. "Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure." Circulation. Vol. 110, no. 18. (November 2004.): 2864-2868.

Abraham,William,T. "Preventing cardiovascular events in patients with diabetes mellitus.." American journal of medicine. Vol. 116, (March 2004.): 39S-46S.

Franciosa,J,A; Massie,B,M; Lukas,M,A; Nelson,J,J; Lottes,S; Abraham,W,T; Fowler,M; Gilbert,E,M; Greenberg,B. "beta-Blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry." American Heart Journal. Vol. 148, no. 4. (October 2004.): 718-726.

Knudsen,C,W; Omland,T; Clopton,P; Westheim,A; Abraham,W,T; Storrow,A,B; McCord,J; Nowak,R,M; Aumont,M,C; Duc,P; Hollander,J,E; Wu,A,HB; McCullough,P,A; Maisel,A,S. "Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea." AMERICAN JOURNAL OF MEDICINE. Vol. 116, no. 6. (March 2004.): 363-368.

Auricchio,A; Abraham,W,T. "Cardiac resynchronization therapy: Current state of the art - Cost versus benefit." Circulation. Vol. 109, no. 3. (January 2004.): 300-307.

Abraham,William,T; Iyengar,Srinivas. "Practical considerations for switching beta-blockers in heart failure patients.." Reviews in cardiovascular medicine. Vol. 5, (January 2004.): S36-44.

Dulin,B; Abraham,W,T. "Pharmacology of carvedilol." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 93, no. 9A. (May 2004.): 3B-6B.

Iyengar,Srinivas; Abraham,William,T. "Pharmacogenomics and heart failure: tailor-made therapy?." Congestive Heart Failure (Greenwich, Conn.). Vol. 10, no. 6. (November 2004.): 273-?.

McCord, James; Mundy, Brian, J; Hudson, Michael, P; Maisel, Alan, S; Hollander, Judd, E; Abraham, William, T; Steg, Philip, G; Omland, Torbjorn; Knudsen, Cathrine, W; Sandberg, Keisha, R; McCullough, Peter, A; McCullough, Peter A. "Relationship between obesity and B-type natriuretic peptide levels.." Archives of internal medicine. Vol. 164, no. 20. (January 2004.): 2247-52.

Franciosa, Joseph, A; Massie, Barry, M; Lukas, Mary Ann; Nelson, Jeanenne, J; Lottes, Sandra; Abraham, William, T; Fowler, Michael; Gilbert, Edward, M; Greenberg, Barry; Greenberg, Barry. "Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.." American heart journal. Vol. 148, no. 4. (January 2004.): 718-26.

Forman DE; Butler J; Wang Y; Abraham WT; O'Connor CM; Gottlieb SS; Loh E; Massie BM; Rich MW; Stevenson LW; Young JB; Krumholz HM. "Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.." Journal Of The American College Of Cardiology. Vol. 43, no. 1. (January 2004.): 61-.

Fonarow, Gregg, C; Abraham, William, T; Albert, Nancy, M; Gattis, Wendy, A; Gheorghiade, Mihai; Greenberg, Barry; O'Connor, Chris, M; Yancy, Clyde, W; Young, James. "Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.." American heart journal. Vol. 148, no. 1. (January 2004.): 43-51.

Adamson, Philip, B; Smith, Andrew, L; Abraham, William, T; Kleckner, Karen, J; Stadler, Robert, W; Shih, Alex; Rhodes, Melissa, M; Rhodes, Melissa M. "Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.." Circulation. Vol. 110, no. 16. (January 2004.): 2389-94.

Abraham, William, T; Young, James, B; Leon, Angel, R; Adler, Stuart; Bank, Alan, J; Hall, Shelley, A; Lieberman, Randy; Liem, L Bing; O'Connell, John, B; Schroeder, John, S; Wheelan, Kevin, R; Wheelan, Kevin R. "Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.." Circulation. Vol. 110, no. 18. (January 2004.): 2864-8.

Abraham WT; Iyengar S. "Practical considerations for switching beta-blockers in heart failure patients.." Reviews In Cardiovascular Medicine. Vol. 5 Suppl 1, (January 2004.): S36-.

Abraham WT. "Reviews in Depth: Alternatives to Cardiac Transplantation. Overview." Coronary Artery Dis. no. 15. (January 2004.): 77-79.

Abraham WT. "Preventing cardiovascular events in patients with diabetes mellitus." Am J Med. no. 116. (January 2004.): 39S-46S.

Abraham WT. "Neurohormones and the progression of cardiovascular disease: what’s behind high risk?." Cardiol Rev. no. 21. (January 2004.): 2-6.

Abraham WT. "Biventricular pacing in heart failure." Published in Japanese in The Circulation Frontier. no. 8. (January 2004.): 36-45.

Abraham WT. "Cardiology Board Review Study Guide." Resident & Staff Physician. (April 2004.): 1-13.

Curtis AB; Abraham WT; Chen PS; Ellenbogen KA; Epstein AE; Friedman PA; Hohnloser SH; Kanter RJ; Stevenson WG. "Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, California.." Journal Of The American College Of Cardiology. Vol. 44, no. 8. (October 2004.): 1550-.

McCord J; Mundy BJ; Hudson MP; Maisel AS; Hollander JE; Abraham WT; Steg PG; Omland T; Knudsen CW; Sandberg KR; McCullough PA. "Relationship between obesity and B-type natriuretic peptide levels.." Archives Of Internal Medicine. Vol. 164, no. 20. (November 2004.): 2247-.

Fonarow GC; Gheorghiade M; Abraham WT. "Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.." The American Journal Of Cardiology. Vol. 94, no. 9. (November 2004.): 1155-.

Iyengar, Srinivas; Abraham, William T. "Pharmacogenomics and heart failure: tailor-made therapy?." Congest Heart Fail. Vol. 10, no. 6. (January 2004.): 273, 288-.

Curtis, Anne, B; Abraham, William, T; Chen, Peng-Sheng; Ellenbogen, Kenneth, A; Epstein, Andrew, E; Friedman, Paul, A; Hohnloser, Stefan, H; Kanter, Ronald, J; Stevenson, William G. "Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, California.." Journal of the American College of Cardiology. Vol. 44, no. 8. (January 2004.): 1550-6.

Bristow, M, R; Krause-Steinrauf, H; Nuzzo, R; Liang, Cheng-Seng; Lindenfeld, J; Lowes, B, D; Hattler, B; Abraham, W, T; Olson, L; Krueger, S; Thaneemit-Chen, S; Hare, J, M; Loeb, H, S; Domanski, M, J; Eichhorn, E, J; Zelis, R; Lavori, P. "Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.." Circulation. Vol. 110, no. 11. (January 2004.): 1437-42.

Knudsen CW; Omland T; Clopton P; Westheim A; Abraham WT; Storrow AB; McCord J; Nowak RM; Aumont MC; Duc P; Hollander JE; Wu AH; McCullough PA; Maisel AS. "Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea.." The American Journal Of Medicine. Vol. 116, no. 6. (March 2004.): 363-.

Trupp, Robin, J; Hardesty, Peggy; Osborne, Julia; Shelby, Shelly; Lamba, Sumant; Ali, Vaqar; Jansen, Donald, E; Kunik, Cherie, L; Abraham, William T. "Prevalence of sleep disordered breathing in a heart failure program.." Congest Heart Fail. Vol. 10, no. 5. (January 2004.): 217-20.

Abraham WT, Trupp RJ. "New concepts in increasing heart efficiency: using the evidence in clinical practice." A CME-accredited educational monograph and CD from CME–Today. (March 2004.): -.

Butler,J; Forman,D,E; Abraham,W,T; Gottlieb,S,S; Loh,E; Massie,B,M; O'Connor,C,M; Rich,M,W; Stevenson,L,W; Wang,Y,F; Young,J,B; Krumholz,H,M. "Relationship between heart failure treatment and development of worsening renal function among hospitalized patients." American Heart Journal. Vol. 147, no. 2. (February 2004.): 331-338.

Iyengar,S; Feldman,D,S; Trupp,R; Abraham,W,T. "Nesiritide for the treatment of congestive heart failure." Expert opinion on pharmacotherapy. Vol. 5, no. 4. (April 2004.): 901-907.

Bristow,M,R; Krause-Steinrauf,H; Nuzzo,R; Liang,C,S; Lindenfeld,J; Lowes,B,D; Hattler,B; Abraham,W,T; Olson,L; Krueger,S; Thaneemit-Chen,S; Hare,J,M; Loeb,H,S; Domanski,M,J; Eichhorn,E,J; Zelis,R; Lavori,P. "Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial." Circulation. Vol. 110, no. 11. (September 2004.): 1437-1442.

Wu,A,HB; Omland,T; Duc,P; McCord,J; Nowak,R,M; Hollander,J,E; Herrmann,H,C; Steg,P,G; Knudsen,C,W; Storrow,A,B; Abraham,W,T; Perez,A; Kamen,R; Clopton,P; Maisel,A,S; McCullough,P,A. "The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea - An analysis from the breathing not properly multinational study." Diabetes Care. Vol. 27, no. 10. (October 2004.): 2398-2404.

Dulin,B,R; Haas,S,J; Abraham,W,T; Krum,H. "Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of > 12,000 patients in large-scale clinical trials." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 95, no. 7. (April 2005.): 896-898.

Hiestand,Brian; Abraham,William,T. "Implications of heart failure drug trials: COMET, CHARM, EPHESUS.." Reviews in cardiovascular medicine. Vol. 6, (January 2005.): S4-11.

Hiestand B; Abraham WT. "Implications of heart failure drug trials: COMET, CHARM, EPHESUS.." Reviews In Cardiovascular Medicine. Vol. 6 Suppl 2, (January 2005.): S4-.

Nishijima Y; Feldman DS; Bonagura JD; Ozkanlar Y; Jenkins PJ; Lacombe VA; Abraham WT; Hamlin RL; Carnes CA. "Canine nonischemic left ventricular dysfunction: a model of chronic human cardiomyopathy.." Journal Of Cardiac Failure. Vol. 11, no. 8. (October 2005.): 638-.

The ESCAPE Investigators and ESCAPE Study Coordinators. "Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness. The ESCAPE Trial." JAMA. no. 294. (January 2005.): 1625-1633.

Fonarow,G,C; Adams,K,F; Abraham,W,T; Yancy,C,W; Boscardin,W,J. "Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 293, no. 5. (February 2005.): 572-580.

Wu,A,HB; Omland,T; Knudsen,C,W; McCord,J; Nowak,R,M; Hollander,J,E; Duc,P; Storrow,A,B; Abraham,W,T; Clopton,P; Maisel,A,S; McCullough,P,A. "Relationship of B-Type natriuretic peptide and anemia in patients with and without heart failure: A substudy from the breathing not properly (BNP) multinational study." American journal of hematology. Vol. 80, no. 3. (November 2005.): 174-180.

Abraham,William,T; Cheng,Mei,L; Smoluk,Geraldine. "Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.." Congestive Heart Failure (Greenwich, Conn.). Vol. 11, no. 2. (March 2005.): 59-64.

Yu,C,M; Abraham,W,T; Bax,J; Chung,E; Fedewa,M; Ghio,S; Leclercq,C; Leon,A,R; Merlino,J; Nihoyannopoulos,P; Notabartolo,D; Sun,J,P; Tavazzi,L. "Predictors of response to cardiac resynchronization therapy (PROSPECT) - study design." American Heart Journal. Vol. 149, no. 4. (April 2005.): 600-605.

Knudsen,C,W; Clopton,P; Westheim,A; Klemsdal,T,O; Wu,A,HB; Duc,P; McCord,J; Nowak,R,M; Hollander,J,E; Storrow,A,B; Abraham,W,T; McCullough,P,A; Maisel,A,S; Omland,T. "Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: An analysis from the breathing not properly multinational study." Annals Of Emergency Medicine. Vol. 45, no. 6. (June 2005.): 573-580.

Iyengar,Srinivas; Abraham,William,T. "Cardiology patient page. Cardiac resynchronization therapy: a better and longer life for patients with advanced heart failure.." Circulation. Vol. 112, no. 13. (September 2005.): e236-7.

Iyengar,S; Abraham,W,T. "Cardiac resynchronization therapy - A better and longer life for patients with advanced heart failure." CIRCULATION. Vol. 112, no. 13. (September 2005.): E236-E237.

Hunt,Sharon,Ann; Abraham,William,T; Chin,Marshall,H; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Jessup,Mariell; Konstam,Marvin,A; Mancini,Donna,M; Michl,Keith; Oates,John,A; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W; Antman,Elliott,M; Smith,Sidney,C; Adams,Cynthia,D; Anderson,Jeffrey,L; Faxon,David,P; Fuster,Valentin; Halperin,Jonathan,L; Hiratzka,Loren,F; Jacobs,Alice,K; Nishimura,Rick; Ornato,Joseph,P; Page,Richard,L; Riegel,Barbara. "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.." Circulation. Vol. 112, no. 12. (September 2005.): e154-235.

Hunt,S,A; Abraham,W,T; Chin,M,H; Feldman,A,M; Francis,G,S; Ganiats,T,G; Jessup,M; Konstam,M,A; Mancini,D,M; Michl,K; Oates,J,A; Rahko,P,S; Silver,M,A; Stevenson,L,W; Yancy,C,W. "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Summary article." CIRCULATION. Vol. 112, no. 12. (September 2005.): 1825-1852.

Konstam, Marvin, A; Czerska, Barbara; Bohm, Michael; Oren, Ron, M; Sadowski, Jerzy; Khanal, Sanjaya; Abraham, William, T; Wasler, Andrae; Dahm, Johannes, B; Gavazzi, Antonello; Gradinac, Sinisa; Legrand, Victor; Mohacsi, Paul; Poelzl, Gerhard; Radovancevic, Branislav; Van Bakel, Adrian, B; Zile, Michael, R; Cabuay, Barry; Bartus, Krzysztof; Jansen, Piet. "Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure.." Circulation. Vol. 112, no. 20. (January 2005.): 3107-14.

Knudsen, Cathrine, W; Clopton, Paul; Westheim, Arne; Klemsdal, Tor Ole; Wu, Alan H, B; Duc, Philippe; McCord, James; Nowak, Richard, M; Hollander, Judd, E; Storrow, Alan, B; Abraham, William, T; McCullough, Peter, A; Maisel, Alan, S; Omland, Torbjorn. "Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.." Annals of emergency medicine. Vol. 45, no. 6. (January 2005.): 573-80.

Iyengar, Srinivas; Abraham, William T. "Role of medical therapy in the device era for the treatment of heart failure.." Expert review of cardiovascular therapy. Vol. 3, no. 5. (January 2005.): 783-5.

Iyengar S, Abraham WT. "Neutral endopeptidase inhibitors and endothelin antagonists: why did the clinical trials not demonstrate beneficial effects?." Heart Fail Clin. no. 1. (January 2005.): 95-102.

Iyengar S, Abraham WT. "Cardiac resynchronization therapy: a better and longer life for patients with advanced heart failure." Circulation Patient Pages. no. 112. (January 2005.): e236-237.

Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J. "In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).." Journal Of The American College Of Cardiology. Vol. 46, no. 1. (July 2005.): 57-.

Wickrama KA; Conger RD; Abraham WT. "Early adversity and later health: the intergenerational transmission of adversity through mental disorder and physical illness.." The Journals Of Gerontology. Series B, Psychological Sciences And Social Sciences. Vol. 60 Spec No 2, (October 2005.): 125-.

Adams,K,F; Fonarow,G,C; Emerman,C,L; LeJemtel,T,H; Costanzo,M,R; Abraham,W,T; Berkowitz,R,L; Galvao,M; Horton,D,P. "Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE)." American Heart Journal. Vol. 149, no. 2. (February 2005.): 209-216.

Hunt,S,A; Abraham,W,T; Chin,M,H; Feldman,A,M; Francis,G,S; Ganiats,T,G; Jessup,M; Konstam,M,A; Mancini,D,M; Michl,K; Oates,J,A; Rahko,P,S; Silver,M,A; Stevenson,L,W; Yancy,C,W. "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult." CIRCULATION. Vol. 112, no. 12. (September 2005.): E154-235.

McAlister,F,A; Wiebe,A; Abraham,W. "Cardiac resynchronization therapy in heart failure - In response." ANNALS OF INTERNAL MEDICINE. Vol. 142, no. 4. (February 2005.): 307-308.

Adamson,P,B; Smith,A,L; Abraham,W,T; Kleckner,K,J; Stadler,R,W; Rhodes,M,M. "Letter regarding article by Adamson et al, " Continuous autonomic assessment in patients with symptomatic heart failure: Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device" - Reply." CIRCULATION. Vol. 112, no. 2. (July 2005.): E37-E38.

Abraham,W,T; Adams,K,F; Fonarow,G,C; Costanzo,M,R; Berkowitz,R,L; LeJemtel,T,H; Cheng,M,L; Wynne,J. "In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications - An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)." Journal of the American College of Cardiology. Vol. 46, no. 1. (July 2005.): 57-64.

McCord,J; Nowak,R,M; Jacobsen,G; Sallach,J,A; Wu,A,HB; Perez,A; Omland,T; Knudsen,C,W; Westheim,A; Duc,P; Steg,P,G; Hollander,J,E; Herrmann,H,C; Storrow,A,B; Abraham,W,T; Lamba,S; McCullough,P,A; Maisel,A. "B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 96, no. 10. (November 2005.): 1370-1373.

Iyengar,Srinivas; Abraham,William,T. "Neutral endopeptidase inhibitors and endothelin antagonists: why did the clinical trials not demonstrate beneficial effects?." Heart Failure Clinics. Vol. 1, no. 1. (April 2005.): 95-102.

Adamson,P,B; Abraham,W,T; Love,C; Reynolds,D. "Heart failure training: Care for older adults with chronic heart failure - Reply." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Vol. 45, no. 12. (June 2005.): 2098-2098.

Steg,P,G; Joubin,L; McCord,J; Abraham,W,T; Hollander,J,E; Omland,T; Mentre,F; McCullough,P,A; Maisel,A,S. "B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea." Chest. Vol. 128, no. 1. (July 2005.): 21-29.

Nishijima,Y; Feldman,D,S; Bonagura,J,D; Ozkanlar,Y; Jenkins,P,J; Lacombe,V,A; Abraham,W,T; Hamlin,R,L; Carnes,C,A. "Canine nonischemic left ventricular dysfunction: A model of chronic human cardiomyopathy." Journal of cardiac failure. Vol. 11, no. 8. (October 2005.): 638-644.

Fonarow,G,C; Adams,K,F; Abraham,W,T; Yancy,C,W; Boscardin,W. "Risk stratification for in-hospital mortality in acutely decompensated heart failure - Reply." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 293, no. 20. (May 2005.): 2468-2468.

Konstam,M,A; Czerska,B; Bohm,M; Oren,R,M; Sadowski,J; Khanal,S; Abraham,W,T; Wasler,A; Dahm,J,B; Gavazzi,A; Gradinac,S; Legrand,V; Mohacsi,P; Poelzl,G; Radovancevic,B; Van Bakel,A,B; Zile,M,R; Cabuay,B; Bartus,K; Jansen,P. "Continuous aortic flow augmentation - A pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure." Circulation. Vol. 112, no. 20. (November 2005.): 3107-3114.

Iyengar,S; Abraham,W,T. "Anemia in chronic heart failure: can EPO reduce deaths?." Cleveland Clinic Journal Of Medicine. Vol. 72, no. 11. (November 2005.): 1027-1032.

Javaheri S, Abraham WT. "Cardiovascular consequences of obstructive sleep apnea." Cardiology Special Edition. no. 11. (January 2005.): 19-23.

Haas GJ, Abraham WT. "The challenge of heart failure therapy: so many drugs, so little blood pressure." Cur J Rev. no. 14. (January 2005.): 36-40.

Wu AH; Omland T; Wold Knudsen C; McCord J; Nowak RM; Hollander JE; Duc P; Storrow AB; Abraham WT; Clopton P; Maisel AS; McCullough PA. "Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study.." American Journal Of Hematology. Vol. 80, no. 3. (November 2005.): 174-.

Abraham WT. "Background and findings from the ADHERE National Registry." EMCREG-International. (March 2005.): 27-32.

McCord J; Nowak RM; Jacobsen G; Sallach JA; Wu AH; Perez A; Omland T; Knudsen CW; Westheim A; Duc P; Steg PG; Hollander JE; Herrmann HC; Storrow AB; Abraham WT; Lamba S; McCullough PA; Maisel A. "B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction.." The American Journal Of Cardiology. Vol. 96, no. 10. (November 2005.): 1370-.

Wickrama KA; Lorenz FO; Fang SA; Abraham WT; Elder GH Jr. "Gendered trajectories of work control and health outcomes in the middle years: a perspective from the rural Midwest.." Journal Of Aging And Health. Vol. 17, no. 6. (December 2005.): 779-.

Leon, Angel, R; Abraham, William, T; Curtis, Anne, B; Daubert, James, P; Fisher, Westby, G; Gurley, John; Hayes, David, L; Lieberman, Randy; Petersen-Stejskal, Susan; Wheelan, Kevin; Wheelan, Kevin. "Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.." Journal of the American College of Cardiology. Vol. 46, no. 12. (January 2005.): 2348-56.

Leon, Angel, R; Abraham, William, T; Brozena, Susan; Daubert, James, P; Fisher, Westby, G; Gurley, John, C; Liang, Chang Seng; Wong, George; Wong, George. "Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.." Journal of the American College of Cardiology. Vol. 46, no. 12. (January 2005.): 2298-304.

Fonarow, Gregg, C; Adams, Kirkwood F Jr; Abraham, William, T; Yancy, Clyde, W; Boscardin, W John; Boscardin, W John. "Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.." JAMA : the journal of the American Medical Association. Vol. 293, no. 5. (January 2005.): 572-80.

Adams, Kirkwood F Jr; Fonarow, Gregg, C; Emerman, Charles, L; LeJemtel, Thierry, H; Costanzo, Maria Rosa; Abraham, William, T; Berkowitz, Robert, L; Galvao, Marie; Horton, Darlene, P; Horton, Darlene P. "Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).." American heart journal. Vol. 149, no. 2. (January 2005.): 209-16.

Abraham, William, T; Cheng, Mei, L; Smoluk, Geraldine; Smoluk, Geraldine. "Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.." Congest Heart Fail. Vol. 11, no. 2. (January 2005.): 59-64.

Abraham WT. "Pharmacologic treatment of patients with acute decompensated heart failure." CME Today. no. 2. (January 2005.): 17-23.

Abraham WT. "Nesiritide and mortality risk: individual and pooled analyses of randomized controlled trials." Prev Cardiovasc Med. (January 2005.): 1-3.

Dulin BR; Haas SJ; Abraham WT; Krum H. "Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.." The American Journal Of Cardiology. Vol. 95, no. 7. (April 2005.): 896-.

Knudsen CW; Omland T; Clopton P; Westheim A; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A. "Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study.." Journal Of The American College Of Cardiology. Vol. 46, no. 5. (September 2005.): 838-.

Iyengar S; Abraham WT. "Role of medical therapy in the device era for the treatment of heart failure.." Expert Review Of Cardiovascular Therapy. Vol. 3, no. 5. (September 2005.): 783-.

Feldman DS; Carnes CA; Abraham WT; Bristow MR. "Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.." Nature Clinical Practice. Cardiovascular Medicine. Vol. 2, no. 9. (September 2005.): 475-.

Feldman,D,S; Carnes,C,A; Abraham,W,T; Bristow,M,R. "Mechanisms of Disease: beta-adrenergic receptors - alterations in signal transduction and pharmacogenomics in heart failure." NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE. Vol. 2, no. 9. (September 2005.): 475-483.

Leon,A,R; Abraham,W,T; Brozena,S; Daubert,J,P; Fisher,W,G; Gurley,J,C; Liang,C,S; Wong,G. "Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure." Journal Of The American College Of Cardiology. Vol. 46, no. 12. (December 2005.): 2298-2304.

Knudsen,C,W; Omland,T; Clopton,P; Westheim,A; Wu,A,HB; Duc,P; McCord,J; Nowak,R,M; Hollander,J,E; Storrow,A,B; Abraham,W,T; McCullough,P,A; Maisel,A. "Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients - An analysis from The Breathing Not Properly Multinational Study." Journal of the American College of Cardiology. Vol. 46, no. 5. (September 2005.): 838-844.

Leon,A,R; Abraham,W,T; Curtis,A,B; Daubert,J,P; Fisher,W,G; Gurley,J; Hayes,D,L; LIEBERMAN,R; Petersen-Stejskal,S; Wheelan,K. "Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure - Combined results of over 2,000 patients from a multicenter study program." Journal Of The American College Of Cardiology. Vol. 46, no. 12. (December 2005.): 2348-2356.

Abraham,W,T; Shamshirsaz,A,A; McFann,K; Oren,R,M; Schrier,R,W. "Aquaretic efect of Lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients." Journal Of The American College Of Cardiology. Vol. 47, no. 8. (April 2006.): 1615-1621.

Collins,S,P; Lindsell,C,J; Storrow,A,B; Abraham,W,T. "Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure." Annals Of Emergency Medicine. Vol. 47, no. 1. (January 2006.): 13-18.

Packer,Milton; Abraham,William,T; Mehra,Mandeep,R; Yancy,Clyde,W; Lawless,Christine,E; Mitchell,Judith,E; Smart,Frank,W; Bijou,Rachel; O'Connor,Christopher,M; Massie,Barry,M; Pina,Ileana,L; Greenberg,Barry,H; Young,James,B; Fishbein,Daniel,P; Hauptman,Paul,J; Bourge,Robert,C; Strobeck,John,E; Murali,Srinvivas; Schocken,Douglas; Teerlink,John,R; Levy,Wayne,C; Trupp,Robin,J; Silver,Marc,A. "Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure." Journal Of The American College Of Cardiology. Vol. 47, no. 11. (June 2006.): 2245-2252.

Pires,L,A; Abraham,W,T; Young,J,B; Johnson,K,M. "Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials." American Heart Journal. Vol. 151, no. 4. (April 2006.): 837-843.

Strunk,Adam; Bhalla,Vikas; Clopton,Paul; Nowak,Richard,M; McCord,James; Hollander,Judd,E; Duc,Philippe; Storrow,Alan,B; Abraham,William,T; Wu,Alan,HB; Steg,Gabriel; Perez,Alberto; Kazanegra,Radmila; Herrmann,Howard,C; Aumont,Marie,Claude; McCullough,Peter,A; Maisel,Alan. "Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.." American journal of medicine. Vol. 119, no. 1. (January 2006.): 69 e1-11.

Abraham,W,T. "Cardiac resynchronization therapy." Progress in cardiovascular diseases. Vol. 48, no. 4. (January 2006.): 232-238.

Cappola,T,P; Harsch,M,R; Jessup,M; Abraham,W,T; Young,J,B; Petersen-Stejskal,S; Plappert,T; Sutton,M,SJ. "Predictors of remodeling in the CRT era: Influence of mitral regurgitation, BNP, and gender." Journal Of Cardiac Failure. Vol. 12, no. 3. (April 2006.): 182-188.

Hill,James,A; Yancy,Clyde,W; Abraham,William,T. "Beyond diuretics: Management of volume overload in acute heart failure syndromes." AMERICAN JOURNAL OF MEDICINE. Vol. 119, no. 12. (December 2006.): 37-44.

Hill,James,A; Yancy,Clyde,W; Abraham,William,T. "Beyond diuretics: management of volume overload in acute heart failure syndromes.." American journal of medicine. Vol. 119, no. 12. (December 2006.): S37-44.

Greenberg,Barry; Lottes,Sandra,R; Nelson,Jeanenne,J; Lukas,Mary,Ann; Fowler,Michael,B; Massie,Barry,M; Abraham,William,T; Gilbert,Edward,M; Franciosa,Joseph,A. "Predictors of clinical outcomes in patients given carvedilol for heart failure." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 98, no. 11. (December 2006.): 1480-1484.

McClean, Dougal; Aragon, Joseph; Jamali, Aamer; Kar, Saibal; Ritzema-Carter, Jay; Troughton, Richard; Krum, Henry; Doughty, Robert; Abraham, William, T; Whiting, James, S; Eigler, Neal. "Noninvasive calibration of cardiac pressure transducers in patients with heart failure: an aid to implantable hemodynamic monitoring and therapeutic guidance.." Journal of cardiac failure. Vol. 12, no. 7. (January 2006.): 568-76.

Daniels, Lori, B; Clopton, Paul; Bhalla, Vikas; Krishnaswamy, Padma; Nowak, Richard, M; McCord, James; Hollander, Judd, E; Duc, Philippe; Omland, Torbjorn; Storrow, Alan, B; Abraham, William, T; Wu, Alan H, B; Steg, Philippe, G; Westheim, Arne; Knudsen, Cathrine Wold; Perez, Alberto; Kazanegra, Radmila; Herrmann, Howard, C; McCullough, Peter, A; Maisel, Alan S. "How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.." American heart journal. Vol. 151, no. 5. (January 2006.): 999-1005.

Butler, Javed; Young, James, B; Abraham, William, T; Bourge, Robert, C; Adams, Kirkwood F Jr; Clare, Robert; O'Connor, Christopher; O'Connor, Christopher. "Beta-blocker use and outcomes among hospitalized heart failure patients.." Journal of the American College of Cardiology. Vol. 47, no. 12. (January 2006.): 2462-9.

Abraham, William, T; Shamshirsaz, Alireza, A; McFann, Kim; Oren, Ron, M; Schrier, Robert W. "Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.." Journal of the American College of Cardiology. Vol. 47, no. 8. (January 2006.): 1615-21.

Abraham WT. "New approaches to monitoring heart failure before symptoms appear.." Reviews In Cardiovascular Medicine. Vol. 7 Suppl 1, (January 2006.): S33-.

Abraham WT. "Cardiac resynchronization therapy.." Progress In Cardiovascular Diseases. Vol. 48, no. 4. (January 2006.): 232-.

Abraham WT. "Cardiac resynchronization therapy is important for all patients with congestive heart failure and ventricular dysynchrony." Circulation. Vol. 2692, no. 114. (January 2006.): 2698-.

Iyengar S; Abraham WT. "Diuretic resistance in heart failure.." Current Heart Failure Reports. Vol. 3, no. 1. (April 2006.): 41-.

Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie BM, Fowler MB, Greenberg B, Gilbert EM, Abraham WT; COHERE Participant Physicians.. "Heart failure in community practice: relationship to age and sex in a beta-blocker registry.." Congestive Heart Failure. Vol. 6, no. 12. (November 2006.): 317-323.

Hasan,Ayesha; Abraham,William,T; Quinn-Tate,Lori; Brown,Lei; Amkieh,Ali. "Optimization of cardiac resynchronization devices using acoustic cardiography: a comparison to echocardiography.." Congestive heart failure (Greenwich, Conn.). Vol. 12, no. July-August. (July 2006.): 25-31.

Liggett,Stephen,B; Mialet-Perez,Jeanne; Thaneemit-Chen,Surai; Weber,Stewart,A; Greene,Scott,M; Hodne,Danielle; Nelson,Bradley; Morrison,Jennifer; Domanski,Michael,J; Wagoner,Lynne,E; Abraham,William,T; Anderson,Jeffrey,L; Carlquist,John,F; Krause-Steinrauf,Heidi,J; Lazzeroni,Laura,C; Port,J,David; Lavori,Philip,W; Bristow,Michael,R. "A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure." Proceedings Of The National Academy Of Sciences Of The United States Of America. Vol. 103, no. 30. (July 2006.): 11288-11293.

Abraham,William,T. "New approaches to monitoring heart failure before symptoms appear." REVIEWS IN CARDIOVASCULAR MEDICINE. Vol. 7, no. 7(suppl.1). (January 2006.): S33-S41.

Sutton,M,GS; Plappert,T; Hilpisch,K,E; Abraham,W,T; Hayes,D,L; Chinchoy,E. "Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology - Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE)." Circulation. Vol. 113, no. 2. (January 2006.): 266-272.

Ritzema-Carter,Jay,LT; Smyth,David; Troughton,Richard,W; Crozier,Ian,G; Melton,Iain,C; Richards,A,Mark; Eigler,Neal; Whiting,James; Kar,Saibal; Krum,Henry; Abraham,William,T. "Images in cardiovascular medicine. Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device.." Circulation. Vol. 113, no. 15. (April 2006.): e705-6.

Iyengar,Srinivas; Abraham,William,T. "Diuretic resistance in heart failure.." Current heart failure reports. Vol. 3, no. 1. (April 2006.): 41-45.

Freemantle,N; Tharmanathan,P; Calvert,M,J; Abraham,W,T; Ghosh,J; Cleland,J,GF. "Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis." EUROPEAN JOURNAL OF HEART FAILURE. Vol. 8, no. 4. (June 2006.): 433-440.

Butler,Javed; Young,James,B; Abraham,William,T; Bourge,Robert,C; Adams,Kirkwood,F; Clare,Robert; O'Connor,Christopher. "Beta-blocker use and outcomes among hospitalized heart failure patients." Journal Of The American College Of Cardiology. Vol. 47, no. 12. (June 2006.): 2462-2469.

Collins,Sean,P; Lindsell,Christopher,J; Storrow,Alan,B; Abraham,William,T. "Response to: Misleading negative chest radiographs: should we ADHERE to the conclusions?." Annals Of Emergency Medicine. Vol. 48, no. 3. (September 2006.): 341-341.

Abraham,William,T; Trupp,Robin,J; Phillilps,Barbara; Bourge,Robert,C; Bailey,Brian; Harding,Susan,M; Schofield,Peter; Pilsworth,Samantha; Shneerson,John,M; Di Salvo,Thomas; Camuso,Janice; Johnson,Douglas; King,Martin; Javaheri,Shahrokh. "Validation and clinical utility of a simple in-home testing tool for sleep-disordered breathing and arrhythmias in heart failure: results of the Sleep Events, Arrhythmias, and Respiratory Analysis in Congestive Heart Failure (SEARCH) study.." Congestive Heart Failure (Greenwich, Conn.). Vol. 12, no. 5. (September 2006.): 241-247.

De Luca,Leonardo; Abraham,William,T; Fonarow,Gregg,C; Gheorghiade,Mihai. "Congestion in acute heart failure syndromes: Importance of early recognition and treatment." Reviews In Cardiovascular Medicine. Vol. 7, no. 2. (March 2006.): 69-74.

McClean,Dougal; Aragon,Joseph; Jamali,Aamer; Kar,Saibal; Ritzema-Carter,Jay; Troughton,Richard; Krum,Henry; Doughty,Robert; Abraham,William,T; Whiting,James,S; Eigler,Neal. "Noninvasive calibration of cardiac pressure transducers in patients with heart failure: An aid to implantable hemodynamic monitoring and therapeutic guidance." Journal Of Cardiac Failure. Vol. 12, no. 7. (September 2006.): 568-576.

Franciosa,Joseph,A; Nelson,Jeanenne,J; Lukas,Mary,Ann; Lottes,Sandra,R; Massie,Barry,M; Fowler,Michael,B; Greenberg,Barry; Gilbert,Edward,M; Abraham,William,T. "Heart failure in community practice: relationship to age and sex in a beta-blocker registry.." Congestive Heart Failure (Greenwich, Conn.). Vol. 12, no. 6. (November 2006.): 317-323.

Gheorghiade,Mihai; Shin,David,D; Thomas,Tarita,O; Brandimarte,Filippo; Fonarow,Gregg,C; Abraham,William,T. "Congestion is an important diagnostic and therapeutic target in heart failure." REVIEWS IN CARDIOVASCULAR MEDICINE. Vol. 7, no. 7(suppl.1). (January 2006.): S12-S24.

Strunk, Adam; Bhalla, Vikas; Clopton, Paul; Nowak, Richard, M; McCord, James; Hollander, Judd, E; Duc, Philippe; Storrow, Alan, B; Abraham, William, T; Wu, Alan H, B; Steg, Gabriel; Perez, Alberto; Kazanegra, Radmila; Herrmann, Howard, C; Aumont, Marie Claude; McCullough, Peter, A; Maisel, Alan. "Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.." The American journal of medicine. Vol. 119, no. 1. (January 2006.): 69.e1-11.

Pires, Luis, A; Abraham, William, T; Young, James, B; Johnson, Katrina, M; Johnson, Katrina M. "Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and." American heart journal. Vol. 151, no. 4. (January 2006.): 837-43.

Hill JA, Yancy CW, Abraham WT. "Beyond diuretics: management of volume overload in acute heart failure syndromes." Am J Med. no. 119(suppl.12A). (January 2006.): S37-S44.

Abraham WT. "Cardiac resynchronization therapy is important for all patients with congestive heart failure and ventricular dyssynchrony.." Circulation. Vol. 114, no. 24. (December 2006.): 2692-.

Ritzema-Carter, Jay L, T; Smyth, David; Troughton, Richard, W; Crozier, Ian, G; Melton, Iain, C; Richards, A Mark; Eigler, Neal; Whiting, James; Kar, Saibal; Krum, Henry; Abraham, William T. "Images in cardiovascular medicine. Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device.." Circulation. Vol. 113, no. 15. (January 2006.): e705-6.

Gheorghiade M; Shin DD; Thomas TO; Brandimarte F; Fonarow GC; Abraham WT. "Congestion is an important diagnostic and therapeutic target in heart failure.." Reviews In Cardiovascular Medicine. Vol. 7 Suppl 1, (January 2006.): S12-.

Collins, Sean, P; Lindsell, Christopher, J; Storrow, Alan, B; Abraham, William, T; Abraham, William T. "Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure.." Annals of emergency medicine. Vol. 47, no. 1. (January 2006.): 13-8.

Collins, Sean, P; Lindsell, Christopher, J; Storrow, Alan, B; Abraham, William T. "Response to: Misleading negative chest radiographs: should we ADHERE to the conclusions?." Annals of emergency medicine. Vol. 48, no. 3. (January 2006.): 341; author reply 341-2.

Hasan A; Abraham WT; Quinn-Tate L; Brown L; Amkieh A. "Optimization of cardiac resynchronization devices using acoustic cardiography: a comparison to echocardiography.." Congestive Heart Failure (Greenwich, Conn.). Vol. 12 Suppl 1, (July 2006.): 25-.

Greenberg B, Lottes SR, Nelson JJ, Lukas MA, Fowler MB, Massie BM, Abraham WT, Gilbert EM, Franciosa JA; COHERE Participant Physicians.. "Predictors of clinical outcomes in patients given carvedilol for heart failure." American Journal of Cardiology. Vol. 11, no. 98. (December 2006.): 1480-1484.

Linde, Cecilia; Gold, Michael; Abraham, William, T; Daubert, Jean-Claude; Daubert, Jean-Claude. "Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization." American heart journal. Vol. 151, no. 2. (January 2006.): 288-94.

DeLuca L, Abraham WT, Fonarow GC, Gheorghiade M. "Congestion in acute heart failure syndromes: importance of early recognition and treatment." Rev Cardiovasc Med. no. 7. (January 2006.): 69-74.

Cappola, Thomas, P; Harsch, Manya, R; Jessup, Mariell; Abraham, William, T; Young, James, B; Petersen-Stejskal, Susan; Plappert, Ted; St John Sutton, Martin. "Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender.." Journal of cardiac failure. Vol. 12, no. 3. (January 2006.): 182-8.

Freemantle N; Tharmanathan P; Calvert MJ; Abraham WT; Ghosh J; Cleland JG. "Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction -- a systematic review and meta-analysis.." European Journal Of Heart Failure: Journal Of The Working Group On Heart Failure Of The European Society Of Cardiology. Vol. 8, no. 4. (June 2006.): 433-.

Gheorghiade,Mihai; Abraham,William,T; Albert,Nancy,M; Greenberg,Barry,H; O'Connor,Christopher,M; She,Lilin; Gattis Stough,Wendy; Yancy,Clyde,W; Young,James,B; Fonarow,Gregg,C. "Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 296, no. 18. (November 2006.): 2217-2226.

Linde,C; Gold,M; Abraham,W,T; Daubert,J,C. "Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure - the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study." American Heart Journal. Vol. 151, no. 2. (February 2006.): 288-.

Daniels,Lori,B; Clopton,Paul; Bhalla,Vikas; Krishnaswamy,Padma; Nowak,Richard,M; McCord,James; Hollander,Judd,E; Duc,Philippe; Omland,Torbjorn; Storrow,Alan,B; Abraham,William,T; Wu,Alan,HB; Steg,Philippe,G; Westheim,Arne; Knudsen,Cathrine,Wold; Perez,Alberto; Kazanegra,Radmila; Herrmann,Howard,C; McCullough,Peter,A; Maisel,Alan,S. "How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study." American Heart Journal. Vol. 151, no. 5. (May 2006.): 999-1005.

Klodell CT Jr; McGiffin DC; Rayburn BK; Sun B; Abraham WT; Conte JV; Russell SD; Pae WE Jr; Boehmer JP; Aranda JM Jr. "Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure.." The Journal Of Thoracic And Cardiovascular Surgery. Vol. 133, no. 1. (January 2007.): 204-.

Nishijima Y, Sridhar A, Viatchenko-Karpinski S, Shaw C, Bonagura JD, Abraham WT, Joshi MS, Bauer JA, Hamlin RL, Gyorke S, Feldman DS, Carnew CA. "Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy." Life Sci. no. 81. (January 2007.): 1152-1159.

Yamokoski,Laura,M; Haas,Garrie,J; Gans,Bradley; Abraham,William,T. "OptiVol (R) fluid status monitoring with an implantable cardiac device: a heart failure management system." Expert Review Of Medical Devices. Vol. 4, no. 6. (November 2007.): 775-780.

Abraham,William,T; Massie,Barry,M; Lukas,Mary,Ann; Lottes,Sandra,R; Nelson,Jeanenne,J; Fowler,Michael,B; Greenberg,Barry; Gilbert,Edward,M; Franciosa,Joseph,A. "Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.." Congestive Heart Failure (Greenwich, Conn.). Vol. 13, no. 1. (January 2007.): 16-21.

Klodell CT Jr, McGiffin DC, Rayburn BK, Sun B, Abraham WT, Conte JV, Russell SD, Pae WE Jr, Boehmer JP, Aranda JM Jr.. "Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure.." Journal of Thoracic Cardiovascular Surgery. Vol. 1, no. 133. (January 2007.): 204-209.

Hasan A, Abraham WT. "Cardiac resynchronization treatment of heart failure." Annu Rev Med. no. 58. (January 2007.): 63-74.

Fowler MB, lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie Bm, Abraham WT, Fanciosa JA, for the COHERE Participant Physicians. "Beta-blocker dosing in community-based treatment of heart failure." Am Heart J. no. 153. (January 2007.): 1029-1036.

Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM. Sun JL, Yancy CW, Young JB, on behalf of the OPTIMIZE-HF Investigators and Hospitals. "Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry." J Am Coll Cardiol. Vol. 50, no. 21. (January 2007.): 768-777.

Fonarow GC, Abraham Wt, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, on behalf of the OPTIMIZE-HF Investigators and Coordinators. "Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF." J Card Fail. no. 13. (January 2007.): 722-731.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB; OPTIMIZE-HF Investigators and Coordinators.. "Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).." American Heart Journal. Vol. 1, no. 153. (January 2007.): 82.e1-82.e11.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Pieper K, Sun JL, Yancy C, and Young JB for the OPTIMIZE-HF Investigators and Hospitals. "Association between Performance Measures and Clinical Outcomes for Patients Hospitalized with Heart Failure." Journal of the American Medical Association. Vol. 3, no. 297. (January 2007.): 61-70.

Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, on behalf of the OPTIMIZE-HF Investigators and Hospital. "Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." Arch Intern Med. no. 167. (January 2007.): 1493-1502.

Adamson, Philip, B; Conti, Jamie, B; Smith, Andrew, L; Abraham, William, T; Aaron, Mark, F; Aranda, Juan M Jr; Baker, James; Bourge, Robert, C; Warner-Stevenson, Lynne; Sparks, Brandon. "Reducing events in patients with chronic heart failure (REDUCEhf ) study design: continuous hemodynamic monitoring with an implantable defibrillator.." Clinical Cardiology. Vol. 30, no. 11. (January 2007.): -.

Abraham WT. "Intrathoracic impedance monitoring for early detection of impending heart failure decompensation." CHF. no. 13. (January 2007.): 113-115.

Massie BM, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA; COHERE Participant Physicians.. "Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.." American Journal of Cardiology. Vol. 9, no. 99. (May 2007.): 1263-1268.

Hiestand B, Abraham WT. "Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials." Cur Cardiol Rep. no. 9. (January 2007.): 182-186.

Gheorghiade,Mihai; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Greenberg,Barry,H; O'Connor,Christopher,M; She,Lilin; Yancy,Clyde,W; Young,James; Fonarow,Gregg,C. "Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry." European Heart Journal. Vol. 28, no. 8. (April 2007.): 980-988.

Fowler,Michael,B; Lottes,Sandra,R; Nelson,Jeanenne,J; Lukas,Mary,Ann; Gilbert,Edward,M; Greenberg,Barry; Massie,Barry,M; Abraham,William,T; Franciosa,Joseph,A. "beta-blocker dosing in community-based treatment of heart failure." American Heart Journal. Vol. 153, no. 6. (June 2007.): 1029-1036.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Pieper,Karen; Sun,Jie,Lena; Yancy,Clyde; Young,James,B. "Association between performance measures and clinical outcomes for patients hospitalized with heart failure." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 297, no. 1. (January 2007.): 61-70.

Nishijima,Yoshinori; Sridhar,Arun; Viatchenko-Karpinski,Serge; Shaw,Courtney; Bonagura,John,D; Abraham,William,T; Joshi,Mandar,S; Bauer,John,Anthony; Hamlin,Robert,L; Gyoerke,Sandor; Feldman,David,S; Carnes,Cynthia,A. "Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy." Life Sciences. Vol. 81, no. 14. (September 2007.): 1152-1159.

Fonarow,Gregg,C; Yancy,Clyde,W; Abraham,William,T; Greenberg,Barry,H. "Performance measures and outcomes for patients hospitalized with heart failure - Reply." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Vol. 297, no. 14. (April 2007.): 1548-1549.

Hasan,Ayesha; Abraham,William,T. "Cardiac resynchronization treatment of heart failure." Annual Review Of Medicine. Vol. 58, (January 2007.): 63-74.

Feldman AM, Oren RM, Abraham WT, Boehmer JP, Carson PE, Eichhorn E, Gilbert EM, Kao A, Leier CV, Lowes BD, Mathier MA, McGrew FA, Metra M, Zisman LS, Shakar SF, Krueger SK, Robertson AD, White BG, Gerber MJ, Wold GE, Bristow MR; EMOTE Study Group.. "Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.." American Heart Journal. Vol. 5, no. 154. (November 2007.): 861-869.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Pieper,Karen; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure - Results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)." Archives Of Internal Medicine. Vol. 167, no. 14. (July 2007.): 1493-1502.

Abraham,William,T. "Intrathoracic impedance monitoring for early detection of impending heart failure decompensation.." Congestive Heart Failure (Greenwich, Conn.). Vol. 13, no. 2. (March 2007.): 113-115.

Iyengar,Srinivas; Abraham,William,T. "Diuretics for the treatment of acute decompensated heart failure." Heart Failure Reviews. Vol. 12, no. 2. (June 2007.): 125-130.

Greenberg,Barry; Thomas,Ignatius; Banish,Dorothy; Goldman,Steven; Havranek,Edward; Massie,Barry,M; Zhu,Ying; Ticho,Barry; Abraham,William,T. "Effects of multiple oral doses of an A(1) adenosine antagonist, BG9928, in patients with heart failure - Results of a placebo-controlled, dose-escalation study." Journal Of The American College Of Cardiology. Vol. 50, no. 7. (August 2007.): 600-606.

Greenberg,Barry,H; Abraham,William,T; Albert,Nancy,M; Chiswell,Karen; Clare,Robert; Stough,Wendy,Gattis; Gheorghiade,Mihai; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B; Fonarow,Gregg,C. "Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." AMERICAN HEART JOURNAL. Vol. 154, no. 2. (August 2007.): 646-.

Greenberg,Barry,H; Abraham,William,T; Albert,Nancy,M; Chiswell,Karen; Clare,Robert; Stough,Wendy,Gattis; Gheorghiade,Mihai; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B; Fonarow,Gregg,C. "Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." American Heart Journal. Vol. 154, no. 4. (October 2007.): 647-654.

Massie,Barry,M; Nelson,Jeanenne,J; Lukas,Mary,Ann; Greenberg,Barry; Fowler,Michael,B; Gilbert,Edward,M; Abraham,William,T; Lottes,Sandra,R; Franciosa,Joseph,A. "Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 99, no. 9. (May 2007.): 1263-1268.

Iyengar,Srinivas; Haas,Garrie; Lamba,Sumant; Orsinelli,David,A; Babu,Gopal,J; Ferketich,Amy,K; Yamokoski,Laura; Periasamy,Muthu; Abraham,William,T. "Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy." Journal Of Cardiac Failure. Vol. 13, no. 4. (May 2007.): 304-311.

Hiestand,Brian; Abraham,William,T. "Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.." Current Cardiology Reports. Vol. 9, no. 3. (May 2007.): 182-186.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: Results from OPTIMIZE-HF." Journal Of Cardiac Failure. Vol. 13, no. 9. (November 2007.): 722-731.

Feldman,Arthur,M; Oren,Ron,M; Abraham,William,T; Boehmer,John,P; Carson,Peter,E; Eichhorn,Eric; Gilbert,Edward,M; Kao,Andrew; Leier,Carl,V; Lowes,Brian,D; Mathier,Michael,A; McGrew,Frank,A; Metra,Marco; Zisman,Lawrence,S; Shakar,Simon,F; Krueger,Steven,K; Robertson,Alastair,D; White,Bill,G; Gerber,Michael,J; Wold,Gwyn,E; Bristow,Michael,R. "Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial." American Heart Journal. Vol. 154, no. 5. (November 2007.): 861-869.

Adamson,Philip,B; Conti,Jamie,B; Smith,Andrew,L; Abraham,William,T; Aaron,Mark,F; Aranda,Juan,M; Baker,James; Bourge,Robert,C; Warner-Stevenson,Lynne; Sparks,Brandon. "Reducing events in patients with chronic heart failure (REDUCEhf) study design: Continuous Hemodynamic monitoring with an Implantable defibrillator." Clinical Cardiology. Vol. 30, no. 11. (November 2007.): 567-575.

Ritzema,Jay; Melton,Iain,C; Richards,A,Mark; Crozier,Ian,G; Frampton,Chris; Doughty,Robert,N; Whiting,James; Kar,Saibal; Eigler,Neal; Krum,Henry; Abraham,William,T; Troughton,Richard,W. "Direct left atrial pressure monitoring in ambulatory heart failure patients - Initial experience with a new permanent implantable device." Circulation. Vol. 116, no. 25. (December 2007.): 2952-2959.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde; Young,James,B. "Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." American Heart Journal. Vol. 153, no. 1. (January 2007.): 82.e1-.

Albert,Nancy,M; Fonarow,Gregg,C; Abraham,William,T; Chiswell,Karen; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Predictors of delivery of hospital-based heart failure patient education: A report from OPTIMIZE-HF." Journal Of Cardiac Failure. Vol. 13, no. 3. (April 2007.): 189-198.

Greenberg,Barry; Czerska,Barbara; Abraham,William,T; Neaton,James,D; Delgado,Reynolds,M; Mather,Paul; Bourge,Robert; Parker,Irene,C; Konstam,Marvin,A. "Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: The MOMENTUM trial." Journal Of Cardiac Failure. Vol. 13, no. 9. (November 2007.): 715-721.

Whellan DJ, O'Connor CM, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston-Miller N, Fleg JL, Schulman KA, Pina IL, on behalf of the HF-Action Trial Investigators. "Heart Failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale." Am Heart J. no. 153. (January 2007.): 201-211.

Ritzema J, Melton IC, Richards AM, Crozier IG, Frampton C, Doughty RN, Whiting J, Kar S, Eigler N, Krum H, Abraham WT, Troughton RW. "Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device." Circulation. no. 116. (January 2007.): 2952-2959.

Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, She L, Yancy CW, Young J, Fonarow GC; OPTIMIZE-HF Investigators and Coordinators.. "Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.." European Heart Journal. Vol. 8, no. 28. (April 2007.): 980-988.

Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT.. "Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study." Journal of the American College of Cardiology. Vol. 7, no. 50. (August 2007.): 600-606.

Iyengar S, Haas G, Lamba S, Orsinelli DA, Babu GJ, Ferketich AK, Yamokoski L, Periasamy M, Abraham WT. "Effect of cardiac resynchronization therapy on myocardial gene expression in patients with non-ischemic dilated cardiomyopathy." J Card Fail. no. 13. (January 2007.): 304-311.

Iyengar S, Abraham WT. "Diuretics for the treatment of acute decompensated heart failure." Heart Fail Rev. no. 12. (January 2007.): 125-130.

Greenberg B, Czerska B, Abraham WT, Neaton JD, Delgado RM, Mather P, Bourge R, Parker IC, Konstam MA; MOMENTUM Investigators and Coordinators.. "Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trial.." Journal of Cardiac Failure. Vol. 9, no. 13. (November 2007.): 715-721.

Yamokoski LM, Haas GJ, Gans B, Abraham WT. "OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system." Expert Rev Med Devices. no. 4. (January 2007.): 775-780.

Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O'Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC, on behalf of the OPTIMIZE-HF Investigators and Coordinators. "Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-JF)." Am Heart J. no. 154:277.el-277.e8. (January 2007.): -.

Fonarow,Gregg,C; Stough,Wendy,Gattis; Abraham,William,T; Albert,Nancy,M; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure - A report from the OPTIMIZE-HF registry." Journal Of The American College Of Cardiology. Vol. 50, no. 8. (August 2007.): 768-777.

Rossi,Joseph,S; Flaherty,James,D; Fonarow,Gregg,C; Nunez,Eduardo; Stough,Wendy,Gattis; Abraham,William,T; Albert,Nancy,M; Greenberg,Barry,H; O'Connor,Christopher,M; Yancy,Clyde,W; Young,James,B; Davidson,Charles,J; Gheorghiade,Mihai. "Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)." EUROPEAN JOURNAL OF HEART FAILURE. Vol. 10, no. 12. (December 2008.): 1215-1223.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Dosing of Beta-Blocker Therapy Before, During, and After Hospitalization for Heart Failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure)." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 102, no. 11. (December 2008.): 1524-1529.

Pu M; Abraham WT. "Resynchronisation therapy in heart failure: searching for predictors.." Heart (British Cardiac Society). Vol. 94, no. 1. (January 2008.): 4-.

Feldman D; Menachemi DM; Abraham WT; Wexler RK. "Management strategies for stage-D patients with acute heart failure.." Clinical Cardiology. Vol. 31, no. 7. (July 2008.): 297-.

Linde,Cecilia; Gold,Michael; Abraham,William,T; Daubert,Jean-Claude. "Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study.." Congestive Heart Failure (Greenwich, Conn.). Vol. 14, no. 2. (March 2008.): 66-74.

Young JB, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, She L, Sun JL, Yancy CW, Fonarow GC.. "Relation of Low Hemoglobin and Anemia to Morbidity and Mortality in Patients Hospitalized with Heart Failure (Insight from the OPTIMIZE-HF Registry)." Am J Cardiol. no. 101. (January 2008.): 223-230.

Pu M, Abraham WT. "Resynchronization therapy in heart failure: searching for predictors." Heart. no. 94. (January 2008.): 4-5.

Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. "Baseline characteristics of patients randomized in the Resynchronization Reverse Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study." Congest Heart Fail. no. 14. (January 2008.): 66-74.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE Study Group. "Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms." J Am Coll Cardiol. no. 52. (January 2008.): 1834-1843.

Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P. "Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.." Circulation. Vol. 117, no. 4. (January 2008.): 526-.

Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P; Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group.. "Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.." Circulation. Vol. 4, no. 117. (January 2008.): 526-535.

Chung ES, Leon AR, Tavarzzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. "Results of the Predictors of Response to CRT (PROSPECT) Trial." Circulation. no. 117. (January 2008.): 2608-2616.

Boerrigter G, Costello-Boerrigter LC, Abraham WT, Sutton MG, Heublein DM, Kruger KM, Hill MR, McCullough PA, Burnett JC Jr.. "Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate.." J Card Fail. Vol. 14, (January 2008.): 539-546.

Abraham. "Managing hyponatremia in heart failure." US Cardiology. no. 5. (January 2008.): 57-60.

O'Connor,Christopher,M; Abraham,William,T; Albert,Nancy,M; Clare,Robert; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; Yancy,Clyde,W; Young,James,B; Fonarow,Gregg,C. "Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." American Heart Journal. Vol. 156, no. 4. (October 2008.): 662-673.

Chung,Eugene,S; Leon,Angel,R; Tavazzi,Luigi; Sun,Jing-Ping; Nihoyannopoulos,Petros; Merlino,John; Abraham,William,T; Ghio,Stefano; Leclercq,Christophe; Bax,Jeroen,J; Yu,Cheuk-Man; Gorcsan,John; Sutton,Martin,St John; De Sutter,Johan; Murillo,Jaime. "Results of the predictors of response to CRT (PROSPECT) trial." Circulation. Vol. 117, no. 20. (May 2008.): 2608-2616.

Bourge,Robert,C; Abraham,William,T; Adamson,Philip,B; Aaron,Mark,F; Aranda,Juan,M; Magalski,Anthony; Zile,Michael,R; Smith,Andrew,L; Smart,Frank,W; O'Shaughnessy,Mark,A; Jessup,Mariell,L; Sparks,Brandon; Naftel,David,L; Stevenson,Lynne,Warner. "Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure - The COMPASS-HF study." Journal Of The American College Of Cardiology. Vol. 51, no. 11. (March 2008.): 1073-1079.

Somers,Virend,K; White,David,P; Amin,Raouf; Abraham,William,T; Costa,Fernando; Culebras,Antonio; Daniels,Stephen; Floras,John,S; Hunt,Carl,E; Olson,Lyle,J; Pickering,Thomas,G; Russell,Richard; Woo,Mary; Young,Terry. "Sleep apnea and cardiovascular disease - An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing." Journal Of The American College Of Cardiology. Vol. 52, no. 8. (August 2008.): 686-717.

Somers,Virend,K; White,David,P; Amin,Raouf; Abraham,William,T; Costa,Fernando; Culebras,Antonio; Daniels,Stephen; Floras,John,S; Hunt,Carl,E; Olson,Lyle,J; Pickering,Thomas,G; Russell,Richard; Woo,Mary; Young,Terry. "Sleep apnea and cardiovascular disease - An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing." CIRCULATION. Vol. 118, no. 10. (September 2008.): 1080-1111.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure." Journal Of The American College Of Cardiology. Vol. 52, no. 3. (July 2008.): 190-199.

Linde,Cecilia; Abraham,William,T; Gold,Michael,R; Sutton,Martin,StJohn; Ghio,Stefano; Daubert,Claude. "Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms." Journal Of The American College Of Cardiology. Vol. 52, no. 23. (December 2008.): 1834-1843.

Hasan A; Abraham WT. "Optimization of cardiac resynchronization therapy after implantation.." Current Treatment Options In Cardiovascular Medicine. Vol. 10, no. 4. (August 2008.): 319-.

Feldman,David; Menachemi,Doron,M; Abraham,William,T; Wexler,Randell,K. "Management strategies for stage-D patients with acute heart failure." CLINICAL CARDIOLOGY. Vol. 31, no. 7. (July 2008.): 297-301.

Zile,Michael,R; Bennett,Tom,D; Sutton,Martin,StJohn; Cho,Yong,K; Adamson,Philip,B; Aaron,Mark,F; Aranda,Juan,M; Abraham,William,T; Smart,Frank,W; Stevenson,Lynne,Warner; Kueffer,Fred,J; Bourge,Robert,C. "Transition from chronic compensated to acute decompensated heart failure - Pathophysiological insights obtained from continuous monitoring of intracardiac pressures." Circulation. Vol. 118, no. 14. (September 2008.): 1433-1441.

Boerrigter,Guido; Costello-Boerrigter,Lisa,C; Abraham,William,T; Sutton,Martin,GStJohn; Heublein,Denise,M; Kruger,Kristin,M; Hill,Michael,RS; McCullough,Peter,A; Burnett,John,C. "Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate." Journal Of Cardiac Failure. Vol. 14, no. 7. (September 2008.): 539-546.

Abraham,William,T. "Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.." Congestive Heart Failure (Greenwich, Conn.). Vol. 14, no. 5. (September 2008.): 272-280.

Abraham,William,T; Burkhoff,Daniel; Nademance,Koonlawee; Carson,Peter; Bourge,Robert; Ellenbogen,Kenneth,A; Parides,Michael; Kadish,Alan. "A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics." American Heart Journal. Vol. 156, no. 4. (October 2008.): 641-648.

Stevenson,Lynne,W; Hellkamp,Anne,S; Leier,Carl,V; Sopko,George; Koelling,Todd; Warnica,J,Wayne; Abraham,William,T; Kasper,Edward,K; Rogers,Joseph,G; Califf,Robert,M; Schramm,Elizabeth,E; O'Connor,Christopher,M. "Changing Preferences for Survival After Hospitalization With Advanced Heart Failure." Journal Of The American College Of Cardiology. Vol. 52, no. 21. (November 2008.): 1702-1708.

Zile,Michael,R; Bourge,Robert,C; Bennett,Tom,D; Stevenson,Lynne,Warner; Cho,Yong,K; Adamson,Philip,B; Aaron,Mark,F; Aranda,Juan,M; Abraham,William,T; Smart,Frank,W; Kueffer,Fred,J. "Application of Implantable Hemodynamic Monitoring in the Management of Patients With Diastolic Heart Failure: A Subgroup Analysis of the COMPASS-HF Trial." Journal Of Cardiac Failure. Vol. 14, no. 10. (December 2008.): 816-823.

Young,James,B; Abraham,William,T; Bourge,Robert,C; Konstam,Marvin,A; Stevenson,Lynne,Warner. "Task force 8: training in heart failure endorsed by the Heart Failure Society of America.." Journal Of The American College Of Cardiology. Vol. 51, no. 3. (January 2008.): 383-389.

Peacock,W,Frank; Fonarow,Gregg,C; Ander,Douglas,S; Maisel,Alan; Hollander,Judd,E; Januzzi,James,L; Yancy,Clyde,W; Collins,Sean,P; Gheorghiade,Mihai; Weintraub,Neal,L; Storrow,Alan,B; Pang,Peter,S; Abraham,William,T; Hiestand,Brian; Kirk,J,Douglas; Filippatos,Gerasimos; Gheorghiade,Mihai; Pang,Peter,S; Levy,Phillip; Amsterdam,Ezra,A. "Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee.." Critical Pathways In Cardiology. Vol. 7, no. 2. (June 2008.): 83-86.

Hasan,Ayesha; Abraham,William,T. "Optimization of cardiac resynchronization therapy after implantation.." Current treatment options in cardiovascular medicine. Vol. 10, no. 4. (August 2008.): 319-328.

Iyengar,Srinivas; Abraham,William,T. "Neutral endopeptidase inhibitors and endothelin antagonists." Cardiology Clinics. Vol. 26, no. 1. (February 2008.): 41-?.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Nunez,Eduardo; Yancy,Clyde,W; Young,James,B. "Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart Failure Findings From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)." CIRCULATION-HEART FAILURE. Vol. 1, no. 1. (May 2008.): 50-57.

Abraham,William,T; Trupp,Robin,J; Phillips,Barbara; Bourge,Robert,C; Harding,Susan,M; Schofield,Peter; Pilsworth,Samantha; Shneerson,John,M; Di Salvo,Thomas; Camuso,Janice; Johnson,Douglas,C; King,Martin. "Effect of treatment with continuous positive airway pressure or oxygen on sleep-disordered breathing in patients with heart failure: results of the Sleep Events, Arrhythmias, and Respiratory Analysis in Chronic Heart Failure (SEARCH) study.." Congestive Heart Failure (Greenwich, Conn.). Vol. 14, no. 4. (July 2008.): 197-201.

Greenberg,Barry; Czerska,Barbara; Delgado,Reynolds,M; Bourge,Robert; Zile,Michael,R; Silver,Marc; Klapholz,Marc; Haeusslein,Ernest; Mehra,Mandeep,R; Mather,Paul; Abraham,William,T; Neaton,James,D; Brown,B,Scott; Parker,Irene,C; Konstam,Marvin,A. "Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy - Results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)." Circulation. Vol. 118, no. 12. (September 2008.): 1241-1249.

Haas,Garrie,J; Pestritto,Vincent,M; Abraham,William,T. "Ultrafiltration for volume control in decompensated heart failure.." Heart Failure Clinics. Vol. 4, no. 4. (October 2008.): 519-534.

Khayat,Rami,N; Abraham,William,T; Patt,Brian; Roy,Monica; Hua,Keding; Jarjoura,David. "Cardiac Effects of Continuous and Bilevel Positive Airway Pressure for Patients With Heart Failure and Obstructive Sleep Apnea A Pilot Study." Chest. Vol. 134, no. 6. (December 2008.): 1162-1168.

Stevenson LW, Hellkamp AS, Leier CV, Sopko G, Koelling T, Warnica JW, Abraham WT, Kasper Ek, Rogers JG, Califf RM, Schramm EE, O'Connor CM. "Changing preferences for survival after hospitalization with advanced heart failure." J Am Coll Cardiol. no. 52. (January 2008.): 1702-1708.

Rossi JS, Flaherty JD, Fonarow GC, Nunez E, Gattis Stough W, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, Yancy CW, Young JB, Davidson CJ, Gheorghiade M.. "Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).." Eur J Heart Fail. Vol. 10, (January 2008.): 1215-1223.

Abraham WT, Trupp RJ, Phillips B, Bourge RC, Harding SM, Schofield P, Pilsworth S, Shneerson JM, Di Salvo T, Camuso J, Johnson DC, King M. "Effect of treatment with continuous positive airway pressure or oxygen on sleep-disordered breathing in patients with heart failure: results of the Sleep Events, Arrhythmias, and Respiratory Analysis in Chronic Heart Failure (SEARCH) study.." Congest Heart Fail. Vol. 14, no. 4. (July 2008.): 197-201.

Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Coordinators. "Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).." J Am Coll Cardiol. Vol. 52, no. 5. (July 2008.): 347-356.

Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, She Lilin, Sun JL, Young JB, Fonarow GC. "Quality of Care of and Outcomes for African Americans Hospitalized with Heart Failure: Findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry." J Am Coll Cardiol. no. 51. (January 2008.): 1675-1684.

Fonarow GC, Abraham WT, Albert NM< Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE HF Investiagors and coordinators. "Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE HF program." J Am Coll Cardiol. no. 52. (January 2008.): 190-199.

Fonarow GC, Abraham WT, Albert NM< Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB. "Dosing of beta-blocker therapy before, during, and after hopsitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)." Am J Cardiol. no. 102. (January 2008.): 1524-1529.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB; OPTIMIZE HF Investigators and Hospital. "Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: finding from OPTIMIZE HF." Arch Intern Med. no. 168. (January 2008.): 847-854.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Nunez E, Yancy CW, Young JB. "Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart Failure: Findings From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." Circulation. no. 1. (January 2008.): 50-57.

Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW; COMPASS-HF Study Group.. "Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.." Journal of the American College of Cardiology. Vol. 11, no. 51. (March 2008.): 1073-1079.

Yancy CW; Abraham WT; Albert NM; Clare R; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; She L; Sun JL; Young JB; Fonarow GC. "Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry.." Journal Of The American College Of Cardiology. Vol. 51, no. 17. (April 2008.): 1675-.

Somers VK; White DP; Amin R; Abraham WT; Costa F; Culebras A; Daniels S; Floras JS; Hunt CE; Olson LJ; Pickering TG; Russell R; Woo M; Young T. "Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health).." Circulation. Vol. 118, no. 10. (September 2008.): 1080-.

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology. "Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)." Circulation. no. 118. (January 2008.): 1080-1111 Erratum in: Circulation 2009; 119:e380..

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T. "Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing." Am Coll Cardiol. no. 52. (January 2008.): 686-717.

O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC. "Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).." Am Heart J. Vol. 156, (January 2008.): 662-673.

Klodell CT Jr; Aranda JM Jr; McGiffin DC; Rayburn BK; Sun B; Abraham WT; Pae WE Jr; Boehmer JP; Klein H; Huth C. "Worldwide surgical experience with the Paracor HeartNet cardiac restraint device.." The Journal Of Thoracic And Cardiovascular Surgery. Vol. 135, no. 1. (January 2008.): 188-.

Iyengar S, Abraham WT. "Neutral endopeptidase inhibitors and endothelin antagonists." Cardiol Clin. no. 26. (January 2008.): 41-48.

Greenberg B, Czerska B, Delgado RM, Bourge R, Zile MR, Silver M, Klapholz M, Haeusslein E, Mehra MR, Mather P, Abraham WT, Neaton JD, Brown BS, Parker IC, Konstam MA; MOMENTUM Investigators and Coordinators. "Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).." Circulation. Vol. 118, (January 2008.): 1241-1249.

Abraham WT; Greenberg BH; Yancy CW. "Pharmacologic therapies across the continuum of left ventricular dysfunction.." The American Journal Of Cardiology. Vol. 102, no. 5A. (September 2008.): 21G-.

Khayat RN, Abraham WT, Patt B, Roy M, Hua K, Jarjoura D.. "Cardiac Effects of Continuous and Bi-level Positive Airway Pressure for Patients with Heart Failure and Obstructive Sleep Apnea: A Pilot Study." Chest. (July 2008.): -.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Nunez,Eduardo; Yancy,Clyde,W; Young,James,B. "A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF." European Heart Journal. Vol. 29, no. 16. (August 2008.): 1983-1991.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Pieper,Karen; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Factors identified as precipitating hospital admissions for heart failure and clinical outcomes." Archives Of Internal Medicine. Vol. 168, no. 8. (April 2008.): 847-854.

Young,James,B; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; She,Lilin; Sun,Jie,Lend; Yancy,Clyde,W; Fonarow,Gregg,C. "Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (Insight from the OPTIMIZE-HF registry)." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 101, no. 2. (January 2008.): 223-230.

Abraham,William,T; Greenberg,Barry,H; Yancy,Clyde,W. "Pharmacologic therapies across the continuum of left ventricular dysfunction." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 102, no. 5A. (September 2008.): 21G-28G.

Yancy,Clyde,W; Abraham,William,T; Albert,Nancy,M; Clare,Robert; Stough,Wendy,Gattis; Gheorghlade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; She,Lilin; Sun,Jie,Lena; Young,James,B; Fonarow,Gregg,C. "Quality of care of and outcomes for African Americans hospitalized with heart failure." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Vol. 51, no. 17. (April 2008.): 1675-1684.

Abraham,William,T; Fonarow,Gregg,C; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Barry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde,W; Young,James,B. "Predictors of in-hospital mortality in patients hospitalized for heart failure - Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." Journal Of The American College Of Cardiology. Vol. 52, no. 5. (July 2008.): 347-356.

Fonarow,Gregg,C; Abraham,William,T; Albert,Nancy,M; Stough,Wendy,Gattis; Gheorghiade,Mihai; Greenberg,Berry,H; O'Connor,Christopher,M; Sun,Jie,Lena; Yancy,Clyde; Young,James,B. "Age- and Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized With Heart Failure (from OPTIMIZE-HF)." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 104, no. 1. (July 2009.): 107-115.

Sutton,Martin,StJohn; Ghio,Stefano; Plappert,Ted; Tavazzi,Luigi; Scelsi,Laura; Daubert,Claude; Abraham,William,T; Gold,Michael,R; Hassager,Christian; Herre,John,M; Linde,Cecilia. "Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure." Circulation. Vol. 120, no. 19. (November 2009.): 1858-1865.

Peacock,W,Frank; Fonarow,Gregg,C; Ander,Douglas,S; Collins,Sean,P; Gheorghiade,Mihai; Kirk,J,Douglas; Filippatos,Gerasimos; Diercks,Deborah,B; Trupp,Robin,J; Hiestand,Brian; Amsterdam,Ezra,A; Abraham,William,T; Amsterdam,Ezra,A; Dodge,Gail; Gaieski,David,F; Gurney,Diane; Hayes,Christy,O; Hollander,Judd,E; Holmes,Kay; Januzzi,James,L; Levy,Phillip; Maisel,Alan; Miller,Chadwick,D; Pang,Peter,S; Selby,Elsie; Storrow,Alan,B; Weintraub,Neal,L; Yancy,Clyde,W; Bahr,Raymond,D; Blomkalns,Andra,L; McCord,James; Nowak,Richard,M; Stomel,Robert,J. "Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6.." Acute Cardiac Care. Vol. 11, no. 1. (January 2009.): 3-42.

Collins,Sean,P; Peacock,W,Frank; Lindsell,Christopher,J; Clopton,Paul; Diercks,Deborah,B; Hiestand,Brian; Hogan,Chris; Kontos,Michael,C; Mueller,Christian; Nowak,Richard; Chen,Wen-Jone; Huang,Chien-Hua; Abraham,William,T; Amsterdam,Ezra; Breidthardt,Tobias; Daniels,Lori; Hasan,Ayesha; Hudson,Mike; McCord,James; Naz,Tehmina; Wagoner,Lynne,E; Maisel,Alan. "S3 Detection as a Diagnostic and Prognostic Aid in Emergency Department Patients With Acute Dyspnea." Annals Of Emergency Medicine. Vol. 53, no. 6. (June 2009.): 748-757.

Gras,Daniel; Gupta,Manish,S; Boulogne,Eric; Guzzo,Lisa; Abraham,William,T. "Optimization of AV and VV Delays in the Real-World CRT Patient Population: An International Survey on Current Clinical Practice." PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. Vol. 32, (March 2009.): S236-S239.

Albert,Nancy,M; Fonarow,Gregg,C; Abraham,William,T; Gheorghiade,Mihai; Greenberg,Barry,H; Nunez,Eduardo; O'Connor,Christopher,M; Stough,Wendy,G; Yancy,Clyde,W; Young,James,B. "Depression and Clinical Outcomes in Heart Failure: An OPTIMIZE-HF Analysis." AMERICAN JOURNAL OF MEDICINE. Vol. 122, no. 4. (April 2009.): 366-373.

Markowitz SM, Lewen JM, Wiggenhorn CJ, Abraham WT, Stein KM, Iwai S, Lerman BB. "Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization." J Cardiovasc Electrophysiol. no. 20. (January 2009.): 293-298.

Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E, O'Connor CM, Stough WG, Yancy CW, Young JB. "Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis." Am J Med. no. 122. (January 2009.): 366-373.

Abraham WT, Lowes BD, Roden RL, White M, Zisman LS, Gilbert EM, Gill EA, Rose CP, Bristow MR.. "Increased cardiac adrenergic activity in chronic heart failure: evidence for decreased cardiac neuronal norepinephrine uptake.." . (in preparation).. (January 2009.): -.

Abraham WT, Lowes BD, Roden RL, Lindenfeld J, Wolfel EE, Zisman L, Gilbert EM, White M, Rose CP, Bristow MR.. "Tracer norepinephrine kinetics in the coronary circulation of orthotopic heart transplant recipients: evidence for re-innervation late following cardiac transplantation.." (in preparation).. (January 2009.): -.

Abraham WT, Baliga RR. "Elevated ventricular filling pressures, which typically begin rising weeks before hospitalization, play a major role in the underlying pathophysiology of acute decompensated heart failure. Preface." Heart Fail Clin. no. 5. (January 2009.): xv-.

Abraham WT, Ascheim D, DeMarco T, Klapholz M, Kukin M, Miller A, Yellen L, Holcslaw TL, Packer M, for the ENCOR Investigators and Coordinators.. "Effects of Enrasentan, a Nonselective Endothelin Receptor Antagonist, in Class II-III Heart Failure: Results of the Enrasentan Cooperative Randomized (ENCOR) Evaluation.." (in preparation).. (January 2009.): -.

Trupp RJ; Abraham WT. "American College of Cardiology/American Heart Association 2009 clinical guidelines for the diagnosis and management of heart failure in adults: update and clinical implications.." Polskie Archiwum Medycyny Wewnȩtrznej. Vol. 119, no. 7-8. (July 2009.): 436-.

Krum,Henry; Schlaich,Markus; Whitbourn,Rob; Sobotka,Paul,A; Sadowski,Jerzy; Bartus,Krzysztof; Kapelak,Boguslaw; Walton,Anthony; Sievert,Horst; Thambar,Suku; Abraham,William,T; Esler,Murray. "Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study." Lancet. Vol. 373, no. 9671. (April 2009.): 1275-1281.

Jessup,Mariell; Abraham,William,T; Casey,Donald,E; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Konstam,Marvin,A; Mancini,Donna,M; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W; Hunt,Sharon,Ann; Chin,Marshall,H. "2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines." CIRCULATION. Vol. 119, no. 14. (April 2009.): 1977-2016.

Hunt,Sharon,Ann; Abraham,William,T; Chin,Marshall,H; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Konstam,Marvin,A; Mancini,Donna,M; Michl,Keith; Oates,John,A; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W; Jessup,Mariell; Casey,Donald,E. "2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines." CIRCULATION. Vol. 119, no. 14. (April 2009.): E391-E479.

Krum H, Abraham WT. "Heart Failure." Lancet. no. 6. (January 2009.): 57-64.

Jessup,Mariell; Abraham,William,T; Casey,Donald,E; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Konstam,Marvin,A; Mancini,Donna,M; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W; Hunt,Sharon,Ann; Chin,Marshall,H; Jessup,Mariell; Michl,Keith; Oates,John,A; Smith,Sidney,C; Jacobs,Alice,K; Buller,Christopher,E; Creager,Mark,A; Ettinger,Steven,M; Krumholz,Harlan,M; Kushner,Frederick,G; Lytle,Bruce,W; Nishimura,Rick,A; Page,Richard,L; Tarkington,Lynn,G; Yancy,Clyde,W; Lewin,John,C; May,Charlene; Bradfield,Lisa; Stewart,Mark,D; Keller,Sue; McDougall,Allison; Brown,Nancy; Whitman,Gayle,R. "2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Vol. 53, no. 15. (April 2009.): 1343-1382.

Jessup,Mariell; Abraham,William,T; Casey,Donald,E; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Konstam,Marvin,A; Mancini,Donna,M; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W; Hunt,Sharon,Ann; Chin,Marshall,H; Jessup,Mariell; Michl,Keith; Oates,John,A; Smith,Sidney,C; Jacobs,Alice,K; Buller,Christopher,E; Creager,Mark,A; Ettinger,Steven,M; Krumholz,Harlan,M; Kushner,Frederick,G; Lytle,Bruce,W; Nishimura,Rick,A; Page,Richard,L; Tarkington,Lynn,G; Yancy,Clyde,W; Lewin,John,C; May,Charlene; Bradfield,Lisa; Stewart,Mark,D; Keller,Sue; McDougall,Allison; Brown,Nancy; Whitman,Gayle,R. "2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Vol. 53, no. 15. (April 2009.): 1343-1382.

Hunt,Sharon,Ann; Abraham,William,T; Chin,Marshall,H; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Jessup,Mariell; Konstam,Marvin,A; Mancini,Donna,M; Michl,Keith; Oates,John,A; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W; Casey,Donald,E; Smith,Sidney,C; Jacobs,Alice,K; Buller,Christopher,E; Creager,Mark,A; Ettinger,Steven,M; Krumholz,Harlan,M; Kushner,Frederick,G; Lytle,Bruce,W; Nishimura,Rick,A; Page,Richard,L; Tarkington,Lynn,G; Yancy,Clyde,W; Lewin,John,C; May,Charlene; Stewart,Mark,D; Keller,Sue; McDougall,Allison; Brown,Nancy; Whitman,Gayle,R. "2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation." Journal Of The American College Of Cardiology. Vol. 53, no. 15. (April 2009.): E1-E90.

Salazar,Christina; Abraham,William,T. "Biventricular and novel pacing mechanisms in heart failure.." Current Heart Failure Reports. Vol. 6, no. 1. (March 2009.): 14-18.

Markowitz,Steven,M; Lewen,Jason,M; Wiggenhorn,Christopher,J; Abraham,William,T; Stein,Kenneth,M; Iwai,Sei; Lerman,Bruce,B. "Relationship of Reverse Anatomical Remodeling and Ventricular Arrhythmias After Cardiac Resynchronization." Journal Of Cardiovascular Electrophysiology. Vol. 20, no. 3. (March 2009.): 293-298.

Jessup,Mariell; Abraham,William,T; Casey,Donald,E; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Konstam,Marvin,A; Mancini,Donna,M; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W. "2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.." Circulation. Vol. 119, no. 14. (April 2009.): 1977-2016.

Hunt,Sharon,Ann; Abraham,William,T; Chin,Marshall,H; Feldman,Arthur,M; Francis,Gary,S; Ganiats,Theodore,G; Jessup,Mariell; Konstam,Marvin,A; Mancini,Donna,M; Michl,Keith; Oates,John,A; Rahko,Peter,S; Silver,Marc,A; Stevenson,Lynne,Warner; Yancy,Clyde,W. "2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.." Circulation. Vol. 119, no. 14. (April 2009.): e391-479.

Linde,Cecilia; Abraham,William,T; Gold,Michael,R; Sutton,Martin,St John; Ghio,Stefano; Daubert,Claude. "No Benefit From Cardiac Resynchronization Therapy in Asymptomatic Patients Reply." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Vol. 53, no. 23. (June 2009.): 2198-2199.

Pahle,Andreas,S; Sorli,Daniel; Omland,Torbjorn; Knudsen,Cathrine,Wold; Westheim,Arne; Wu,Alan,HB; Steg,Philippe,Gabriel; McCord,James; Nowak,Richard,M; Hollander,Judd,E; Storrow,Alan,B; Abraham,William,T; McCullough,Peter,A; Maisel,Alan. "Impact of Systemic Hypertension on the Diagnostic Performance of B-Type Natriuretic Peptide in Patients With Acute Dyspnea." AMERICAN JOURNAL OF CARDIOLOGY. Vol. 104, no. 7. (October 2009.): 966-971.

Klapholz,Marc; Abraham,William,T; Ghali,Jalal,K; Ponikowski,Piotr; Anker,Stefan,D; Knusel,Beat; Sun,Yan; Wasserman,Scott,M; van Veldhuisen,Dirk,J. "The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure." EUROPEAN JOURNAL OF HEART FAILURE. Vol. 11, no. 11. (November 2009.): 1071-1077.

Khayat,Rami,N; Jarjoura,David; Patt,Brian; Yamokoski,Todd; Abraham,William,T. "In-hospital Testing for Sleep-disordered Breathing in Hospitalized Patients With Decompensated Heart Failure: Report of Prevalence and Patient Characteristics." Journal Of Cardiac Failure. Vol. 15, no. 9. (November 2009.): 739-746.

Burkhoff,Daniel; Parides,Michael; Borggrefe,Martin; Abraham,William,T; Kadish,Alan. """Responder Analysis" for Assessing Effectiveness of Heart Failure Therapies Based on Measures of Exercise Tolerance."." Journal Of Cardiac Failure. Vol. 15, no. 2. (March 2009.): 108-115.

Abraham,Theodore; Kass,David; Tonti,Giovanni; Tomassoni,Gery,F; Abraham,William,T; Bax,Jeroen,J; Marwick,Thomas,H. "Imaging Cardiac Resynchronization Therapy." JACC-CARDIOVASCULAR IMAGING. Vol. 2, no. 4. (April 2009.): 486-497.

Flaherty,James,D; Rossi,Joseph,S; Fonarow,Gregg,C; Nunez,Eduardo; Stough,Wendy,Gattis; Abraham,William,T; Albert,Nancy,M; Greenberg,Barry,H; O'Connor,Christopher,M; Yancy,Clyde,W; Young,James,B; Davidspm-Son,Charles,J; Davidson,Charles,J; Gheorghiade,Mihai. "Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: Findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." American Heart Journal. Vol. 157, no. 6. (June 2009.): 1018-1025.

Khayat,Rami,N; Abraham,William,T; Patt,Brian; Pu,Min; Jarjoura,David. "In-Hospital Treatment of Obstructive Sleep Apnea During Decompensation of Heart Failure." Chest. Vol. 136, no. 4. (October 2009.): 991-.

Boerrigter,Guido; Costello-Boerrigter,Lisa,C; Abraham,William,T; Sutton,Martin,GStJohn; Heublein,Denise,M; Kruger,Kristin,M; Hill,Michael,RS; McCullough,Peter,A; Burnett,John,C. "Cardiac Resynchronization Therapy Improves Renal Function: Importance of Forward and Backward Failure Response." JOURNAL OF CARDIAC FAILURE. Vol. 15, no. 1. (February 2009.): 79-80.

Bench,Travis; Burkhoff,Daniel; O'Connell,John,B; Costanzo,Maria,Rosa; Abraham,William,T; St John Sutton,Martin; Maurer,Mathew,S. "Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction.." Current Heart Failure Reports. Vol. 6, no. 1. (March 2009.): 57-64.

Collins,Sean,P; Levy,Phillip,D; Lindsell,Christopher,J; Pang,Peter,S; Storrow,Alan,B; Miller,Chadwick,D; Naftilan,Allen,I; Thohan,Vinay; Abraham,William,T; Hiestand,Brian; Filippatos,Gerasimos; Diercks,Deborah,B; Hollander,Judd; Nowak,Richard; Peacock,W,Frank; Gheorghiade,Mihai. "The Rationale for an Acute Heart Failure Syndromes Clinical Trials Network." Journal Of Cardiac Failure. Vol. 15, no. 6. (August 2009.): 467-474.

Ben Johnson,W; Abraham,William,T; Young,James,B; Wheelan,Kevin; Smith,Andrew,L; Chang,Yanping; Brinkman,Paula. "Long-Term Performance of the Attain Model 4193 Left Ventricular Lead." PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. Vol. 32, no. 9. (September 2009.): 1111-1116.

Metra,Marco; Eichhorn,Eric; Abraham,William,T; Linseman,Jennifer; Boehm,Michael; Corbalan,Ramon; DeMets,David; De Marco,Teresa; Elkayam,Uri; Gerber,Michael; Komajda,Michel; Liu,Peter; Mareev,Vyacheslev; Perrone,Sergio,V; Poole-Wilson,Philip; Roecker,Ellen; Stewart,Jennifer; Swedberg,Karl; Tendera,Michal; Wiens,Brian; Bristow,Michael,R. "Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials." European Heart Journal. Vol. 30, no. 24. (December 2009.): 3015-3026.

Salazar C, Abraham WT. "Biventricular and novel pacing mechanisms in heart failure." Curr Heart Fail Rep. no. 6. (January 2009.): 14-18.

Abraham WT; Baliga RR. "Hemodynamic monitoring in the diagnosis and management of heart failure. Preface.." Heart Failure Clinics. Vol. 5, no. 2. (April 2009.): xv-.

Collins SP, Peacock WF, Lindsell CJ, Clopton P, Diercks DB, Histand B, Hogan C, Kontos MC, Mueller C, Nowak R, Chen WJ, Huang CH, Abraham WT, Amsterdam E, Breidthardt T, Daniels L, Hasan A, Hudson M, McCord J, Naz T, Wagoner LE, Maisel A.. "S3 detection as a diagnostic and prognostic aid in emergency department pateints with acute dyspenea." Ann Emerg Med. no. 53. (January 2009.): 748-757.

Bench T, Burkhoff D, O'Connell JB, Costanzo MR, Abraham WT, St John Sutton M, Maurer MS. "Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction." Curr Heart Fail Rep. no. 6. (January 2009.): 57-64.

Roden RL, Protter AA, Asano K, Wichman SE, Hoover EM, Bristow MR, Abraham WT.. "Effect of human B-type natriuretic peptide on contractile response in the Langendorff-perfused rabbit heart and in isolated human right ventricular trabeculae.." submitted. (January 2009.): -.

O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis Sj, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL; HF-ACTIOn Investicators. "Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION rancomized controlled trial." JAMA. no. 301. (January 2009.): 1439-1450.

Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL; STICH Hypothesis 2 Investigators. "Coronary bypass surgery with or without surgical ventricular reconstruction.." N Engl J Med. Vol. 360, (January 2009.): 1705-1717.

Gras D, Gubta MS, Boulogne E, Guzzo L, Abraham WT. "Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice." Pacing Clin Electrophysiol. no. 32 (suppl 1). (January 2009.): S236-S239.

Ritz E; Krum H; Schlaich M; Whitbourn R; Sobotka PA; Sadowski J; Bartus K; Kapelak B; Walton A; Sievert H; Thambar S; Abraham WT; Esler M; Wang Y; Tsun Z; Machnik A; Neuhofer W; Jantsch J; Dahlmann A; Tammela T; Machura K; Park JK; Beck FX; Müller DN; Derer W; Goss J; Ziomber A; Dietsch P; Wagner H; van Rooijen N; Kurtz A; Hilgers KF; Alitalo K; Eckardt KU; Luft FC; Kerjaschki D; Titze J. "New approaches to pathogenesis and management of hypertension.." Clinical Journal Of The American Society Of Nephrology: CJASN. Vol. 4, no. 12. (December 2009.): 1886-.

Krum,Henry; Abraham,William,T. "Heart failure." Lancet. Vol. 373, no. 9667. (March 2009.): 941-955.

Van Bommel,Rutger,J; Bax,Jeroen,J; Abraham,William,T; Chung,Eugene,S; Pires,Luis,A; Tavazzi,Luigi; Zimetbaum,Peter,J; Gerritse,Bart; Kristiansen,Nina; Ghio,Stefano. "Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis." European Heart Journal. Vol. 30, no. 20. (October 2009.): 2470-2477.

Daubert,Claude; Gold,Michael,R; Abraham,William,T; Ghio,Stefano; Hassager,Christian; Goode,Grahame; Szili-Torok,Tamas; Linde,Cecilia. "Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial." Journal Of The American College Of Cardiology. Vol. 54, no. 20. (November 2009.): 1837-1846.

Abraham,William,T; Gras,Daniel; Yu,Cheuk,Man; Guzzo,Lisa; Gupta,Manish,S. "Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial." American Heart Journal. Vol. 159, no. 6. (June 2010.): 944-U1.

Bristow,Michael,R; Murphy,Guinevere,A; Krause-Steinrauf,Heidi; Anderson,Jeffrey,L; Carlquist,John,F; Thaneemit-Chen,Surai; Krishnan,Vaishali; Abraham,William,T; Lowes,Brian,D; Port,J,David; Davis,Gordon,W; Lazzeroni,Laura,C; Robertson,Alastair,D; Lavori,Phillip,W; Liggett,Stephen,B. "An alpha(2C)-Adrenergic Receptor Polymorphism Alters the Norepinephrine-Lowering Effects and Therapeutic Response of the beta-Blocker Bucindolol in Chronic Heart Failure." CIRCULATION-HEART FAILURE. Vol. 3, no. 1. (January 2010.): 21-28.

Chung,Eugene,S; Katra,Rodolphe,P; Ghio,Stefano; Bax,Jeroen; Gerritse,Bart; Hilpisch,Kathryn; Peterson,Brett,J; Feldman,David,S; Abraham,William,T. "Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction > 35%: a PROSPECT trial substudy." EUROPEAN JOURNAL OF HEART FAILURE. Vol. 12, no. 6. (June 2010.): 581-587.

Abraham,William,T; Aranda,Juan,M; Boehmer,John,P; Elkayam,Uri; Gilbert,Edward,M; Gottlieb,Stephen,S; Hasenfuss,Gerd; Kukin,Marrick; Lowes,Brian,D; O'Connell,John,B; Tavazzi,Luigi; Feldman,Arthur,M; Ticho,Barry; Orlandi,Cesare. "Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study." CTS-CLINICAL AND TRANSLATIONAL SCIENCE. Vol. 3, no. 5. (October 2010.): 249-253.

Abraham,William,T; Trupp,Robin,J; Jarjoura,David. "Nesiritide in Acute Decompensated Heart Failure: A Pooled Analysis of Randomized Controlled Trials." Clinical Cardiology. Vol. 33, no. 8. (August 2010.): 484-489.

Keteyian,Steven,J; Brawner,Clinton,A; Ehrman,Jonathan,K; Ivanhoe,Russell; Boehmer,John,P; Abraham,William,T. "Reproducibility of Peak Oxygen Uptake and Other Cardiopulmonary Exercise Parameters Implications for Clinical Trials and Clinical Practice." Chest. Vol. 138, no. 4. (October 2010.): 950-955.

Abraham,William,T; Anand,Inder,S; Klapholz,Marc; Ponikowski,Piotr; Scarlata,Debra; Wasserman,Scott,M; van Veldhuisen,Dirk,J. "Treatment of anemia with darbepoetin alfa in heart failure.." Congestive Heart Failure (Greenwich, Conn.). Vol. 16, no. 3. (May 2010.): 87-95.

Stevenson,Lynne,Warner; Zile,Michael; Bennett,Tom,D; Kueffer,Fred,J; Jessup,Mariell,L; Adamson,Philip; Abraham,William,T; Manda,Ven; Bourge,Robert,C. "Chronic Ambulatory Intracardiac Pressures and Future Heart Failure Events." CIRCULATION-HEART FAILURE. Vol. 3, no. 5. (September 2010.): 580-587.

Linde,Cecilia; Abraham,William,T; Gold,Michael,R; Daubert,Claude. "Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study." Journal Of The American College Of Cardiology. Vol. 56, no. 22. (November 2010.): 1826-1831.

Froehlich,Georg; Steffel,Jan; Huerlimann,David; Enseleit,Frank; Luescher,Thomas,F; Ruschitzka,Frank; Abraham,William,T; Holzmeister,Johannes. "Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling." European Heart Journal. Vol. 31, no. 12. (June 2010.): 1477-1485.

Singh JP; Abraham WT. "Enhancing the response to cardiac resynchronization therapy: is it time to individualize the left ventricular pacing site?." Journal Of The American College Of Cardiology. Vol. 55, no. 6. (February 2010.): 576-.

Holzmeister J; Abraham WT. "Device therapy: Indications for ICD-CRT in mildly symptomatic heart failure.." Nature Reviews. Cardiology. Vol. 7, no. 1. (January 2010.): 7-.

van Bommel,R,J; Gorcsan,J; Chung,E,S; Abraham,W,T; Gjestvang,F,T; Leclercq,C; Monaghan,M,J; Nihoyannopoulos,P; Peraldo,C; Yu,C-M; Demas,M; Gerritse,B; Bax,J,J. "Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT." HEART. Vol. 96, no. 14. (July 2010.): 1107-1113.

Peacock,W,Frank; Braunwald,Eugene; Abraham,William; Albert,Nancy; Burnett,John; Christenson,Rob; Collins,Sean; Diercks,Deborah; Fonarow,Greg; Hollander,Judd; Kellerman,Art; Gheorghiade,Mihai; Kirk,Doug; Levy,Phil; Maisel,Alan; Massie,Barry,M; O'Connor,Christopher; Pang,Peter; Shah,Monica; Sopko,George; Stevenson,Lynne; Storrow,Alan; Teerlink,John. "National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Vol. 56, no. 5. (July 2010.): 343-351.

Ritzema,Jay; Troughton,Richard; Melton,Iain; Crozier,Ian; Doughty,Robert; Krum,Henry; Walton,Anthony; Adamson,Philip; Kar,Saibal; Shah,Prediman,K; Richards,Mark; Eigler,Neal,L; Whiting,James,S; Haas,Garrie,J; Heywood,J,Thomas; Frampton,Christopher,M; Abraham,William,T. "Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure." Circulation. Vol. 121, no. 9. (March 2010.): 1086-1095.

Georgakopoulos,Dimitrios; Little,William,C; Abraham,William,T; Weaver,Fred,A; Zile,Michael,R. "Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection Fraction." Journal Of Cardiac Failure. Vol. 17, no. 2. (February 2011.): 167-178.

Krum,Henry; Massie,Barry; Abraham,William,T; Dickstein,Kenneth; Kober,Lars; McMurray,John,JV; Desai,Ashkay; Gimpelewicz,Claudio; Kandra,Albert; Reimund,Bernard; Rattunde,Henning; Armbrecht,Juergen. "Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study." European Journal Of Heart Failure. Vol. 13, no. 1. (January 2011.): 107-114.

Ritzema,Jay,L; Richards,A,Mark; Crozier,Ian,G; Frampton,Christopher,F; Melton,Iain,C; Doughty,Robert,N; Stewart,James,T; Eigler,Neal; Whiting,James; Abraham,William,T; Troughton,Richard,W. "Serial Doppler Echocardiography and Tissue Doppler Imaging in the Detection of Elevated Directly Measured Left Atrial Pressure in Ambulant Subjects With Chronic Heart Failure." JACC-CARDIOVASCULAR IMAGING. Vol. 4, no. 9. (September 2011.): 927-934.

Javaheri,Shahrokh; Ben Caref,E; Chen,Er; Tong,Kuo,Bianchini; Abraham,William,T. "Sleep Apnea Testing and Outcomes in a Large Cohort of Medicare Beneficiaries with Newly Diagnosed Heart Failure." American Journal Of Respiratory And Critical Care Medicine. Vol. 183, no. 4. (February 2011.): 539-546.

Velazquez,Eric,J; Lee,Kerry,L; Deja,Marek,A; Jain,Anil; Sopko,George; Marchenko,Andrey; Ali,Imtiaz,S; Pohost,Gerald; Gradinac,Sinisa; Abraham,William,T; Yii,Michael; Prabhakaran,Dorairaj; Szwed,Hanna; Ferrazzi,Paolo; Petrie,Mark,C; O'Connor,Christopher,M; Panchavinnin,Pradit; She,Lilin; Bonow,Robert,O; Rankin,Gena,Roush; Jones,Robert,H; Rouleau,Jean-Lucien. "Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 364, no. 17. (April 2011.): 1607-1616.

Ruschitzka,Frank; Abraham,William,T. "Heart failure: In search of improved therapies for acute heart failure.." Nature Reviews. Cardiology. Vol. 8, no. 1. (January 2011.): 9-10.

Kadish,Alan; Nademanee,Koonlawee; Volosin,Kent; Krueger,Steven; Neelagaru,Suresh; Raval,Nirav; Obel,Owen; Weiner,Stanislav; Wish,Marc; Carson,Peter; Ellenbogen,Kenneth; Bourge,Robert; Parides,Michael; Chiacchierini,Richard,P; Goldsmith,Rochelle; Goldstein,Sidney; Mika,Yuval; Burkhoff,Daniel; Abraham,William,T. "A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure." American Heart Journal. Vol. 161, no. 2. (February 2011.): 329-U582.

Abraham,William,T; Compton,Steven; Haas,Garrie; Foreman,Blair; Canby,Robert,C; Fishel,Robert; McRae,Scott; Toledo,Gloria,B; Sarkar,Shantanu; Hettrick,Douglas,A. "Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).." Congestive Heart Failure (Greenwich, Conn.). Vol. 17, no. 2. (March 2011.): 51-55.

Abraham,William,T; Adamson,Philip,B; Hasan,Ayesha; Bourge,Robert,C; Pamboukian,Salpy,V; Aaron,Mark,F; Raval,Nirav,Y. "Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure." American Heart Journal. Vol. 161, no. 3. (March 2011.): 558-566.

Adamson,Philip,B; Zile,Michael,R; Cho,Yong,K; Bennett,Tom,D; Bourge,Robert,C; Aaron,Mark,F; Aranda,Juan,M; Abraham,William,T; Kueffer,Fred,J; Taepke,Robert,T. "Hemodynamic Factors Associated With Acute Decompensated Heart Failure: Part 2-Use in Automated Detection." Journal Of Cardiac Failure. Vol. 17, no. 5. (May 2011.): 366-373.

Sarkar,Shantanu; Hettrick,Douglas,A; Koehler,Jodi; Rogers,Tyson; Grinberg,Yanina; Yu,Cheuk-Man; Abraham,William,T; Small,Roy; Tang,W,HWilson. "Improved Algorithm to Detect Fluid Accumulation via Intrathoracic Impedance Monitoring in Heart Failure Patients With Implantable Devices." Journal Of Cardiac Failure. Vol. 17, no. 7. (July 2011.): 569-576.

Anker,Stefan,D; Koehler,Friedrich; Abraham,William,T. "Telemedicine and remote management of heart failure Reply." LANCET. Vol. 378, no. 9806. (November 2011.): E10-E10.

Adamson,Philip,B; Abraham,William,T; Aaron,Mark; Aranda,Juan,M; Bourge,Robert,C; Smith,Andrew; Stevenson,Lynne,W; Bauman,Jordan,G; Yadav,Jay,S. "CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System." Journal Of Cardiac Failure. Vol. 17, no. 1. (January 2011.): 3-10.

Pires,Luis,A; Ghio,Stefano; Chung,Eugene,S; Tavazzi,Luigi; Abraham,William,T; Gerritse,Bart. "Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure.." Congestive Heart Failure (Greenwich, Conn.). Vol. 17, no. 2. (March 2011.): 65-70.

Houmsse,Mahmoud; Franco,Veronica; Abraham,William,T. "Epidemiology of sudden cardiac death in patients with heart failure.." Heart Failure Clinics. Vol. 7, no. 2. (April 2011.): 147-?.

Gottlieb,Stephen,S; Ticho,Barry; Deykin,Aaron; Abraham,William,T; DeNofrio,David; Russell,Stuart,D; Chapman,Douglas; Smith,William; Goldman,Steven; Thomas,Ignatius. "Effects of BG9928, an Adenosine A(1) Receptor Antagonist, in Patients With Congestive Heart Failure." Journal Of Clinical Pharmacology. Vol. 51, no. 6. (June 2011.): 899-907.

Anker,Stefan,D; Koehler,Friedrich; Abraham,William,T. "Telemedicine and remote management of patients with heart failure.." Lancet. Vol. 378, no. 9792. (August 2011.): 731-739.

Abraham,William,T; Nademanee,Koonlawee; Volosin,Kent; Krueger,Steven; Neelagaru,Suresh; Raval,Nirav; Obel,Owen; Weiner,Stanislav; Wish,Marc; Carson,Peter; Ellenbogen,Kenneth; Bourge,Robert; Parides,Michael; Chiacchierini,Richard,P; Goldsmith,Rochelle; Goldstein,Sidney; Mika,Yuval; Burkhoff,Daniel; Kadish,Alan. "Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure." JOURNAL OF CARDIAC FAILURE. Vol. 17, no. 9. (September 2011.): 710-717.

Abraham WT; Nademanee K; Volosin K; Krueger S; Neelagaru S; Raval N; Obel O; Weiner S; Wish M; Carson P; Ellenbogen K; Bourge R; Parides M; Chiacchierini RP; Goldsmith R; Goldstein S; Mika Y; Burkhoff D; Kadish A. "Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.." Journal Of Cardiac Failure. Vol. 17, no. 9. (September 2011.): 710-.

Zile,Michael,R; Adamson,Philip,B; Cho,Yong,K; Bennett,Tom,D; Bourge,Robert,C; Aaron,Mark,F; Aranda,Juan,M; Abraham,William,T; Stevenson,Lynne,Warner; Kueffer,Fred,J. "Hemodynamic Factors Associated With Acute Decompensated Heart Failure: Part 1-Insights into Pathophysiology." Journal Of Cardiac Failure. Vol. 17, no. 4. (April 2011.): 282-291.

Troughton,Richard,W; Ritzema,Jay; Eigler,Neal,L; Melton,Iain,C; Krum,Henry; Adamson,Philip,B; Kar,Saibal; Shah,Prediman,K; Whiting,James,S; Heywood,J,Thomas; Rosero,Spencer; Singh,Jagmeet,P; Saxon,Leslie; Matthews,Ray; Crozier,Ian,G; Abraham,William,T. "Direct Left Atrial Pressure Monitoring in Severe Heart Failure: Long-Term Sensor Performance." Journal Of Cardiovascular Translational Research. Vol. 4, no. 1. (February 2011.): 3-13.

Gold,Michael,R; Linde,Cecilia; Abraham,William,T; Gardiwal,Ajmal; Daubert,Jean-Claude. "The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure." HEART RHYTHM. Vol. 8, no. 5. (May 2011.): 679-684.

Adamson,Philip,B; Abraham,William,T; Yadav,Jay. "Wireless pulmonary artery haemodynamic monitoring Reply." LANCET. Vol. 377, no. 9784. (June 2011.): 2177-2177.

Smith,Sakima,A; Abraham,William,T. "Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.." Congestive Heart Failure (Greenwich, Conn.). Vol. 17, no. 5. (September 2011.): 220-.

Abraham,William,T; Adamson,Philip,B; Bourge,Robert,C; Aaron,Mark,F; Costanzo,Maria,Rosa; Stevenson,Lynne,W; Strickland,Warren; Neelagaru,Suresh; Raval,Nirav; Krueger,Steven; Weiner,Stanislav; Shavelle,David; Jeffries,Bradley; Yadav,Jay,S. "Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial." Lancet. Vol. 377, no. 9766. (February 2011.): 658-666.

Steffel,Jan; Holzmeister,Johannes; Abraham,William,T. "Recent Advances in Cardiac Resynchronization Therapy." Postgraduate Medicine. Vol. 123, no. 2. (March 2011.): 18-26.

Anker,Stefan,D; Koehler,Friedrich; Abraham,William,T. "Heart Failure 4 Telemedicine and remote management of patients with heart failure." Lancet. Vol. 378, no. 9792. (August 2011.): 731-739.

Mazzaferri,Ernest,L; Gradinac,Sinisa; Sagic,Dragan; Otasevic,Petar; Hasan,Ayesha,K; Goff,Thomas,L; Sievert,Horst; Wunderlich,Nina; Nikolic,Serjan,D; Abraham,William,T. "Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial." AMERICAN HEART JOURNAL. Vol. 163, no. 5. (May 2012.): 812-?.

Ponikowski,Piotr; Javaheri,Shahrokh; Michalkiewicz,Dariusz; Bart,Bradley,A; Czarnecka,Danuta; Jastrzebski,Marek; Kusiak,Aleksander; Augostini,Ralph; Jagielski,Dariusz; Witkowski,Tomasz; Khayat,Rami,N; Oldenburg,Olaf; Gutleben,Klaus-Juergen; Bitter,Thomas; Karim,Rehan; Iber,Conn; Hasan,Ayesha; Hibler,Karl; Germany,Robin; Abraham,William,T. "Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure." EUROPEAN HEART JOURNAL. Vol. 33, no. 7. (April 2012.): 889-894.

Ghali,Jalal,K; Orlandi,Cesare; Abraham,William,T. "The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study." EUROPEAN JOURNAL OF HEART FAILURE. Vol. 14, no. 6. (June 2012.): 642-651.

Costanzo,Maria,Rosa; Ivanhoe,Russell,J; Kao,Andrew; Anand,Inder,S; Bank,Alan; Boehmer,John; DeMarco,Teresa; Hergert,Cheryl,M; Holcomb,Richard,G; Maybaum,Simon; Sun,Benjamin; Vassiliades,Thomas,A; Rayburn,Barry,K; Abraham,William,T. "Prospective Evaluation of Elastic Restraint to Lessen the Effects of Heart Failure (PEERLESS-HF) Trial." JOURNAL OF CARDIAC FAILURE. Vol. 18, no. 6. (June 2012.): 446-458.

 

Reference Works

January 1989 Abraham WT, Schrier RW."The hepatorenal syndrome: reversal of diuretic resistance with increased effective arterial blood volume" .
January 1989 Abraham WT, Hensen J, Dürr J, Schrier RW."Elevated plasma norepinephrine concentrations in patients with congestive heart failure: dependence on increased secretion rates" .
January 1989 Hensen J, Dürr JA, Lesnefsky E, Abraham WT, Schrier RW."Untersuchungen zur pharmakokinetik von h-ANF bei patienten mit herzinsuffizienz" .
January 1989 Hensen J, Dürr J, Abraham WT, Lesnefsky E, Groves B, Lindenfeld J, Ganousis L, Schrier RW."Atrial natriuretic peptide kinetics in patients with congestive heart failure" .
January 1990 Abraham WT, Kim JK, Hensen J, Durr J, Schrier RW."Relationships between hemodynamic state, plasma atrial natriuretic factor, and urinary cyclic guanosine monophosphate in patients with congestive heart failure" .
January 1990 Hensen J, Abraham WT, Dürr J, Gross P, Schrier RW."Rolle von aldosteron in der natriumretention bei patienten mit herzinsuffizienz" .
January 1992 Rahman SN, Abraham WT, Van Putten V, Hasbargen J, Schrier RW."Norepinephrine kinetic studies in patients with nephrotic syndrome" .
January 1992 Abraham WT, Hensen J, Lauwaars M, Dürr J, Kim JK, Schrier RW."Atrial natriuretic peptide in patients with congestive heart failure" .
January 1993 Cody RJ, Leier CV, Bristow MR, Fifer MA, Binkley PF, Haas GJ, Starling RC, Abraham WT, Lowes BD, Dec GW, Semigran MJ, Cowart TD."OPC-18790 produces titratable hemodynamic benefit in hospitalized patients with severe congestive heart failure" .
January 1993 Lauwaars M, Abraham WT, Kim JK, Summer SN, Schrier RW."Increased distal tubular sodium delivery reverses the atrial natriuretic peptide resistance associated with decompensated cirrhosis" .
January 1993 White M, Roden RL, Abraham WT, Hagan MB, Wollmering MM, Skerl L, Port JD, Bristow MR."Decreased G protein functional activity and uncoupling of -adrenergic receptors from mechanical response in potential donor hearts with unexplained dysfunction" .
January 1993 White M, Abraham WT, Gilbert EM, O'Connell JB, Anderson JA, Bristow MR."Predictors of left ventricular functional "hyperresponse" in patients with congestive heart failure treated with -adrenergic receptor blocking agents" .
January 1994 Lindenfeld J, Gilbert EM, Abraham WT, Olsen S, Wolfel E, Bristow MR."Does gender affect the response to medical therapy in heart failure?" .
January 1994 Abraham WT, Raynolds MV, Bristow MR, Badesch DB, Groves BM, Lowes BD, Wynne KM, Voelkel NF, Perryman MB."Increased frequency of the angiotensin converting enzyme D/D genotype in patients with severe pulmonary hypertension" .
January 1994 Abraham WT, Lowes BD, Rose CP, Larrabee P, Bristow MR."Angiotensin II selectively increases cardiac adrenergic activity in patients with heart failure" .
January 1995 Pickrell JW, Abraham WT, Port JD, Roden RL, Bristow MR, Hammond EH."Evidence for decreased adrenergic nerve density in the failing human heart" .
January 1995 Abraham WT, Raynolds MV, Badesch DB, Lowes BD, Groves BM, Wynne KM, Voelkel NF, Perryman MB, Bristow MR."The angiotensin converting enzyme DD genotype is associated with preserved right ventricular function in patients with severe primary pulmonary hypertension" .
January 1995 Abraham WT, Lowes BD, Ferguson DA, Wolfel EE, Lindenfeld J, Schrier RW, Bristow MR."Systemic hemodynamic and renal excretory effects of a continuous 4-hour infusion of human brain natriuretic peptide in patients with heart failure" .
January 1995 Abraham WT, Lowes BD, Ferguson DA, Wolfel EE, Lindenfeld J, Schrier RW, Bristow MR."Systemic hemodynamic and renal excretory effects of a continuous 4-hour infusion of human brain natriuretic peptide in patients with heart failure" .
January 1995 Khan MF, Lowes BD, Ferguson DA, Abraham WT."Human brain natriuretic peptide reduces pulmonary vascular resistance in patients with heart failure" .
January 1995 White M, Gilbert EM, Anderson J, O'Connell JB, Renlund D, Olsen S, Mealy P, Abraham WT, Rouleau JL, Bristow MR."What patient with congestive heart failure responds to -blocking agents: a meta-analysis" .
January 1995 Chapman AB, Zamudio S, Abraham WT, Merouani A, Johnson AM, Moore L, Dahms T, Coffin C, Schrier RW."Renal and hemodynamic changes in the first trimester of human pregnancy occur prior to placentation." .
January 1995 Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger R, Kubo SH, Narahara KA, Ingersoll H, for the MOCHA Investigators."Multicenter oral carvedilol heart failure assessment (MOCHA): a six-month dose-response evaluation in class II-IV patients" .
January 1995 Zisman LS, Abraham WT, Meixell GE, Vamvakias BN, Quaife RA, Lowes BD, Roden RL, Peacock SJ, Groves BM, Raynolds MV, Bristow MR, Perryman MB."Angiotensin II formation in the intact human heart: predominance of the angiotensin converting enzyme pathway" .
January 1995 Zisman LS, Abraham WT, Meixell GE, Vamvakias BN, Lowes BD, Roden RL, Quaife RA, Groves BM, Perryman MB, Bristow MR."Angiotensin II formation in the intact human heart: predominance of the angiotensin converting enzyme pathway" .
January 1995 Mitchusson KD, Roden RL, Abraham WT, Bristow MR, Port JD."Regulation of the neuronal norepinephrine transporter by its endogenous ligand" .
January 1995 Minobe W, Lowes BD, Abraham WT, Feldman AM, Bristow MR."In vivo measurement of myocardial gene expression in the human heart" .
January 1995 Lowes BD, Abraham WT, Minobe W, Feldman AM, Bristow MR."Assessment of gene expression in endomyocardial biopsy specimens from failing and nonfailing human hearts" .
January 1996 Lowes BD, Gill EA, Rodriguez-Larrain J, Abraham WT, Bristow MR, Gilbert EM."Carvedilol is associated with a reversal of remodeling in chronic heart failure" .
January 1996 Lowes BD, Abraham WT, Dutcher DL, Roden RL, Crisman TS, Minobe W, Port JD, Larrabee P, Gilbert EM, Bristow MR."Comparative anti-adrenergic effects of carvedilol and metoprolol in a randomized, placebo-controlled trial" .
January 1996 Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger R, Kubo SH, Narahara KA, Robertson AD, Krueger S, for the MOCHA Investigators."Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or nonischemic dilated cardiomyopathy" .
January 1996 Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger R, Kubo SH, Narahara KA, Robertson AD, Krueger S, for the MOCHA Investigators."Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or nonischemic dilated cardiomyopathy" .
January 1996 Bristow MR, Abraham WT, Gilbert EM, Yoshikawa T, Port JD."Relationships between carvedilol stereoisomer plasma concentrations and -receptor occupancies in subjects with chronic heart failure in the MOCHA trial" .
January 1996 Abraham WT, Lowes BD, Roden RL, Lindenfeld J, Wolfel EE, Zisman LS, Kaufman D, Rose CP, Bristow MR."Cardiac tracer norepinephrine kinetics in orthotopic heart transplant recipients: evidence for late re-innervation" .
January 1996 Abraham WT, Lowes BD, Ferguson DA, Wolfel EE, Robertson AD, Lindenfeld J, Bristow MR, Schrier RW."Distal tubular sodium delivery is a determinant of the natriuretic response to hBNP in heart failure patients" .
January 1996 Abraham WT."Systemic hemodynamic, neurohormonal, and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with chronic decompensated heart failure" .
January 1996 Odom JH, Lowes BD, Crisman TS, Ferguson DA, Wolfel EE, Lindenfeld J, Bristow MR, Schrier RW, Abraham WT."Systemic hemodynamic effects of a steady-state infusion of human brain natriuretic peptide in patients with chronic decompensated heart failure" .
January 1997 Lowes BD, Minobe WA, Abraham WT, Roden RL, Port JD, Gilbert EM, Larrabee P, Bristow MR."Downregulation of - and upregulation of -myosin heavy chain in intact, failing human ventricles" .
January 1997 Bristow MR, Gilbert EM, Lowes B, Minobe WA, Shakar S, Quaife RA, Abraham WT."Changes in myocardial gene expression associated with -blocker-related improvement in ventricular systolic function" .
January 1997 Bies RD, Maeda M, Holder E, Valent S, Roden R, Abraham W, Bristow M."Microtubule assembly affects -adrenergic mediated contractility in human ischemic dilated cardiomyopathy" .
January 1997 Abraham WT, Oren RM, Schrier RW."Effects of an oral, nonpeptide, selective V2 receptor vasopressin antagonist in human heart failure" .
January 1997 Abraham WT, Oren RM, Robertson AD, Schrier RW."Effects of an oral, nonpeptide, selective V2 receptor AVP antagonist in human heart failure" .
January 1997 Abraham WT, Oren RM, Crisman TS, Robertson AD, Shakar S, Lowes BD, Panther L, Kelley P, Pies CJ, Bristow MR, Schrier RW."Effects of an oral, nonpeptide, selective V2 receptor vasopressin antagonist in patients with chronic heart failure" .
January 1997 Abraham WT, Lowes BD, Roden RL, Gilbert EM, Havranek EP, White M, Zisman LS, Rose CP, Bristow MR."Tracer norepinephrine kinetics in the coronary circulation of patients with idiopathic dilated cardiomyopathy: evidence for decreased neuronal norepinephrine reuptake" .
January 1997 Abraham WT, Lowes BD, Roden RL, Gilbert EM, Havranek EP, White M, Zisman LS, Rose CP, Bristow MR."Mechanism of increased cardiac adrenergic activity in heart failure: evidence for decreased cardiac neuronal norepinephrine reuptake" .
January 1997 Martin PY, Abraham WT, Xu L, Oren RM, Olson BR, Ohara M, Schrier RW."Selective V2-receptor AVP antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure" .
January 1997 Gill EA Jr, Gilbert EM, Lowes BD, Abraham WT, Bristow MR, Reiter MJ."Carvedilol reduces QT dispersion in patients with congestive heart failure" .
January 1998 Tsvetkova T, Farber DJ, Abraham WT, Kelly P, Eichhorn E, Gilbert EM, Robertson AD, Lindenfeld J, Wolfel EE, Zisman LS, Bristow MR, Lowes BD."Comparative hemodynamic effects of milrinone and dobutamine in heart failure patients treated chronically with carvedilol" .
January 1998 Lowes BD, Abraham WT, Minobe WA, Gilbert EM, Roden RL, Bristow MR."Regulation of - and -myosin heavy chain gene expression in the intact, failing human heart: reciprocal regulation and possible signaling by wall stress" .
January 1998 Lowes BD, Abraham WT, Minobe WA, Gilbert EM, Roden RL, Bristow MR."Dynamic changes in expression of contractility-regulating genes in the failing human heart associated with improvement or deterioration in ventricular systolic function" .
January 1998 Roden RL, Asano K, Wichman S, Hoover E, Bristow MR, Abraham WT."Inotropic effect of human B-type natriuretic peptide in the failing human heart" .
January 1998 Bourge RC, Abraham WT, Wagoner LE, Horton DP, LeJemtel TH."Nesiritide improves hemodynamics in patients with acutely decompensated heart failure: hemodynamic subgroup analysis" .
January 1998 Bourge RC, Abraham WT, Wagoner LE, Horton DP."Nesiritide improves hemodynamics in patients with acutely decompensated heart failure: hemodynamic subgroup analysis" .
January 1998 Abraham WT, Tsvetkova T, Lowes BD, Ferguson DA, Gilbert EM, Bristow MR.."Carvedilol improves renal hemodynamics in patients with chronic heart failure" .
January 1998 Abraham WT, Tsvetkova T, Lowes BD, Ferguson DA, Gilbert EM, Bristow MR."Carvedilol improves renal hemodynamics in patients with chronic heart failure" .
January 1998 Abraham WT."Pathophysiology of chronic heart failure: mechanism of increased adrenergic activity and its role in disease progression" .
January 1999 Bourge RC, Abraham WT, Wagoner LE, Horton DP, LeJemtel TH."Nesiritide improves hemodynamics in patients with acutely decompensated heart failure: hemodynamic subgroup analysis" .
January 1999 Bourge RC, Abraham WT, Wagoner LE, Horton DP, LeJemtel TH."Nesiritide improves hemodynamics in patients with acutely decompensated heart failure: hemodynamic subgroup analysis" .
January 1999 Abraham WT, Suresh DP, Wagoner LE, McCord J, Haas GJ, Rydzinski SM, Nelson C, Bakker-Arkema RG."Effects of the V1a and V2 vasopressin receptor antagonist YM087 in hyponatremic patients with chronic heart failure" .
January 1999 Abraham WT, Suresh DP, Wagoner LE, Haas GJ, McCord J, Rydzinski SM, Nelson C, Bakker-Arkema RG."Pharmacotherapy for hyponatremia in heart failure: effects of a new dual V1a/V2 vasopressin antagonist YM087" .
January 1999 Abraham WT, Johnson AD, Wagoner L, Givertz MM, Horton DP."Nesiritide (human B-type natriuretic peptide) improves symptoms and hemodynamics in NYHA class III and IV heart failure" .
January 1999 Abraham WT, Johnson AD, Wagoner L, Givertz MM, Horton DP."Nesiritide (human B-type natriuretic peptide) improves symptoms and hemodynamics in NYHA class III and IV heart failure." .
January 1999 Wolfel EE, Lowes B, Shakar S, Noori A, Abraham WT, Roden R, Lindenfeld J, Gilbert EM, Bristow MR."Lack of effect of acute withdrawal of either carvedilol or metoprolol therapy on peak and submaximal exercise capacity in nonischemic cardiomyopathy patients with chronic heart failure" .
January 1999 Wolfel E, Lowes B, Abraham WT, Roden R, Robertson A, Lindenfeld J, Gilbert EM, Bristow MR."Withdrawal of chronic beta blockade in heart failure patients does not influence exercise hemodynamics" .
January 1999 Wagoner LE, Giesting RM, Bell BJ, McGuire NC, Abraham WT."Is Viagra (sildenafil) safe and effective in cardiac transplant recipients?" .
January 1999 Wagoner LE, Craft LL, Abraham WT, Zengel PW, Hornung RW, Liggett SB."The Ile 164 2-adrenergic receptor polymorphism is associated with decreased exercise capacity in patients with heart failure" .
January 1999 Wagoner LE, Craft LL, Abraham WT, Zengel PW, Hornung RW, Liggett SB."The Ile 164 2-adrenergic receptor polymorphism is associated with decreased exercise capacity in patients with heart failure" .
January 1999 Melvin DV, Melvin AJ, Glos DL, Abraham WT."Rapid relaxation of imposed bending shear stress by the ventricular wall" .
January 1999 Takeishi Y, Jalili T, Kirkparick DL, Wagoner LE, Abraham WT, Walsh RA."Differential alterations in Ca2+ cycling and Gq signaling proteins after left ventricular assist device support in failing human hearts" .
January 1999 Takeishi Y, Jalili T, Kirkparick DL, Wagoner LE, Abraham WT, Walsh RA."Differential alterations in Ca2+ cycling and Gq signaling proteins after left ventricular assist device support in failing human hearts" .
January 1999 Lowes BD, Wolfel EE, Gilbert EM, Abraham WT, Ferguson D, Robertson AD, Minobe WA, Bristow MR."-blocker related improvement in exercise capacity is associated with increased expression of SR Ca+2 ATPase" .
January 1999 Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Roden RL, Bristow MR."Beta-blocker-related improvement in ventricular function is associated with increased gene expression of SR Ca2+ ATPase" .
January 1999 Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Roden RL, Bristow MR."Effects of changes in cardiac adrenergic activity on gene expression in the intact failing human heart" .
January 2000 Wagoner LE, Lamba S, Craft LL, Zengel PW, McGuire N, Abraham WT, Rathz DA, Liggett SB."The Gly389 polymorphism of the 1-adrenergic receptor imparts depressed exercise capacity in patients with heart failure" .
January 2000 Wagoner LE, Lamba S, Craft LL, Zengel PW, McGuire N, Abraham WT, Rathz DA, Dorn GW, Liggett SB."Polymorphic Gly389 1-adrenergic receptors depress exercise capacity in heart failure" .
January 2000 Franciosa JA, Abraham WT, Fowler M, Gilbert EM, Greenberg B, Massie BM, Lukas MA, Chen T, Nelson JJ, COHERE Participant Physicians."Rationale, design, and methods for COHERE (the Coreg Heart Failure Registry)" .
January 2000 Takeishi Y, Huang Q, Abe J-I, Abraham WT, Wagoner LE, Hoit BD, Walsh RA."Activation of multiple mitogen-activated protein kinases and P90 ribosomal S6 kinase in failing human hearts" .
January 2000 Leon A, Delurgio D, Kocovic DZ, Fisher W, Hayes D, Curtis AB, Abraham WT."Left ventricular pacing thresholds with new cardiac vein lead compared with right ventricular thresholds" .
January 2000 Lamba S, Abraham WT, Craft LL, Zengel PW, Hoffman RO, McGuire N, Wagoner LE."Utility of invasive exercise hemodynamic testing in assessment of functional impairment in patients with diastolic heart failure" .
January 2000 Krumholz HM, Abraham WT, Butler J, Forman DE, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Warner Stevenson L, Young JB, on behalf of the Renal Function and Heart Failure Study investigators."Confirmation of the incidence, consequences, and predictors of worsening renal function for patients hospitalized with heart failure" .
January 2000 Krumholz HM, Abraham WT, Butler J, Forman DE, Gottlieb SS, Loh E, Massie B, O’Connor CM, Rich M, Stevenson LW, Wang Y."Stratifying patients hospitalized with heart failure by their risk of developing worsening renal function: a multicenter study" .
January 2000 Young JB, Warner Stevenson L, Abraham WT, Horton DP, for the VMAC Investigators."Rationale and design of the VMAC Trial: Vasodilation in the Management of Acute Congestive Heart Failure" .
January 2000 Young JB, Abraham WT, Horton DP, for the VMAC Investigators."Demographic characteristics of patients in the VMAC Trial (Vasodilation in the Management of Acute Congestive Heart Failure)" .
January 2000 Baas LS, Beery TA, Fontana JA, Allen GA, Wizer M, Abraham WT."Is an increase in body awareness associated with somatization, anxiety, or depression in persons with heart failure?" .
January 2000 Abraham WT, Suresh DP, Wagoner LE, Haas GJ, Nelson C, Bakker-Arkema RG."Pharmacotherapy for hyponatremia in heart failure: effects of a new combined vasopressin V1a/V2 receptor antagonist, conivaptan (YM087) administered orally" .
January 2000 Abraham WT, Koren M, Bichet DG, Verbalis JG, Klapholz M, Selaru P, Bakker-Arkema RG, Rummel SA."Treatment of hyponatremia in patients with SIADH or CHF with intravenous conivaptan (YM087), a new combined vasopressin V1a/V2 receptor antagonist" .
January 2000 Abraham WT."Mechanism of increased adrenergic drive in the failing human heart. In: 20th Anniversary of the ACC/Merck Fellowship Awards Program" .
January 2000 Vadlamani L, Wayne D, Suresh DP, Sanghvi V, Wagoner L, Meyer M, Lamba S, Abraham WT."Carvedilol dose-response in heart failure: experience in clinical practice" .
January 2000 Vadlamani L, Abraham WT."Pulsus alternans: a non-invasive predictor of hospital readmissions" .
January 2001 Dash R, Schmidt AG, Gerst MJ, Biniakiewicz D, Abraham WT, Kranias EG."Estrogen-dependent modulation of MAP kinase protects against catecholamine-induced hypertrophy, but not depressed contractility, in phospholamban overexpression hearts" .
January 2001 Conti JB, Curtis AB, Aranda JM, Abraham WT, Petersen-Stejskal S."Gender differences in patient response to biventricular pacing therapy in the MIRACLE trial" .
January 2001 Coble W, Lamba S, Bradsher T, Trupp RJ, Abraham WT."Initiating beta-blockade in hospitalized patients with decompensated heart failure: results of an observational study" .
January 2001 Wagoner LE, Zengel PW, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Smith SJ, Tang ASL, Pearson AM."Cardiac resynchronization therapy with the InSync stimulation system improves exercise performance in patients with heart failure. MIRACLE trial substudy results" .
January 2001 Wagoner LE, Zengel PW, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Smith SJ, Tang ASL, Pearson AM."Cardiac resynchronization therapy with the InSync stimulation system improves exercise performance in patients with heart failure: MIRACLE trial substudy results" .
January 2001 Trupp R, Underwood J, Heeke S, Pickering F, Goffredo L, Truex C, Trusty J, Petersen-Stejskal S, Abraham WT."Management of a randomized, double-blinded implant device trial in advanced heart failure" .
January 2001 Massie BM, Greenberg B, Gilbert EM, Fowler M, Abraham WT, Franciosa JA, Lukas MA, Nelson JJ, The COHERE Physicians."Carvedilol initiation by community physicians in COHERE: comparison with US carvedilol trials and compassionate use protocols" .
January 2001 Gottlieb SS, Abraham WT, Butler J, Forman DE, Krumholz HM, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB."The impact of different definitions of worsening renal function in CHF" .
January 2001 Gottlieb S, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Beckman E, Abraham W."BG9719 (CVT-124), an A-1 adenosine receptor antagonist, protects against the decline in renal function observed with standard congestive heart failure therapy" .
January 2001 Adamson PB, Abraham WT, Kleckner KJ, VanHout WL, Srinivasan S."Cardiac resynchronization increases heart rate range in heart failure patients with ventricular dysynchrony" .
January 2001 Abraham WT, on behalf of the VMAC Study Group."Effects of nesiritide (B-type natriuretic peptide) in decompensated heart failure patients receiving beta-blockers" .
January 2001 Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Smith SJ, Tang ASL, for the MIRACLE Investigators and Coordinators."Multicenter InSync Randomized Clinical Evaluation (MIRACLE): Results of a Randomized, Double-Blind, Controlled Trial to Assess Cardiac Resynchronization Therapy in Heart Failure Patients" .
January 2001 Abraham WT, Fisher W, Delurgio D, Leon A, Smith A, Kocovic D, Clavell AL, Hayes DL, Manda V, Johnson JW."Impact of cardiac resynchronization on health-related quality of life in heart failure patients" .
January 2001 Abraham WT, Ascheim D, DeMarco T, Klapholz M, Kukin M, Miller A, Yellen L, Holcslaw TL, Packer M, for the ENCOR Investigators and Coordinators."Effects of Enrasentan, a Nonselective Endothelin Receptor Antagonist, in Class II-III Heart Failure: Results of the Enrasentan Cooperative Randomized (ENCOR) Evaluation." .
January 2001 Abraham WT."Cardiac resynchronization for heart failure" .
January 2001 St. John-Sutton MG, Plappert T, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Hill MRS."Cardiac resynchronization therapy results in left ventricular reverse remodeling: evidence from the MIRACLE trial" .
January 2001 St. John-Sutton MG, Plappert T, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Hill MRS."Cardiac resynchronization therapy improves diastolic ventricular function in advanced heart failure: the MIRACLE trial" .
January 2001 St. John Sutton M, Plappert T, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Hill MRS."Cardiac resynchronization therapy results in reverse remodeling: evidence from the MIRACLE trial" .
January 2001 Smith AL, Leon AR, Delurgio DB, Abraham WT."Cardiac resynchronization improves measures of functional status in MIRACLE study" .
January 2001 Franciosa JA, Abraham WT, Fowler M, Gilbert EM, Greenberg B, Massie BM, Lukas MA, Nelson JJ, The COHERE Participant Physicians."Coreg Heart Failure Registry (COHERE): characteristics of participating physicians, their patients, and dose-titration experience" .
January 2001 Franciosa JA, Abraham WT, Fowler M, Gilbert EM, Greenberg B, Massie BM, Lukas MA, Nelson JJ, The COHERE Participant Physicians."Coreg Heart Failure Registry (COHERE): characteristics of participating physicians, their patients, and dose-titration experience" .
January 2001 Fisher W, Abraham WT, Tang ASL, Leon A, Delurgio D, Smith A, Kocovic D, Messenger J."The efficacy of cardiac resynchronization therapy is independent of baseline QRS duration" .
January 2001 Wright C, Shah M, Trupp RJ, Lamba S, Abraham WT."Prevalence and associated risk factors for intraventricular conduction delay in patients with chronic heart failure" .
January 2001 Packer M, Abraham W, MIRACLE Study Group."Effect of cardiac resynchronization on a composite clinical status endpoint in patients with chronic heart failure: results of the MIRACLE trial" .
January 2001 Packer M, Abraham W, MIRACLE Investigators and Coordinators."Effect of cardiac resynchronization on a composite clinical status endpoint in patients with chronic heart failure: results of the MIRACLE trial" .
January 2001 Hayes D, Tang ASL, Abraham WT, Curtis A, Sackner-Bernstein J, Ford L, Manda V."Incidence and comparison of heart failure related events in patients receiving cardiac resynchronization: a randomized blinded study" .
January 2001 Chinchoy EC, Hill MRS, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Plappert TJ, St. John Sutton M."Bi-ventricular resynchronization improves chronic myocardial performance index in heart failure patients with abnormal atrial-ventricular filling and contraction durations" .
January 2001 Butler J, Abraham WT, Forman DE, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM."Relationship between heart failure treatment and development of worsening renal function among hospitalized patients" .
January 2001 Butler J, Abraham WT, Forman DE, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM."Relationship between heart failure treatment and development of worsening renal function among hospitalized patients" .
January 2001 Burnett JC, Heublein DM, Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Hill MRS."Cardiac resynchronization therapy suppresses TNS- and norepinephrine in overt CHF" .
January 2001 Bristow MR, Krause-Steinrauf H, Abraham WT, Liang C-S, Hattler B, Kruger S, Lindenfeld J, Lowes BD, Olson L, Thaneemit-Chen S, Zelis R."Sympatholytic effect of bucindolol adversely affected survival, and was disproportionately observed in the class IV subgroup of BEST" .
January 2001 Bourge BC, Kay GN, Abraham WT, The MIRACLE Investigators and Coordinators."Cardiac resynchronization therapy in the MIRACLE study: efficacy in ischemic vs. nonischemic heart failure" .
January 2001 Abraham WT, on behalf of the VMAC Study Group."Effects of nesiritide (B-type natriuretic peptide) in decompensated heart failure patients receiving beta-blockers" .
January 2001 Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Tang ASL, Leon A."Multicenter InSync Randomized Clinical Evaluation (MIRACLE): results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients" .
January 2002 Wagoner LE, Zengel PW, Abraham WT, Young JB, Hanne K, Thomas S."Cardiac resynchronization therapy improves exercise performance in patients with heart failure: combined results of the MIRACLE and MIRACLE ICD trials" .
January 2002 Trupp RJ, Voegtlin L, Abraham WT, Johnson WB, Hayes DL, Hill MRS, Burnes JE."Transthoracic impedance cardiography for optimization of interventricular timing during cardiac resynchronization therapy" .
January 2002 Nowak RM, Maisel AS, McCord J, Kazanegra R, Hlavin P, Lenert LA, Clopton P, Hollander JE, Loh E, Duc P, Steg PG, Westheim A, Omland T, Abraham WT, Lamba S, Storrow AB, Wu AHB, McKay C, McCullough PA."B-type natriuretic peptide compliments clinical judgment in the emergency diagnosis of heart failure" .
January 2002 Young JB, Abraham WT, Liem L, Leon AR."Cardiac resynchronization therapy benefits patients with ICD indications: results of the InSync ICD Trial" .
January 2002 Young JB, Abraham WT, Leon AR, Smith AL, Wilkoff BL, Hannon CH."Cardiac resynchronization improves functional status in patients with ventricular dysynchrony and an ICD indication: results from the MIRACLE ICD trial" .
January 2002 Young JB, Abraham WT, Leon AR, Smith AL, Canby RC, Liem LB, Hannon CH."Cardiac resynchronization improves functional status in patients with ventricular dysynchrony and an ICD indication: results from the MIRACLE ICD trial" .
January 2002 Wolfel EE, Tsvetkova TO, Lowes BD, Lindenfeld J, Shakar S, Abraham WT, Robertson AD, Gilbert EM, Bristow MR."Improved ventilatory response at peak exercise despite no change in peak oxygen consumption with chronic beta-blockade in heart failure patients" .
January 2002 Maisel AS, Kazanegra R, McCord J, Nowak RM, Hollander JE, Duc P, Steg G, Omland T, Wold-Knudsen K, Westheim A, Abraham WT, Storrow AB, Wu AH, Clopton P, Lenert L, McCullough PA, BNP Multinational Study Investigators."The effect of diabetes on B-type natriuretic peptide levels in patients with acute dyspnea" .
January 2002 Maisel AS, Kazanegra R, McCord J, Nowak RM, Hollander JE, Duc P, Steg G, Omland T, Westheim A, Abraham WT, Storrow AB, Lamba S, Wu AH, McCullough PA, BNP Multinational Study Investigators."Primary results of the BNP Multinational Study: B-type natriuretic peptide in the emergency diagnosis of heart failure" .
January 2002 Maisel AS, Hlavin P, McCord J, Nowak RM, Hollander JE, Duc P, Steg G, Omland T, Westheim A, Abraham WT, Storrow AB, McKay CA Jr., Wu AH, McCullough PA, BNP Multinational Study Investigators."B-type natriuretic peptide in the emergency diagnosis of diastolic dysfunction heart failure" .
January 2002 Leon AR, Delurgio D, Brozena S, Liang C-S, Roach A, Abraham WT."Effect of biventricular pacing with variable interventricular timing on stroke volume and functional status in heart failure patients: the U.S. InSync III Trial" .
January 2002 Leon AR, Brozena S, Liang C-S, Roach A, Abraham WT, on behalf of the U.S. InSync III Investigators and Coordinators."Effect of cardiac resynchronization therapy with sequential biventricular pacing on doppler-derived left ventricular stroke volume, functional status and exercise capacity in patients with ventricular dysfunction and conduction delay: the U.S. InSync III" .
January 2002 Leon AR, Brozena S, Lang CS, Abraham WT."Interventricular delay increases stroke volume in cardiac resynchronization patients" .
January 2002 Adamson PB, St. John Sutton MG, Plappert TJ, Abraham WT, Hilpisch KE, Hill MRS."ECHO-derived ventricular dysynchrony predicts magnitude of response to cardiac resynchronization" .
January 2002 Adamson PB, St. John Sutton MG, Plappert TJ, Abraham WT, Hilpisch KE, Hill MRS."ECHO-derived ventricular dysynchrony predicts magnitude of response to cardiac resynchronization" .
January 2002 Abraham WT, Young J, Leon A, Liem L."Benefits of cardiac resynchronization therapy: results of the InSync and InSync ICD trials" .
January 2002 Abraham WT, Young J, Kocovic D, Manda V, Hannon Cole, Cerkvenik J, Leon A."Cardiac resynchronization therapy benefits patients: combined results of the MIRACLE and MIRACLE ICD trials" .
January 2002 Abraham WT, St. John Sutton M, Kocovic D, Leon A."Does the use of beta-blockers influence the effect of cardiac resynchronization on reverse remodeling in heart failure?" .
January 2002 Abraham WT, Phillips B, Foley B, Harding S, Schofield P, Shneerson J, DiSalvo T, Johnson D."Sleep disordered breathing in heart failure patients: a multicenter international study" .
January 2002 Abraham WT, Leon AR, Liang C-S, Shih A, Odryzynski NL."Sequential biventricular pacing provides significant hemodynamic benefit for heart failure patients with ventricular dysynchrony" .
January 2002 Abraham WT, Lamba S, Osborne J, Selby S, Hardesty P, Jansen DE, Kunik CL, Trupp RJ."A prevalence study of sleep disordered breathing in consecutive patients from a heart failure clinic" .
January 2002 Abraham WT, Hayes D, Sackner-Bernstein J, Curtis A."Cardiac resynchronization therapy reduces the risk of hospitalization for heart failure and length of stay: results from the MIRACLE trial." .
January 2002 Abraham WT, Fisher WG, Smith AL, Delurgio DB, Loh E, Leon A, Kocovic DZ, Clavell AL, Hayes DL."Cardiac resynchronization therapy reduces morbidity in patients with moderate to severe systolic heart failure and intraventricular conduction delays" .
January 2002 Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon A, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Tang ASL, Manda V, Petersen-Stejskal S."Long-term improvement in functional status, quality of life and exercise capacity with cardiac resynchronization therapy: the MIRACLE trial experience" .
January 2002 Abraham WT, Fisher W, Smith A, Delurgio D, Leon A, Kocovic D, Hayes D."What are the long-term effects of cardiac resynchronization therapy? The MIRACLE Trial experience" .
January 2002 Abraham WT."Ultrafiltration for congestive heart failure" .
January 2002 Abraham WT."Does sequential biventricular pacing contribute incremental benefit to patient well-being? Results from the InSync III trial" .
January 2002 Sallach JA, McCord JK, Sallach SM, Duc P, Omland T, Nowak RM, Hollander JE, Storrow AB, Abraham WT, Wu AHB, Clopton P, Krishnaswamy P, Maisel AS, McCullough PA."The effect of pre-existing ischemic heart disease on B-type natriuretic peptide levels in patients presenting with dyspnea" .
January 2002 Kocovic DZ, Brozena S, Abraham WT."Does presence of a previous myocardial infarction affect response to cardiac resynchronization?" .
January 2002 Kocovic D, St. John Sutton M, Plappert T, Abraham WT, Smith D, Johnson J, Lynn T."Does cardiac resynchronization therapy result in reverse remodeling in both ischemic and non-ischemic heart failure patients?" .
January 2002 Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow A, McCord JK, Nowak R, Steg G, Duc P, McCullough P, Maisel A."Diagnostic value of chest radiographs in patients with acute dyspnea: comparison with B-type natriuretic peptide" .
January 2002 Das P, Lamba S, Ali V, Gurram NR, Osborne J, Selby S, Hardesty P, Trupp RJ, Abraham WT."Use of a heart failure disease management program to optimize neurohormonal interventions in patients with chronic heart failure" .
January 2002 Curtis AB, Aranda J, Abraham WT, Manda V, Paulsen D."Is cardiac resynchronization therapy effective in patients on beta-blockers?" .
January 2002 Conti J, Curtis A, Aranda J, Abraham WT, Petersen-Stejskal S, Paulsen D."Are there differences in gender response to cardiac resynchronization therapy? Analysis of the MIRACLE Trial" .
January 2002 Hollander JE, Maisel AS, Nowak RM, McCord J, Kazanegra R, Hlavin P, Lenert LA, Clopton P, Loh E, Duc P, Steg PG, Westheim A, Omland T, Abraham WT, Lamba S, Storrow AB, Wu AHB, McKay C, McCullough PA."Impact of acute myocardial ischemia on blood b-type natriuretic peptide in the emergency diagnosis of heart failure." .
January 2002 Hill MRS, Hilpisch KE, Kruger K, Plappert T, Abraham WT, St. John Sutton M, and the MIRACLE Investigators."Cardiac resynchronization therapy results in reduction in left atrial size and mitral regurgitation: implications for atrial fibrillation" .
January 2002 Jaski BE, Denys B, Lamba S, Ha J, Sackner-Bernstein J, Trupp RJ, Abraham WT."Use of a novel continuous peripherally-inserted veno-venous hemofiltration system for rapid treatment of volume-overloaded subjects" .
January 2002 St. John Sutton MG, Plappert TJ, Abraham WT, Young JB, Kocovic DZ, Lieberman RA, Hilpisch KE, Hill MRS."Cardiac resynchronization therapy results in improvement in echocardiographic parameters in heart failure patients: evidence from MIRACLE and MIRACLE ICD trials" .
January 2002 St. John Sutton MG, Plappert TJ, Abraham WT, Young JB, Kocovic DZ, Hilpisch KE, Hill MRS."Cardiac resynchronization therapy results in improvement in echocardiographic parameters in heart failure patients: evidence from MIRACLE and MIRACLE ICD trials" .
January 2002 St. John Sutton M, Plappert T, Abraham WT, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Clavell AL, Hayes DL, Hilpisch KE, Chinchoy E, Hill MR."Echocardiographic predictors of functional class changes during cardiac resynchronization therapy: results from the MIRACLE trial" .
January 2002 St. John Sutton M, Kocovic D, Plappert T, Abraham WT, Smith D, Johnson J, Lynn T."Cardiac resynchronization therapy results in reverse remodeling in both ischemic and non-ischemic heart failure patients" .
January 2002 Smith AL, Abraham WT."Cardiac resynchronization therapy reduces both the risk of hospitalization for worsening heart failure and the average length of stay in patients with ventricular dysynchrony" .
January 2002 McCullough PA, Nowak RM, McCord J, Hollander JE, Steg G, Duc P, Westheim A, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Lenert L, Maisel AS, BNP Multinational Study Investigators."B-type natriuretic peptide adds to clinical judgment in the diagnosis of heart failure: a Bayesian analysis from the BNP Multinational Study" .
January 2002 McCullough PA, Nowak RM, McCord J, Hollander JE, Loh E, Steg G, Duc P, Omland T, Westheim A, Abraham WT, Storrow AB, Wu AH, Hlavin P, Maisel AS, BNP Multinational Study Investigators."The independent contribution to elevations in B-type natriuretic peptide from atrial fibrillation" .
January 2002 McCullough PA, McCord J, Nowak RM, Hollander JE, Duc P, Omland T, Abraham WT, Wu AHB, Krishnaswamy P, Maisel AS."B-type natriuretic peptide should be part of the diagnostic evaluation of heart failure: implications from the Breathing Not Properly (BNP) Multinational Study" .
January 2002 Massie BM, Greenberg B, Gilbert EM, Fowler M, Abraham WT, Franciosa JA, Lukas MA, Nelson JJ, and the COHERE Participant Physicians."Carvedilol initiation by community physicians in COHERE: comparison with U.S. Carvedilol Trials and Compassionate Use Protocols" .
January 2002 Maisel AS, McCullough PA, Nowack RM, McCord J, Hollander J, Abraham WT."Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure: primary results from the Breathing Not Properly (BNP) Multinational Study" .
January 2002 Hayes D, Abraham WT, Curtis A, Sackner-Bernstein J."What effect does cardiac resynchronization have on heart failure related events? Results from the MIRACLE Trial" .
January 2002 Gurram NR, Lewis D, Lamba S, Ali V, Das P, Osborne J, Selby S, Hardesty P, Trupp RJ, Abraham WT."Efficacy and safety of combined nesiritide and milrinone for the treatment of acutely decompensated heart failure" .
January 2002 Abraham WT, Phillips B, Foley B, Harding S, Schofield P, Shneerson J, DiSalvo T, Johnson D."Sleep disordered breathing in heart failure patients: first night treatment response from a multicenter international study" .
January 2003 Leon AR, Young JB, Abraham WT, for the MIRACLE ICD Investigators."Resynchronization does not change the incidence of ventricular arrhythmias" .
January 2003 Leon AR, Delurgio D, Brozena S, Kocovic D, Liang C-S, Daubert J, Gurley J, Abraham WT."Results of the InSync III Trial" .
January 2003 Leon A, Young JB, Abraham WT, for the MIRACLE ICD Investigators."Resynchronization does not change the incidence of ventricular arrhythmias" .
January 2003 Young JB, Abraham WT, for the MIRACLE ICD Study Group."Cardiac resynchronization limits disease progression in patients with mild heart failure and an indication for an ICD – Results of a randomized study" .
January 2003 Young JB, Abraham WT."Effect of cardiac resynchronization on disease progression in patients with mild heart failure symptoms and an indication for an ICD – results of a randomized double blind study" .
January 2003 Young JB, Abraham WT."The effect of cardiac resynchronization on disease progression in patients with mild heart failure and an indication for an ICD – Results of a randomized double blind study" .
January 2003 Wilkoff BL, Hess M, Young JB, Abraham WT on behalf of the MIRACLE ICD investigators."Differences in ICD utilization by primary and secondary prevention patients with cardiac resynchronization therapy indication" .
January 2003 Kocovic D, Brozena S, Abraham WT, Lynn T."Does presence of a myocardial infarction affect cardiac resynchronization response?" .
January 2003 Greenberg BH, Banish D, Goldman S, Thomas I, Havranek E, Bijou R, O’Leary M, Zhu Y, Ticho B, Massie, B, Abraham WT."BG9928, an oral adenosine antagonist, preserves renal function, improves sodium excretion, and is well tolerated in heart failure patients" .
January 2003 Franciosa JA, Massie BM, Greenberg B, Gilbert EM, Fowler M, Abraham WT, Lukas MA, Nelson JJ, Lottes SR for the COHERE Participant Physicians."Titration, tolerability, and results of beta-blocker therapy for heart failure in the community: results of a community-based registry" .
January 2003 Fonarow GC, Abraham WT, Adams K, ADHERE Scientific Advisory Board and Investigators."Risk stratification for in-hospital mortality in heart failure using classification and regression tree (CART) methodology: analysis of 33,046 patients in ADHERE" .
January 2003 Abraham WT, Trupp RJ, Hudnall H."Does minimization of the QRS duration result in increased stroke volume during inter-ventricular timing optimization in cardiac resynchronization therapy?" .
January 2003 Abraham WT, Smith AL, Manda V."A multivariate assessment of cardiac resynchronization therapy on morbidity and mortality" .
January 2003 Abraham WT, Smith AL, Leon AR, Kleckner KJ, Rhodes MM."Use of implanted CRT device diagnostics to determine the risk of heart failure decompensation" .
January 2003 Abraham WT, Smith AL."A multivariate assessment of cardiac resynchronization therapy on morbidity and mortality" .
January 2003 Abraham WT, McCullough PA."Impact of cardiac resynchronization on renal function" .
January 2003 Abraham WT, Massie BM, Franciosa JA, Lukas MA, Lottes SR, Fowler M, Greenberg B, Nelson JJ, Gilbert EM for the COHERE Participant Physicians."Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry" .
January 2003 Abraham WT, Leon AR, Young JB."Benefits of cardiac resynchronization therapy sustained for 18 months: Results from the MIRACLE program" .
January 2003 Abraham WT, Adams KR, Costanzo MR, Berkowitz RL, LeJemtel TH, for the ADHERE Scientific Advisory Committee and Investigators."Comparison of in-hospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: an analysis from a large prospective registry database" .
January 2003 Costanzo MR, Heywood JT, Emerman CL, Abraham WT, Yancy CW, Berkowitz RL, Cheng ML, for the ADHERE Scientific Advisory Board and Investigators."Evaluation of in-hospital mortality in patients treated for acute heart failure within the first 24 hours with nesiritide vs. other vasoactive or inotropic substances" .
January 2003 Kazanegra R, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Perez A, Herrmann HC, Knudsen CW, Aumont C, McCullough PA, Maisel AS."The impact of age, race, and gender on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: Results of the breathing not properly (BNP) multinational study" .
January 2003 Johnson WB, Mayotte M, Bailin S, Hoyt R, Kocovic D, Abraham WT, Leon A, Fisher W, Hayes D, for the MIRACLE Investigator Group."Incidence of coronary sinus dissection and perforation complications from coronary sinus venograms in a large multicenter trial" .
January 2003 Steg PG Duc P, Joubin L, McCord J, Abraham WT, Hollander JE, Bron G, Aumont C, Mentre F, McCullough PA Maisel AS."A comparison of beside B-type natriuretic peptide versus echocardiographic determination of ejection fraction in the diagnosis of heart failure" .
January 2003 St. John Sutton MG, Plappert TJ, Abraham WT, Kilpisch KE, Hill MR."Evidence of continued reverse remodeling after one-year of cardiac resynchronization therapy" .
January 2003 Smith AL, Abraham WT, Leon AR, Kleckner KJ."Determining the risk of heart failure “decompensation” with use of CRT device diagnostics" .
January 2003 McCullough PA, Steg PG, Aumont MC, Duc P, Omland T, Knudsen CW, Nowak RM, McCord J, Hollander JE, Westheim A, Storrow AB, Abraham WT, Lamba S, Wu AH, Maisel AS."What causes elevated B-type natriuretic peptide in patients without heart failure?" .
January 2003 McCullough PA, Omland T, Knudsen CW, Duc P, Nowak RM, McCord J, Hollander JE, Aumont C, Steg PG, Westheim A, Storrow A, Abraham WT, Lamba S, Wu AH, Maisel S."Uncovering heart failure in patients with bronchospasm: Rationale for the early use of B-type natriuretic peptide in the emergency department" .
January 2003 McCullough PA, Nowak RM, McCord J, Omland T, Knudsen CW, Duc P, Hollander JE, Steg PG, Aumont M, Storrow AB, Abraham WT, Lamba S, Wu AH, Maisel AS."What is in the differential diagnosis of a B-type natriuretic peptide level of > 1,000 pg/ml?" .
January 2003 McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Aumont C, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS."B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the BNP multinational study" .
January 2003 Maisel AS, Kazanegra R, McCullough PA, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, Omland T, Storrow AB, Krishnaswamy P, Abraham WT, Clopton P, Steg PG, Westheim A, Knudsen CW, Herrmann HC."Bedside B-type natriuretic peptide in the emergency diagnosis of systolic and nonsystolic heart failure: Results from the Breathing not properly (BNP) multinational study" .
January 2003 Casey DE, Namie M, Creason H, Barrow L, Abraham WT."Closing the gap on heart failure quality of care" .
January 2003 Bourge RC, Magalski A, Adamson PB, Abraham WT, Young JB, Wagoner LE, Stevenson LW, Bank AJ, Sparks BS."The application of clinician care guidelines based on implantable hemodynamic monitoring: impact on healthcare utilization" .
January 2003 Boerrigter G, Madden SC, Costello-Boerrigter LC, Cataliotti A. Hublein DM, Abraham WT, Hill MR, Burnett JC."Plasma neurohormonal changes in response to cardiac resynchronization therapy in patients with congestive heart failure" .
January 2004 Leon AR, Hess MF, Abraham WT, Daubert JP."Does CRT-reverse remodeling in HF patients reduce VT/VF frequency? A retrospective analysis" .
January 2004 Leon AR, Abraham WT, Young JB."Implantation results of over two thousand implant attempts from the MIRACLE program" .
January 2004 Greenberg B, Lottes SR, Nelson JJ, Lukas MS, Fowler MB, Massie BM, Abraham WT, Gilbert EM, Franciosa JA, and the COHERE Participant Physicians."Practical predictors of clinical outcomes in patients initiating beta-blockers for heart failure: findings of a community-based registry" .
January 2004 Bourge RC, Abraham WT, Magalski A, Adamson PB, Stevenson LW, Young JB, Hill MRS, Sparks BS, Roettger AD."COMPASS-HF (Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure) study design" .
January 2004 Boerrigter G, Madden-Vadnais SC, Costello-Boerrigter LC, Cataliotti A, Heublein DM, Abraham WT, Kruger KM, Hill MR, Burnett JC Jr."Baseline ANP and BNP do not predict subsequent symptomatic benefit from cardiac resynchronization therapy in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) trial" .
January 2004 Boerrigter G, Madden-Vadnais SC, Costello-Boerrigter LC, Cataliotti A, Heublein DM, Abraham WT, Hill MRS, Burnett JC Jr."Differential actions of cardiac resynchronization therapy upon ANP and BNP in patients with non-ischemic and ischemic cardiomyopathy" .
January 2004 Boerrigter G, Madden-Vadnais SC, Costello-Boerrigter LC, Cataliotti A, Heublein DM, Abraham WT, Hill MRS, Burnett JC Jr."Effect of cardiac resynchronization therapy on plasma catecholamines in patients with and without beta-blocker therapy" .
January 2004 Boerrigter G, Madden-Vadnais SC, Costello-Boerrigter LC, Cataliotti A, Heublein DM, Abraham WT, Hill MRS, Burnett JC Jr."Effect of cardiac resynchronization therapy on serum creatinine levels in patients with congestive heart failure" .
January 2004 Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Heublein DM, Abraham WT, Burnett JC."Effect of cardiac resynchronization therapy on plasma catecholamines in patients with and without beta-blocker therapy" .
January 2004 Oren RM, Czerska B, Bohm M, Sadowski J, Van Bakel AB, Abraham WT, Wasler A, Cabuay B, Khanal S, Bartus K, Zile MR, Konstam MA."Cancion cardiac recovery system: effects on renal, echocardiographic, and health status parameters during and following treatment with a novel, minimally invasive approach to cardio-renal support in severe acute heart failure" .
January 2004 Oren RM, Czerska B, Bohm M, Sadowski J, Van Bakel AB, Abraham WT, Wasler A, Cabuay B, Khanal S, Bartus K, Zile MR, Konstam MA."Cancion cardiac recovery system (CRS): effects on renal, echocardiographic, and health status parameters during and following treatment with a novel, minimally invasive approach to cardio-renal support in severe heart failure" .
January 2004 Knudsen CW, Omland T, Westheim A, Clopton P, Abraham WT, Storrow A, McCord JK, Nowak R, Duc P, McCullough P, Maisel A."B-type natriuretic peptide and chest radiograph findings as indicators of systolic dysfunction in patients presenting with acute dyspnea" .
January 2004 Knudsen CW, Clopton P, Klemsdal TO, Westheim A, Wu A, Abraham WT, Storrow AB, McCord JA, Nowak RM, McCullough PA, Omland T."Predictors of absence of heart failure in patients with elevated B-type natriuretic peptide levels" .
January 2004 Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie BM, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, The COHERE Participant Physicians."β-blockade in women with heart failure in the community setting: insights from a large prospective β-blocker registry" .
January 2004 Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie BM, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, The COHERE Participant Physicians."Characteristics and outcomes of heart failure patients in clinical practice: how do they relate to age?" .
January 2004 Franciosa JA, Nelson JJ, Lukas MA, Lottes S, Massie BM, Greenberg B, Fowler M, Gilbert EM, Abraham WT, for the COHERE Participant Physicians."Beta-blockade in women with heart failure in the community setting: insights from a large prospective beta-blocker registry" .
January 2004 Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie BM, Abraham WT, Franciosa JA, and the COHERE Participant Physicians."COHERE" .
January 2004 Foreman B, Fishel RS, Odryzynski NL, Abraham WT."Intra-thoracic impedance: a surrogate measure of thoracic fluid – Fluid Accumulation Status Trial (FAST)" .
January 2004 Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators."Initial hospital, patient, and performance measure characteristics of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2004 Dulin BR, Haas SJ, Abraham WT, Krum H."Do elderly systolic heart failure patients benefit from β-blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials" .
January 2004 Adamson PB, Smith AL, Abraham WT, Stadler RW, Kleckner KJ, Rhodes MR."Automated detection of decreases in heart rate variability predicts heart failure decompensation" .
January 2004 Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Rhodes MR."Unique diagnostics identify patients at risk for heart failure decompensation" .
January 2004 Strunk A, Bhalla V, Clopton P, Nowak RM, McCord J, Hollander JE, Storrow AB, Abraham WT, Wu AHB, Steg G, Perez A, Kazanegra R, Herrmann HC, Aumont MC, McCullough PA, Maisel A, for the BNP Multinational Study Investigators."Impact of the history of congestive heart failure on the utility of BNP in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) Multinational Study" .
January 2004 Nicholson D, Haas G, Carnes CA, Abraham WT, Feldman DS."Lack of efficacy of N-acetylcysteine in attenuating contrast induced nephropathy in patients with severe systolic heart failure" .
January 2004 Czerska B, Van Bakel A, Oren R, Abraham W, Bourge R, Zile M, Konstam M."Cancion Cardiac Recovery System in severe heart failure: initial U.S. results of acute sustained hemodynamic and clinical impact" .
January 2004 Czerska B, Oren RM, Bohm M, Sadowski J, Van Bakel AB, Abraham WT, Wasler A, Khanal S, Cabuay B, Bartus K, Zile MR, Konstam MA."Orquis Cancion cardiac recovery system: hemodynamic effects of a novel minimally-invasive approach to cardio-renal support in severe acute heart failure" .
January 2004 Abraham WT, Trupp RJ, Mehra MR, Lawless CE, Mitchell JE, LeJemtel TH, Smart FW, Bijou R, O’Connor CM, Yancy CW, Massie BM, Silver MA, Packer M."A multivariate impedance cardiography composite score can predict the occurrence of major heart failure events: the PREDICT study" .
January 2004 Abraham WT, Massie BM, Lukas MA, Lottes SR, Nelson JJ, Fowler MD, Greenberg B, Gilbert EM, Franciosa JA and the COHERE Participant Physicians."Tolerability, safety and efficacy of beta-blockers in black patients with heart failure in the community setting: insights from a large beta-blocker registry" .
January 2004 Abraham WT, Eisen HJ, Cohn JN."Cardiac resynchronization therapy is effective in patients with atrial fibrillation: interim results from the RESTORE-U.S. Study" .
January 2004 Abraham WT, Bourge RC, Magalski A, Adamson PB, Young JB, Wagoner LE, Stevenson LW, Bank AJ, Heroux A, Boulanger L, Sparks BS, Veath BK, Hill MRS, Roettger AD."Continuous hemodynamic monitoring reduces hospitalizations and health care utilization costs" .
January 2004 Yancy CW, Fonarow GC, Abraham WT, for the ADHERE Scientific Advisory Committee."Clinical differences between high and low mortality risk stratified patients hospitalized with acutely decompensated heart failure: ADHERE Registry data" .
January 2004 Maisel AS, Bhalia MA, Gardetto N, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, Omlan T, Storrow AB, Krisaswamy P, Abraham WT, Clopton P, Steg G, Aumont AC, Westheim A, Knudsen CW, Perez A, Kamin R, Kazanegra R, Herrmann HC, McCullough PA, the BNP Multinational Study."BNP Multinational Study" .
January 2004 Collins SP, Lindsell CJ, Abraham WT, Storrow AB."The emergency department chest radiograph is unreliable in establishing a diagnosis of heart failure" .
January 2004 Carnes CA, Nishijima Y, Jenkins P, da Cunha D, Abraham WT, Feldman DS, Hamlin RL."Left ventricular dysfunction and impaired exercise tolerance in a chronic canine model" .
January 2004 Cappola TP, Harsch M, Jessup M, Abraham WT, Young JB, Petersen-Stejskal S, St. John Sutton M."Men and women remodel differently in chronic systolic heart failure: analyses from MIRACLE and MIRACLE-ICD" .
January 2005 Yancy CW, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenburg BH, O'Connor CM, Young JB, Fonarow GC."Defining the natural history and improving quality of care for African Americans hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2005 Yancy C, Stough W, Abraham W, Greenberg B, She L, Fonarow G."Defining the natural history and improving quality of care for African-Americans hospitalized with heart failure: a report from OPTIMIZE-HF" .
January 2005 Wheelan KR, Young JB, Abraham WT, Johnson WB, Witte LJ, Harsch MR, on behalf of the investigators for the InSync Registry/InSync ICD Registry."the InSync Registry/InSync ICD Registry" .
January 2005 Selzman KA, Ohman ME, Abraham WT, Quinn-Tate L, Amkieh A."Use of computerized audioelectric parameters to detect altered hemodynamics during cardiac resynchronization therapy optimization" .
January 2005 Greenberg BH, Abraham WT, Albert NM, Stough WG, Gheorghiade M, O'Connor CM, She L, Yancy CW, Young JB, Fonarow GC."Influence of diabetes mellitus on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2005 Gheorghiade M, Stough WG, O’Connor CM, Abraham WT, Greenberg BH, Young JB, Albert NM, Yancy CW, She L, Fonarow GC."Serum sodium concentration and mortality in patients admitted with heart failure: an analysis of OPTIMIZE-HF" .
January 2005 Gheorghiade M, Klein L, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC."The relation between admission systolic blood pressure and outcomes in hospitalized patients with heart failure: an OPTIMIZE-HF analysis" .
January 2005 Gheorghiade M, Abraham WT, Albert NM, Greenburg BH, O'Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC."The relation between admission systolic blood pressure and outcomes in hospitalized patients with heart failure with reduced or preserved systolic function: an OPTIMIZE-HF analysis" .
January 2005 Butler J, Young JB, Abraham WT, Bourge RC, Adams KF, Hasan MA, Heroux A, Russell SD, Francis GS, Clare R, O’Connor CM."Beta-blocker use and associated outcomes among hospitalized heart failure patients" .
January 2005 Bourge RC, Aranda JM, Aaron MF, Abraham WT, Magalski A, Smith AL, Roettger AD, Sparks B, Tallaj J."Clinical outcome of a heart failure management strategy based on continuous hemodynamic monitoring" .
January 2005 Bourge RC, Abraham WT, Aaron MF, Aranda JM, Magalski A, Adamson PB, Stevenson LW, Zile MR."COMPASS-HF: a randomized outcomes study using an implantable hemodynamic monitor for the management of advanced heart failure" .
January 2005 Boerrigter G, Madden-Vadnais SC, Costello-Boerrigter LC, Heublein DM, Abraham WT, Kruger KM, Hill MRS, Burnett JC."Differential effects of cardiac resynchronization therapy on plasma levels of BNP based upon baseline values of BNP" .
January 2005 Nohria A, Shah MR, Stebbins A, Hill JA, Abraham WT, Frantz RP, Hamilton MA, Geffen D, Warnica JW, Stevenson LW."Effect of empiric versus pulmonary artery catheter-guided therapy on renal function in patients hospitalized with decompensated heart failure" .
January 2005 Nohria A, Shah MR, Hill JA, Abraham WT, Frantz RP, Hamilton MA, Geffen D, Warnica JW, Sopko G, Stebbins A, Stevenson LW."Effect of empiric versus PAC-guided therapy on renal function in patients hospitalized with decompensated HF" .
January 2005 Fonarow G, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, She L, Yancy CW, Young J."Can gender related disparities for heart failure be reduced? A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2005 Fonarow G, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, She L, Yancy CW, Young J."Impact of evidence-based heart failure therapy use at hospital discharge on treatment rates during follow-up: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2005 Fonarow G, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, She L, Yancy CW, Young J."Does patient age impact the use of evidence-based heart failure therapies at hospital discharge? A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2005 Fonarow G, Abraham W, Albert N, Gheorghiade M, Greenberg B, O’Connor C, Stough W, Yancy C, Young J, She L."Should beta-blocker use at the time of hospital discharge be included as a heart failure performance measure? A report from OPTIMIZE-HF" .
January 2005 Adamson PB, Bourge RC, Abraham WT, Taepke R, Cho YK, Bennett T."Automated detection of hemodynamic changes to predict heart failure hospitalization" .
January 2005 Adamson PB, Aaron MF, Aranda JM, Abraham WT, Taepke B, Bennett T, Bourge RC."Automated detection of hemodynamic changes associated with heart failure decompensation events" .
January 2005 Adamson PB, Aaron MF, Abraham WT, Aranda JM, Cho YK, Taepke R, Madden S, Bennett T, Bourge RC."Automated detection of hemodynamic changes associated with heart failure decompensation events" .
January 2005 Adamson P, Luby A, Aaron M, Aranda J, Abraham W, Smart F, Kjellstrom B, Johnson J, Bennett T, Bourge R."Circadian patterns of heart rate and cardiac pressures in patients with heart failure using continuous hemodynamic monitoring" .
January 2005 Abraham WT, Leon AR, Hannon C, Prather W, Fieberg A."Results of the InSync III Marquis trial" .
January 2005 Abraham WT, Foreman B, Fishel R, Haas G, Moe B."Fluid Accumulation Status Trial (FAST)" .
January 2005 Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenburg H, O'Connor CM, Yancy CW, Fonarow GC."Predictors of in-hospital mortality in patients hospitalized with heart failure: an analysis of 48,152 hospitalizations from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)" .
January 2005 Abraham WT, Aaron MF, Aranda JM, O'Shaughnessy MA, Jessup ML, Calfee K, Cavaglia, Bourge RC."Heart failure treatment strategy based on continuous hemodynamic monitoring decreases the number of extended hospital admission in NYHA Class III patients" .
January 2005 Abraham WT, Aaron MF, Aranda JM, O’Shaughnessy MA, Jessup ML, Calfee K, Cavaglia S, Sparks B, Bourge RC, COMPASS-HF Investigators."Economic implications of continuous hemodynamic monitoring on heart failure care" .
January 2005 Abraham WT."Effect of baseline covariate on mortality in the Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) Trial" .
January 2005 Abraham WT."Nesiritide does not increase 30-day or 6-month mortality risk" .
January 2005 Abraham WT."Serum creatinine elevations in patients receiving nesiritide are related to starting dose" .
January 2005 Abraham WT."Nesiritide does not increase 30-day or 6-month mortality risk" . : II
January 2005 Abraham WT."Effect of baseline covariates on mortality risk in the Vasodilation in the Management of Acute Decompensated Heart Failure (VMAC) trial" .
January 2005 Abraham WT."Serum creatinine elevations in patients receiving nesiritide are related to starting dose" .
January 2005 Abraham W, Foreman B, Fishel R, Odryzynski N."Clinical value in measuring intra-thoracic impedance in patients with chronic heart failure: Fluid Accumulation Status Trial (FAST)" .
January 2005 Zile MR, Oren RM, Bohm M, Sadowski J, Van Bakel AB, Abraham WT, Wasler A, Khanal S, Cabuay B, Bartus K, Konstam MA."Continuous aortic flow augmentation using the Orqis Cancion CRS therapy in patients with severe heart failure: determinants of hemodynamic response" .
January 2005 Zile MR, Oren RM, Bohm M, Sadowski J, Van Bakel AB, Abraham WT, Wasler A, Cabuay B, Bartus K, Konstam MA."Continuous aortic flow augmentation using the Orqis Cancion CRS therapy in patients with severe heart failure: determinants of hemodynamic response" .
January 2005 Zile M, Aaron M, Aranda J, Abraham W, Holmquist-Meyer H, Bennett T, Bourge R."Pathophysiology and management strategy in diastolic heart failure patients using continuous hemodynamic monitoring" .
January 2005 St. John Sutton M, Plappert T, Abraham WT, Leon A, Fieberg A."Optimization of sequential ventricular delay reduces left ventricular dysynchrony during cardiac resynchronization therapy resulting in improved patient functional response: results from the InSync III Marquis Trial" .
January 2005 Smith AL, Abraham WT, Young JB, Wheelan KR, Witte LJ, Harsch MR, Storm CM."CRT therapy in patients with a history of atrial fibrillation" .
January 2005 Mielniczuk L, Aaron MF, Abraham WT, Aranda JM, Smith AL, Adamson PB, Kueffer FJ, Vance JA, Bourge RC, Stevenson LW."Knowledge of intracardiac filling pressures increases frequency of diuretic adjustments in advanced heart failure" .
January 2005 Iyengar S, Haas G, Lamba S, Orsinelli D, Babu G, Ferketich A, Yamokoski L, Periasamy M, Abraham W."Effect of cardiac resynchronization therapy on myocardial gene expression in patients with non-ischemic dilated cardiomyopathy" .
January 2005 Czerska B, Oren RM, Bohm M, Sadowski J, Van Bakel AB, Czerska B, Abraham WT, Wasler A, Cabuay B, Khanal S, Bartus K, Zile MR, Konstam MA."Clinical results with the Orqis Medical Cancion CRS therapy" .
January 2005 Boerrigter G, Costello-Boerrigter LC, Heublein DM, Abraham WT, Kruger KM, Hill MRS, Burnett JC."Differential neurohormonal changes in heart failure patients with deteriorating renal function" .
January 2005 Aranda JM, Aaron MF, Abraham WT, Magalski A, Smith AL, Leach DD, Roettger AD, Sparks B, Bourge RC, COMPASS-HF Investigators."Clinical outcome of a heart failure management strategy based on continuous hemodynamic monitoring" .
January 2005 Tallaj JA, Bourge RC, Aaron MF, Abraham WT, Aranda JM, Magalski A, Roettger AD, Dale S, Grimes J."Continuous hemodynamic monitoring in the management of advanced heart failure patients" .
January 2006 Zile MR, Adamson PB, Abraham WT, Warner-Stevenson L, Bennett TD, Bourge RC."Continuous hemodynamic monitoring: differences in pressures between rest and activity in patients with compensated systolic or diastolic heart failure" . : S12
January 2006 Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals."Carvedilol use at discharge in patients hospitalized for heart failure is associated with markedly improved survival" .
January 2006 Fonarow GC, Abraham WT, Albert NM, Chiswell K, Gattis Stough W, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals."ACC/AHA performance indicators for patients hospitalized with HF: are they predictive of clinical outcomes?" .
January 2006 Boerrigter G, Costello-Boerrigter LC, St. John Sutton MG, Abraham WT, Kruger KM, Hill MR, Burnett JC."Patients with high baseline levels of B-type natriuretic peptide are less likely to experience significant left ventricular reverse remodeling with cardiac resynchronization therapy in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) trial" . : II
January 2006 Boerrigter G, Costello-Boerrigter LC, St. John Sutton MG, Abraham WT, Kruger KM, Hill MRS, Burnett JC Jr."Can B-type natriuretic peptide predict patients who will have significant reverse remodeling with cardiac resynchronization therapy?" . : S59
January 2006 Boerrigter G, Costello-Boerrigter LC, Abraham WT, St. John Sutton MG, Kruger KM, Hill MRS, Burnett JC Jr."Atrial natriuretic peptide may be superior to B-type natriuretic peptide in monitoring cardiac resynchronization therapy" . : S58
January 2006 Ritzema-Carter J, Troughton R, Melton I, Krum H, Walton T, Eigler N, Doughty Abraham WT."Medical therapy directed by a new implantable left atrial pressure sensing device reduces episodes of hemodynamic deterioration in ambulatory heart failure patients" . : II
January 2006 Ritzema-Carter J, Melton IC, Crozier IG, Kar S, Eigler N, Whiting J, Krum H, Abraham WT, Troughton RW."First human experience with a new left atrial pressure monitoring device: validation with simultaneous pulmonary artery occlusion pressure in subjects with heart failure" .
January 2006 Ritzema-Carter J, Melton IC, Crozier IG, Kar S, Eigler N, Whiting J, Krum H, Abraham WT, Troughton RW."First human experience with a new left atrial pressure monitoring device: validation with simultaneous pulmonary artery occlusion pressure in subjects with heart failure" . : S120
January 2006 Renlund DG, Stevenson LW, Abraham WT, Bourge RC, Wagoner LE, Kjellstrom B, Bennett TD."Effect of mechanical circulatory support on pulmonary hypertension assessed by implantable hemodynamic monitoring" . : S52
January 2006 Abraham WT, Fieberg AM, Haas G."Echocardiographically optimized interventricular pacing delay improves CRT clinical response" . : S45
January 2006 Aaron MF, Adamson PB, Stevenson LW, Abraham WT, Sparks B, Bourge RC."Access to implantable hemodynamic monitor information during post-randomization follow-up decreased heart failure hospitalization in the control group of the COMPASS HF study" . : S73
January 2006 O’Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy C, Young JB, Fonarow GC, OPTIMIZE-HF Investigators and Hospitals."Predictors of mortality after discharge in patients hospitalized for heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized patients with Heart Failure (OPTIMIZE-HF)" .
January 2006 Nishijima Y, Sridhar A, Bonagura JD, Abraham WT, Hamlin RL, Gyorke S, Feldman DS, Carnes CA."Cardiac resynchronization therapy normalizes in vivo repolarization and left ventricular action potential duration" . : II
January 2006 Delgado RM, Smith DM, Kar B, Greenberg BH, Czerska B, Abraham WT, Radovancevic B, Bergheim M, Parker I, Konstam MA."Lessons on the patient population for device trials in heart failure: early baseline characteristics in the MOMENTUM trial" . : S79
January 2006 Dae M, Gradinac S, Sievert H, Abraham WT."Early clinical experience with a percutaneous ventricular partitioning device for heart failure patients" . : S54
January 2006 Albert NM, Fonarow GC, Abraham WT, Chiswell K, Gattis Stough W, Gheorghiade M, Greenberg BH, O’Connor CM, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals."Do hospitals that provide heart failure patient education prior to discharge also promote continuity of care? A report from OPTIMIZE-HF" . : 267A
January 2006 Albert NM, Fonarow G, Abraham W, Chiswell K, Gattis Stough W, Gheorghiade M, Greenberg B, O’Connor C, Yancy C, Young J."Do hospitals that provide heart failure education prior to discharge also promote continuity of care? A report from OPTIMIZE-HF" . : S112
January 2006 Adamson PB, Aaron MF, Abraham WT, Aranda JM, Cho YK, Taepke RT, Bennett TD, Bourge RC."Pressure changes associated with heart failure events using an automated detector" . : S128
January 2006 Abraham WT, Klapholz M, Anand I, Knusel B, Rosser D, Baker N, Sun Y, Van Veldhuisen DJ."Safety and efficacy of darbepoetin alpha treatment in anemic patients with symptomatic heart failure: a pooled analysis of two randomized, double-blind, placebo-controlled trials" . : 166
January 2006 Abraham WT, Greenberg BH, Fonarow GC, Albert NM, Chiswell K, Gattis Stough W, Gheorghiade M, O’Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals."Cardiac resynchronization therapy placement during hospitalization for heart failure is associated with a significant improvement in early clinical outcomes" .
January 2006 Rayburn BK, Aranda JM, Boehmer JP, Conte JV, Kreuger SK, Smith AL, Torre-Amione G, Abraham WT."The Paracor Ventricular Support System: initial US experience" . : II
January 2006 Lowes BD, Zolty R, Abraham WT, Robertson AD, Taylor MRG, Liggett SB, Bristow MR."Pharmacogenetic therapeutic enhancement of a prespecified composite morbidity-mortality measurement in BEST" . : S87
January 2006 Lowes BD, Zolty R, Abraham WT, Robertson AD, Taylor MR, Liggett SB, Bristow MR."Pharmacogenetic therapeutic enhancement of a prespecified composite morbidity-mortality measurement in BEST" . : II
January 2006 Ghali JK, Anand I, Abraham WT, Fonarow G, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B."The effect of increased hemoglobin concentration on clinical outcomes in patients with symptomatic heart failure and anemia: results from STAMINA-HF" . : II
January 2006 Ghali JK, Anand I, Abraham WT, Fonarow G, Greenberg B, Krum H, Massie B, Armstrong P, on behalf of the STAMINA-HF Investigators."Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HF" . : 166
January 2006 Gattis Stough W, Fonarow GC, Albert NM, Abraham WT, Lokhnygina Y, Gheorghiade M, Greenberg BH, O’Connor CM, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals."Comparison of factors identified as precipitating heart failure hospital admissions and clinical outcomes: a report from OPTIMIZE-HF" .
January 2006 Gattis Stough W, Fonarow GC, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals."Characteristics, treatments and outcomes of patients hospitalized for heart failure with preserved systolic function: a report from OPTIMIZE-HF" .
January 2006 Casey DE Jr, Abraham W, Barrow L, Namie M, Pina I, Schaeffer J, Snow R."Catholic Healthcare Partners’ Closing the Gap for Heart Failure Initiative: a large multistate health system takes on the challenge to improve quality of care" . : 267A
January 2006 Aranda JM Jr, Klodell CT Jr, Rayburn BK, McGiffin DC, Abraham WT, Sun B, Johannes B, Diegeler A, Huth C, Grothues F, Smid J, Klein H."Early worldwide experience with the Paracor HeartNet elastic restraint device for heart failure" . : S46
January 2007 Ritzema-Carter J, Troughton R, Melton I, Doughty R, Stewart J, Kum H, Whiting J, Eigler N, Haas GJ, Abraham WT, for the HOMEOSTASIS Study Group."Accurate non-invasive calibration of an implantable left atrial pressure monitoring system in heart failure patients during long-term follow-up" . : 95A
January 2007 Albert NM, Fonarow GC, O'Connor CM, Stough WG, Nunez E, Abraham WT, Gheorghiade M, Greenberg BH, Yancy CW, Young JB."Is history of depression a predictor of in-hospital treatment and early post-discharge outcomes in patients with heart failure? a report from OPTIMIZE-HF" . : S162
January 2007 Abraham WT, Young J, Smith AL, Johnson WB, Prather W, Chang Y, Gulabani DP, for the InSync Registry Investigators."Comparison of all-cause mortality in a randomized controlled trial (MIRACLE) and “real-world” (InSync Registry) use of cardiac resynchronization therapy (CRT)" . : S126
January 2007 Abraham WT, Smith A, Johnson B, Young JB, Wheelan K, Chang Y, Gulabani DP."Long-term performance of a left ventricular lead" . : S207
January 2007 Abraham WT, Aranda JM, Rayburn BK, Boehmer JP, Krueger S, Conte JV, Smith AL."A cardiac support device produces incremental clinical benefits in heart failure patients treated with cardiac resynchronization therapy" . : S115
January 2007 Abraham W, Gupta M, Boulogne E, Gras D."FREEDOM (a Frequent Optimization Study Using the QuickOpt™ Method) study design" . : S140
January 2007 Tallaj J, Adamson PB, Aaron MF, Abraham WT, Heywood JT, Bourge RC, Cho YK, Bennett T.."Relationship between right ventricular pressures and heart failure events in patients with heart failure" . : S178
January 2007 Stevenson LW, Cho YK, Heywood JT, Bourge RC, Abraham WT, Manda V, O’Connor CM.."Reverse hemodynamic remodelling may be possible over time" . : II
January 2007 Stevenson L, Renlund D, Jessup M, Abraham B, Adamson P, Bennett T, Bourge R, for the COMPASS Investigators.."Daily weights at home are not reliable for tracking fluid change before heart failure events." . : S174
January 2007 Otasevic P, Sievert H, Elsasser A, Abraham W, Dae M."Percutaneous ventricular restoration in chronic heart failure patients (PARACHUTE) – six month follow-up" . : S113
January 2007 Linde C, Gold M, Abraham WT, Daubert J-C."CRT in patients with asymptomatic and mildly symptomatic heart failure: baseline characteristics of the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study population." . : II
January 2007 Rogers JG, Norhia A, Hellkamp AS, Hill JA, Wagoner LE, Pina IL, Abraham WT, Stevenson LW, O’Connor CM, for the ESCAPE Investigators and Coordinators."Warm-dry clinical profile at 1 month after heart failure hospitalization can be used for triage in advanced heart failure: an analysis from the Evaluation Study of CHF and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trail" . : 50A
January 2007 Khayat RN, Patt BT, Yamokoski T, Abraham WT.."Obstructive sleep apena may play a role in the acute decompensation of heart failure." . : S172
January 2007 Fonarow GC, Albert NM, O'Conner CM, Stough WG, Nunez E, Abraham WT, Gheorghiade M, Greenberg BH, Yancy CW, Young JB.."Does the day of the week heart failure patients are admitted influence length of stay or mortality risk? Findings from OPTIMIZE-HF." . : S174
January 2007 Fonarow GC, Albert NM, O'Conner CM, Stough WG, Nunez E, Abraham WT, Gheorghiade M, Greenberg BH, Yancy CW, Young JB."Predictors of length of stay in patients hospitalized with heart failure: a report from OPTIMIZE-HF" . : S156
January 2007 Flaherty JD, Rossi JS, Davidson CJ, Nunez E, Gattis Stough W, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, Yancy CW, Young JB, Fonarow GC, Gheorghiade M."Influence of etiology and left ventricular systolic function on acute heart failure outcomes: a report from OPTIMIZE-HF" . : 71A
January 2007 Boerrigter G, Costello-Boerrigter LC, Abraham WT, St. John-Sutton MG, Heublein DM, Kruger KM, Hill MRS, McCullough PA, Burnett JC."Cardiac resynchronization therapy improves renal function in heart failure patients with reduced glomerular filtration rate" . : S128
January 2007 Boerrigter G, Costello-Boerrigter LC, Abraham WT, St. John Sutton MG, Heublein DM, Kruger KM, Hill MR, McCullough PA, Burnett JC Jr."Cardiac resynchronization therapy with biventricular pacing improves renal function in heart failure patients with reduced glomerular filtration rate." . : II
January 2008 Zeng X, Khayat RN, Patt B, Holt R, Fan X, Abraham WT, Pu M.."Beneficial effects of continuous positive airway pressure on left ventricular diastolic function in patients with acutely decompensated congestive heart failure and obstructive sleep apnea." . : S870
January 2008 St. John Sutton M, Ghio S, Plappert T, Tavazzi L, Daubert JC, Abraham WT, Gold MR, Linde C.."Changes in left ventricular structure and function over 12 months in patients with mild or asymptomatic heart failure with previous symptoms in the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study." . : S950
January 2008 Gottlieb S, DeNofrio D, Russell S, Zuh Y, Stecher S, Ticho B, Abraham WT."Effects of single IV doses of BG9928, an adenosine A1 antagonist, in patients with heart failure." . : S67
January 2008 Bishara O, Sturm A, Sparks E, Raman S, Westman J, Seidman C, Abraham WT."Identification of a novel mutation in the beta-myosin heavy chain gene associated with variable phenotypic presentation of cardiomyopathy" . : A62
January 2008 Magalski A, Adamson P, Abraham WT, Renlund D, Bourge R, Manda V, Sparks B, Stevenson L, on behalf of the COMPASS-HF investigators."Does lowering filling pressures by using continuously measured intracardiac pressures result in reduced risk of heart failure event?" . : A80
January 2008 Abraham WT, Young J, Wheelan K, Johnson WB, Smith A, Chang Y, Jakkula M."For the InSync Registry and InSync ICD Registry Investigators. Cardiac resynchronization and defibrillator therapy (CRT-D) improves survival compared to CRT alone (CRT-P) in heart failure patients." . : A25
January 2008 Abraham WT, Young J, Wheelan K, Johnson WB, Smith A, Brinkman P, Chang Y."Comparison of sudden cardiac death in heart failure patients with cardiac resynchronization and defibrillator therapy (CRT-D) versus CRT alone (CRT-P)." . : S71
January 2008 Abraham WT, Leon A, Tavazzi L, Sun J, Nihoyannopoulos P, Merlino J, Chung E, Ghio S, Leclercq C.."The heart failure clinical composite score at six months predicts subsequent morbidity and mortality." . : A74
January 2008 Abraham WT, Goldsmith S, Gottlieb S."Effects of lixivaptan, a novel vasopressin V2 receptor antagonist, in chronic heart failure: results from a double-blind, placebo-controlled, multiple-does study" . : S71
January 2008 Abraham WT, Anand I, Aranda Jr J, Rayburn B Boehmer J, Grothues F, Klein H, Ivanhoe R.."A novel ventricular elastic support system reverses remodeling in heart failure patients." . : A74
January 2008 Klapholz M, Abraham WT, Ghali JK, Ponikowski P, Knusel B, Wasserman SM, Sun Y, Van Veldhuisen DJ.."Pooled safety analysis of darbepoetin alfa in the treatment of symptomatic heart failure" . : 507
January 2008 Ghio S, St. John Sutton M, Tavazzi L, Plappert T, Daubert JC, Abraham WT, Gold MR, Linde C.."CRT in mild heart failure: left ventricular remodeling in relation to heart failure etiology. Results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study." . : S869
January 2008 Cleland JGF, Abraham WT, Liu P, Anand I, Colucci WS, Packer M."The effects of satavaptan (SR121463B) an oral vasopressin-2 receptor antagonist in patients with severe heart failure: the AQUAVIT study (AQUAresis Vasopressin-antagonist Intervention Trial)" . : 608
January 2009 Vanderheyden M, Blommaert D, Abraham WT, Guzzo L, Bouchez D, Gras D."Definitions for assessing CRT response in the real-world: outcome of the FREEDOM survey" .
January 2009 Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M.."Symplicity I: Does catheter-based renal sympathetic denervation maintain blood pressure reduction in patients with resistant hypertension over the subsequent 12 months? Complete 12-month efficacy and safety results." .
January 2009 Chung ES, Katra R, Ghio S, Bax J, Gerritse B, Peterson BJ, Feldman D, Abraham WT."Cardiac resynchronization therapy in patients with left ventricular ejection fraction above 35%" .
January 2009 Adamson PB, Bourge RC, Abraham WT, Cho YK, Bennett TD."Differential changes in RV and LV filling pressures during acute decompensation in chronic heart failure patients" .
January 2009 Abraham WT, Javaheri S.."Sleep apnea incidence and outcomes in heart failure patients: a retrospective study of Medicare beneficiaries." . : A154
January 2009 Abraham WT, Javaheri S."Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure" .
January 2009 Abraham WT, Gupta MS, Guzzo L, Gras D.."Assessment of patient’s response to cardiac resynchronization therapy varies between different clinical practices." . : S77
January 2009 Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S."Superior performance of intrathoracic impedance-derived fluid index versus daily weight monitoring in heart failure patients: results of the Fluid Accumulation Status Trial (FAST)." .
January 2009 Abraham WT, Cho YK, Taepke RT, Bennett TD, Adamson PB, Bourge RC."Hemodynamic differences in ambulatory heart failure patients with low vs high heart rates" .
January 2009 Pu M, Gao ZH, Fan XX, Abraham WT, Binkley P, Ryan T, Davidson W Jr.."Adverse effect of early and late long-term beta-blockade on left ventricular remodeling, function and mortality in chronic organic mitral regurgitation." .
January 2009 Rayburn BK, Aranda, Jr. JM, Boehmer JP, Anand I, Klein H, Ivanhoe RJ, Abraham WT.."The Paracor HeartNet™ ventricular elastic support therapy feasibility study: two-year follow-up." . : A188
January 2009 Mazzaferri E, Abraham W."Percutaneous therapy for ischemic heart failure: long term safety and efficacy in 33 patients." .
January 2009 Kadish AH, Nademanee K, Volosin K, Krueger S, Neelagaru, S, Weiner S, Wish M, Bourge R, Parides M, Chiacchierini R, Goldsmith R, Goldstein S, Mike Y, Burkhoff D, Abraham W.."Cardiac contractility modulation improves exercise tolerance in NYHA class III patients with narrow QRS and EF between 25% and 35%: a subgroup analysis of the FIX-HF-5 study." .
January 2009 Gras D, Guzzo L, Gupta, M, Abraham WT."Standard practice survey for optimization of AV/PV delays and V-V timing in the CRT-D population." . : 172
January 2009 Gold MR, Linde C, Lozano IF, Daubert C, Abraham WT.."Relationship of QRS duration to reverse remodeling with cardiac resynchronization therapy in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) trial." . : A135
January 2009 Gold MR, Linde C, Lozano IF, Daubert C, Abraham WT."Impact of QRS duration on clinical response with cardiac resynchronization therapy: results from the REVERSE Trial" .
January 2009 St. John Sutton MG, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, Abraham WT, Gold MR, Hassager C, Herre JM, Derumeaux G, Linde C.."Effects of reverse remodeling with cardiac resynchronization therapy in mild heart failure on left ventricular volume and shape. Results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) trial." . : A192
January 2009 St. John Sutton MG, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, Abraham WT, Gold MR, Hassager C, Herre HM, Derumeaux G.."Cardiac resynchronization therapy induces major structural and functional reverse remodeling in mild heart failure. Results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study." . : A187
January 2009 Linde C, Leman R, Daubert C, Abraham WT, Gold MR.."Cardiac resynchronization therapy in mild heart failure: is there a difference in outcome between NYHA Class I versus II? Results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) trial." . : A188
January 2009 Linde C, Daubert C, Abraham WT, Gold MR, Hassager C, Herre JM, Ghio S, St. John Sutton M, Derumeaux G.."The influence of left ventricular ejection fraction on the extent of reverse remodeling by cardiac resynchronization therapy in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE)" . : A183
January 2009 Linde C, Abraham W, Gold M, St. John Sutton M, Ghio S, Daubert C."CRT in mild heart failure: response in relation to heart failure etiology? Twenty-four month results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study." .
January 2010 Hettrick DA, Sarkar S, Koehler J, Rogers T, Yu CM, Abraham W, Small R, Tang WHW."Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices." .
January 2010 Hettrick DA, Sarkar S, Koehler J, Rogers T, Grinberg Y, Yu CM, Abraham WT, Small R, Tang WHW."Improved algorithm to detect worsening heart failure via intrathoracic impedance monitoring in patients with implantable devices." .
January 2010 Hasan A, Michalkiewicz D, Czarnecka D, Ponikowksi P, Abraham WT."Comparison of right and left unilateral phrenic nerve stimulation in the termination of central apnea events." .
January 2010 Thebault C, Gold M, Linde C, Abraham WT, Kervio G, Leclercq C, Daubert C."Does the change in QRS duration with chronic CRT predict the clinical and echocardiographic response?" .
January 2010 Mazzaferi EL, Hasan AK, Abraham WT."Percutaneous left ventricular partitioning for ischemic heart failure: results of the US-PARACHUTE Feasibility Study" .
January 2010 Linde C, Abraham WT, Gold MR, St. John Sutton M, Ghio S, Daubert JC."CRT in mild heart failure: response in relation to heart failure etiology? 24-month results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study." .
January 2010 Gold MR, Linde C, Maiz AA, Daubert JC, Abraham WT.."Relationship of QRS morphology on reverse remodeling and clinical outcomes with cardiac resynchronization therapy (CRT) in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) trial." .
January 2010 Georgakopoulos D, Kroon A, Bach DS, Kaufman CL, Abraham WT, Little WC, Zile MR.."Improved left ventricular end-systolic myocardial wall stress following chronic baroreflex activation with the Rheos System in resistant hypertension" .
January 2010 Georgakopoulos D, Kroon A, Bach DS, Kaufman CL, Abraham WT, Little WC, Zile MR."Improved ventricular-arterial elastance following chronic treatment using the Rheos System Implantable Device in resistant hypertension." .
January 2010 Burkhoff D, Abraham WT, Kadish A."Impact of cardiac contractility modulation on symptoms and exercise tolerance in patients with heart failure and EF greater than 35%: a subgroup analysis of the FIX-HF-5 study" .
January 2010 Adamson PB, Abraham WT, Bourge RC, Stevenson LW, Yadav J."CardioMEMS heart sensor allows monitoring of pressures to improve outcomes in NYHA Class III heart failure patients (CHAMPION): trial impact of hemodynamic guided care on patients with preserved ejection fraction" .
January 2010 Abraham WT, Gras D, Yu CM, Calo L, Islam N, Klein N, Alawwa A, Santamaria M, Goodman J, Exner DK, Green UB, Clyne C, Mortensen P, Gradaus R, Hasan A, Maounis T, Morgan J, Wijetunga M, Sheppard R, Herre J."Results from the FREEDOM trial: assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy." .
January 2011 Crestanello JA, Phillips G, Sai-Sudhakar C, Sirak J, Firstenberg M, Higgins R, Abraham W.."Relationship between preoperative sodium and clinical outcomes after cardiac surgery" .

Presentations

"Department of Medicine Morbidity and Mortality Conferences." Denver, CO. (January 1989)

"The failing heart: drowling in a mystic sea." Presented at Medical Grand Rounds, Denver, CO. (October 1989)

"The hepatorenal syndrome." Presented at Department of Medicine Noon Conference, Denver, CO. (June 1989)

"The hepatorenal syndrome: reversal of diuretic resistance with increased effective arterial blood volume." Presented at The 70th Annual Session of the American College of Physicians, San Francisco, CA. (April 1989)

"Elevated plasma norepiniphrine concentrations in patients with congestive heart failure: dependence on increased secretion rates." Presented at The American Society of Nephrology 22nd Annual Meeting, Washington DC. (December 1989)

"Preoperative cardiovascular risk assessment." Presented at Ophthalmology Teaching Conference, Denver, CO. (May 1990)

"Relationships between hemodynamic state, plasma atrial natriuretic factor, and urinary cyclic guanosine monophosphate in patients with congestive heart failure." Presented at The American Federation for Clinical Research, Western Regional Meeting, Carmel, CA. (February 1990)

"The renin-angiotensin-aldosterone system and angiotensin converting enzyme inhibition in congestive heart failure." Presented at Cardiology Grand Rounds, Denver, CO. (February 1991)

"Congestive Heart Failure." Presented at Department of Medicine Noon Conference, Denver, CO. (August 1991)

"Renal function in congestive heart failure." Presented at Nephrology Grand Rounds, Denver, CO. (October 1992)

"Renal salt and water handling in congestive heart failure.." Presented at Cardiology Grand Rounds, Denver, CO. (April 1992)

"Atrial natriuretic peptide in patients with congestive heart failure." Presented at The National Institutes of Health/General Clinical Research Centers Program Annual Meeting, Reston, VA. (December 1992)

"Management of congestive heart failure." Presented at Department of Medicine Noon Conference, Denver, CO. (August 1993)

"Review of congestive heart failure: epidemiology, pathophysiology, and management." Presented at Cardiology Grand Rounds, Denver, CO. (February 1993)

"Cardiomyopathies, valvular heart disease, and congestive heart failure." Presented at Internal Medicine Board Review Course, Denver, CO. (February 1993)

"Role of atrial natriuretic peptide in edematous disorders." Presented at Division of Clinical Pharmacology and Toxicology Research Seminar, Denver, CO. (January 1994)

"Pathophysiology and management of heart failure." Presented at Pulmonary Division's Critical Care Lecture Series, Denver, CO. (January 1994)

"Angiotensin converting enzyme inhibition in congestive heart failure." Presented at Cardiology Grand Rounds, Denver, CO. (January 1994)

"Increased frequency of the angiotensin converting enzyme D/D genotype in patients with severe pulmonary hypertension." Presented at The 43rd Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 1994)

"Angiotensin II selectively increases cardiac adrenergic activity in patients with heart failure." Presented at The 43rd Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 1994)

"Congestive Heart Failure." Presented at Department of Medicine Noon Conference, Denver, CO. (July 1994)

"Assessment and management of acute heart failure." Presented at Fellows' Introductory Lecture Series, Division of Cardiology, Denver, CO. (July 1994)

"Management of failure in the ICU." Presented at Fellows' Core Curriculum, Division of Cardiology, Denver, CO. (August 1995)

"Congestive heart failure I: epidemiology, pathophysiology, and diagnosis." Presented at Department of Medicine Noon Conference, Denver, CO. (August 1995)

"Natriuretic peptides in congestive heart failure." Presented at Research Conference, Division of Cardiology, Denver, CO. (December 1995)

"The angiotensin converting enzyme DD genotype is associated with preserved right ventricular function in patients with severe primary pulmonary hypertension." Presented at The 44th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1995)

"Systemic hemodynamic and renal excretory effects of a continuous 4-hour infusion of human brain natriuretic peptide in patients with heart failure." Presented at The 44th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1995)

"Original Contribution Session- Autonomic Nervous System Adaptation in Heart Failure." Presented at The 44th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1995)

"Hemodynamic, neurohormonal, and renal effects of human brain natriuretic peptide in patients with heart failure." Presented at Semi-Annual General Clinical Research Center Scientific Session, Denver, CO. (September 1995)

"Congestive heart failure II: therapeutic approach to heart failure." Presented at Department of medicine Noon Conference, Denver, CO. (September 1995)

"Human brain natriuretic peptide reduces pulmonary vascular resistance in patients with heart failure." Presented at The 68th Annual Scientific Sessions of the American Heart Association, Anaheim, CA. (November 1995)

"Natriuretic peptides in edematous disorders." Presented at Division of Clinical Pharmacology and Toxicology Research Seminar, Denver, CO. (November 1995)

"Systemic hemodynamic and renal excretory effects of a continuous 4-hour infusion of human brain natriuretic peptide in patients with heart failure." Presented at The National Institutes of Health/General Clinical Research Centers Program Annual Meeting, San Diego, CA. (February 1995)

"Cardiac Adrenergic Activiation in Heart Failure." Presented at Cardiology Grand Rounds-Research Conference, Denver, CO. (February 1995)

"Cardiomyopathies, valvular heart disease, and congestive heart failure." Presented at Internal Medicine Board Review Course, Denver, CO. (April 1995)

"Neurohormonal mechanisms in chronic heart failure." Presented at Perspectives in Internal Medicine, Department of Medicine Symposium and 20-Year Housestaff Reunion, Denver, CO. (September 1995)

"Congestive heart failure II." Presented at Department of Medicince Noon Conference, Denver, CO. (July 1996)

"Congestive heart failure I." Presented at Department of Medicine Noon Conference, Denver, CO. (July 1996)

"Cardiorenal adaptation and maladaptation in heart failure." Presented at Medical Grand Rounds, Denver, CO. (February 1996)

"Standard and investigational drug therapy of heart failure." Presented at Cardiology Grand Rounds, Denver, CO. (January 1996)

"Systemic hemodynamic, neurohormonal, and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with chronic decompensated heart failure." Presented at The National Institutes of Health/General Clinical Research Centers Program Annual Meeting, Arlington, VA. (March 1996)

"Neurohormonal activation in heart failure: natriuretic peptides and other factors." Presented at Division of Renal Diseases and Hypertension Grand Rounds, Denver, CO. (September 1996)

"Evaluation and management of chronic heart failure." Presented at Primary Health Care Families and Individuals Program Nurse Practitioner Lecture Series, Denver, CO. (September 1996)

"Cardiac tracer norepinephrine kinetics in orthotopic heart transplant recipients: evidence for late re-innervation." Presented at The XVIIIth Congress of the European Society of Cardiology, Birmingham, GB|GBR. (August 1996)

"Distal tubular sodium delivery is a determinant of the natriuretic resonse to hBNP in heart failure patients." Presented at The 69th Annual Scientific Sessions of the American Heart Association, . (November 1996)

"Case management studies: managing mild to moderate heart failure with multiple pharmacologic approaches." Presented at A New Era in Heart Failure: Translating Mechanism into Management, Satellite Symposium preceding the 69th Annual Scientific Sessions of the American Heart Association, New Orleans, LA. (November 1996)

"Role of vasopressin in the renal water retention of chronic human heart failure." Presented at Research Conference, Division of Cardiology, Denver, CO. (April 1997)

"Effects of an oral, nonpeptide, selective V2 receptor vasopressin antagonist in human heart failure." Presented at The 1997 World Congress of Neurohypophysial Hormones, Montreal, QC, CA|CAN. (August 1997)

"Effects of an oral, nonpeptide, selective V2 receptor AVP antagonist in human heart failure." Presented at The XIVth International Congress of Nephrology, Sydney, AU|AUS. (May 1997)

"Congestive Heart Failure." Presented at Department of medicine noon conference, Denver, CO. (July 1997)

"Original Contribution Session- Renal Function and Interventions in Heart Failure." Presented at The 46th Annual Scientific Session of the American College of Cardiology, Anaheim, CA. (March 1997)

"Luncheon Panel: "Current Therapy of Heart Failure."." Presented at The 46th Annual Scientific Session of the American College of Cardiology, Anaheim, CA. (March 1997)

"Examples of reverse remodeling with carvedilol in heart failure." Presented at Meeting the Challenges of Heart Failure with Beta-Blockade, Satellite Symposium preceding the 46th Annual Scientific Session of the American College of Cardiology, Anaheim, CA. (March 1997)

"Effects of an oral, nonpeptide, selective V2 receptor vasopressin antagonist in patients with chronic heart failure." Presented at The 46th Annual Scientific Session of the American College of Cardiology, Anaheim, CA. (March 1997)

"Mechanism of increased cardiac adrenergic activity in heart failure: evidence for decreased cardiac neuronal norepinephrine reuptake." Presented at The 70th Annual Scientific Sessions of the American Heart Association, Orlando, FL. (November 1997)

"Evaluation and management of heart failure." Presented at Cardiology Grand Rounds, Cincinnati, OH. (November 1997)

"Tracer norepinephrine kinetics in the coronary circulation of patients with idiopathic dilated cardiomyopathy: evidence for decreased neuronal norepinephrine reuptake." Presented at The First Annual Meeting of the Heart Failure Society of America, Baltimore, MD. (September 1997)

"Satellite Symposium: Consideration in Managing Heart Failure, "Interactive Case Studies: Systolic Versus Diastolic Heart Failure."." Presented at The First Annual Scientific Meeting of the Heart Failure Society of America, Baltimore, MD. (September 1997)

"How to use diuretics." Presented at The First Annual Scientific Meeting of the Heart Failure Society of America, Baltimore, MD. (September 1997)

"Hypothesis-testing research in human heart failure: mechanism of increased cardiac adrenergic activity in the failing heart." Presented at Department of Medicine Science in Clinical Medicine Lecture Series, Cincinnati, OH. (May 1998)

"Role of the adrenergic nervous system and use of beta-blockers in chronic heart failure." Presented at Medical Grand Rounds, Cincinnati, OH. (July 1998)

"Management of heart failure." Presented at Cardiology Core Curriculum, Cincinnati, OH. (July 1998)

"Satellite Symposium: Beta-Blockade: Current Views and Future Perspectives, "Interactive case studies: impact of beta-blockade on streamlining care."." Presented at The Second Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 1998)

"Satellite Symposium: Acute Management of Decompensated Heart Failure: New options, New goals, "What are the goals of acute therapy?"." Presented at The Second Annual Scientific meeting of the heart Failure Society of America, Boca Raton, FL. (September 1998)

"Inotropic effect of human B-type natriuretic peptide in the failing human heart." Presented at The Second Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 1998)

"Diuretic therapy in heart failure: what's on the horizon for natriuretic/aquaretic therapy of heart failure?." Presented at The Second Annual Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 1998)

"Carvedilol improves renal hemodynamics in patients with chronic heart failure." Presented at The Second Annual Scientific Meeting of the heart Failure Society of America, Boca Raton, FL. (September 1998)

"Satellite Symposium: Therapeutic options in the Treatment of Hypertension and heart failure, "Beta-blockade in the treatment of heart failure"." Presented at The 1998 Canadian Cardiovascular Society Annual Meeting, Ottawa, ON, CA|CAN. (October 1998)

"Pacing therapies for heart failure." Presented at Cardiology Grand Rounds, Cincinnati, OH. (October 1998)

"Carvedilol improves renal hemodynamics in patients with chronic heart failure." Presented at The 71th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 1998)

"Setting the stage for new ways to treat heart failure." Presented at The Cutting Edge in heart Failure: An Expanded Spectrum of Therapy, Satellite Symposium preceding the 71th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 1998)

"Interactive case studies." Presented at Heart Failure Practice Guidelines: Refining the Role of Beta-Blockade, Satellite Symposium during the 71th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 1998)

"A new era: altering the clinical course of heart failure." Presented at Perspectives and Predictions: Optimal Nursing in Heart Failure, Satellite Symposium during the 71st Annual Scientific Sessions of the American heart Association, Dallas, TX. (November 1998)

"Satellite Symposium: Acute Decompensated CHF: Beyond IV Vasodilators and Inotropes, “Emerging treatment approaches: natriuretic peptides, ‘inodilators’, and other iv agents.�." Presented at The 33rd Annual American Society of Health System Pharmacists Midyear Clinical Meeting, Las Vegas, NV. (December 1998)

"Symposium: "Newer generation beta-blockers in heart failure."." Presented at The 47th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 1998)

"Role of the adrenergic nervous system in cardiovascular disease and the use of beta-adrenergic receptor blockers." Presented at The 62nd Annual Scientific Session of the Japanese Circulation Society, Tokyo, JP|JPN. (March 1998)

"Pathophysiology of chronic heart failure: mechanism of increased adrenergic activity and its role in disease progression." Presented at The 62nd Annual Scientific Session of the Japanese Circulation Society, Tokyo, JP|JPN. (March 1998)

"Original Contribution Session- Neurohormonal Mechanisms in Heart Failure." Presented at The 47th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 1998)

"Luncheon Panel: "Drug Therapy of Heart Failure."." Presented at The 47th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 1998)

"Improving process of care for heart failure." Presented at Department of Emergency Medicince Grand Rounds, Cincinnati, OH. (March 1998)

"Satellite Symposium: Neurohormonal Antagonism in Heart Failure: Implications for Ischemic Versus Non-Ischemic Disease, Debate - "Ischemic versus non-ischemic heart failure require different management strategies, con."." Presented at The XXth Congress of the European Society of Cardiology, Vienna, AT|AUT. (August 1998)

"Satellite Symposium: Neurohormonal Antagonism in Heart Failure: Implications for Ischemic Versus Non-Ischemic Disease, Chairman's Comments-"Why discuss ischemic versus non-ischemic heart failure"." Presented at The XXth Congress of the European Society of Cardiology, Vienna, AT|AUT. (August 1998)

"Cardiac resynchronization for heart failure." Presented at The 17th Annual Veterinary Medical Forum, Chicago, IL. (June 1999)

"Who needs a heart failure program?." Presented at Approach to Advanced Heart Failure: Medical and Surgical Options, American College of Cardiology Heart House Learning Center, Bethesda, MD. (June 1999)

"Newer agents under investigation." Presented at Approach to Advanced Heart Failure: Medical and Surgical Options, American College of Cardiology Heart House Learning Center, Bethesda, MD. (June 1999)

"Neurohormonal activation in heart failure: pathophysiological and therapeutic implications." Presented at The 17th Annual Veterinary Medical Forum, Chicago, IL. (June 1999)

"Blunting the neurohormonal system: adrenergic blockade and RAS antagonists." Presented at Approach to Advanced Heart Failure: Medical and Surgical Options, American College of Cardiology Heart House Learning Center, Bethesda, MD. (June 1999)

"Satellite Symposium: Beta-Blockade, "Treating the complicated patient with beta-blockade." Presented at The XXIst Congress of the European Society of Cardiology, Barcelona, ES|ESP. (August 1999)

"Physiology and therapeutic implications of natriuretic peptides in heart failure." Presented at Cardiology Grand Rounds, Cincinnati, OH. (February 1999)

"Welcome and introduction: impact of heart failure and ventricular conduction abnormalities.." Presented at Novelty or Necessity: Cardiac Resynchronization for Heart Failure, Satellite Symposium preceding the 48th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1999)

"The MIRACLE study: The InSync clinical trial program.." Presented at Novelty or Necessity: Cardiac Resynchronization for Heart Failure, Satellite Symposium preceding the 48th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1999)

"Nesiritide (human B-type natriuretic peptide) improves symptoms and hemodynamics in NYHA class III and IV heart failure." Presented at The 48th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1999)

"Interactive case studies: consensus recommendations for the management of chronic heart failure." Presented at Treatment of Heart Failure in 1999: Challenges and Consensus, Satellite Symposium preceding the 48th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1999)

"Current management practices for the management of acute heart failure.." Presented at The Cutting Edge in Heart Failure: An Expanded Spectrum of Therapy, Satellite Symposium preceding the 48th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 1999)

"Plenary Session: State of the Art Acute heart Failure Management: Challenges and Opportunities- "hBNP for heart failure treatment: clinical results"." Presented at The 8th International Congress on Cardiovascular Pharmacotherapy, Amsterdam. (March 1999)

"Nesiritide (human b-type natriuretic peptide) improves symptoms and hemodynamics in NYHA class III and IV heart failure." Presented at The 8th International Congress on Cardiovascular Pharmacotherapy, Amsterdam. (March 1999)

"Meet-the-Experts: The Worsening Heart Failure Patient: How to Manage - "Acute heart failure"." Presented at The 8th International Congress on Cardiovascular Pharmacotherapy, Amsterdam. (March 1999)

"Nesiritide (human b-type natriuretic peptide) improves symptoms and hemodynamics in NYHA class III and IV heart Failure." Presented at The 1st International Congress on Heart Disease: New Trends in Research, Diagnosis, and Treatment, Washington, D.C.. (May 1999)

"Management of heart failure." Presented at Cardiology Core Curriculum, Cincinnati, OH. (July 1999)

"Satellite Symposium: Angiotensin II in Heart Failure: From Bench to Bedside, “Hypertension and heart failure: the forgotten link." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Symposium: The Kidney in Heart Failure, “Alterations in renal hemodynamics and function in heart failure.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Device Therapy for Heart Failure Patients, “Biventricular pacing in heart failure patients.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Optimal Care Strategies for Chronic Heart Failure: The 1999 Consensus Recommendations, “Clinical case review.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Optimal Care Strategies for Chronic Heart Failure: The 1999 Consensus Recommendations, “Chairman’s Introduction.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Optimal Care Strategies for Chronic Heart Failure: Ischemia and Heart Failure, “Optimal care strategies for chronic heart failure: patients with ischemia.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Optimal Care Strategies for Chronic Heart Failure: Ischemia and Heart Failure, “Chairman’s Introduction.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Optimal Care Strategies for Chronic Heart Failure: Diabetes and Heart Failure, “Chairman’s Introduction.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: New Targeted Treatment for CHF: The Era of VAPTANS, “VAPTANS: initial study results.�." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Beyond Drug Therapy: Cardiac Resynchronization for the Management of Chronic Heart Failure, “The MIRACLE study: InSync clinical trial program.�." Presented at Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Satellite Symposium: Beyond Drug Therapy: Cardiac Resynchronization for the Management of Chronic Heart Failure, “Chairman’s Introduction and Overview.�." Presented at Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Role of the adrenergic nervous system in heart failure." Presented at University-wide CPC Conference, Cincinnati, OH. (September 1999)

"Future advances in the management of heart failure." Presented at Cardiology Grand Rounds, Cincinnati, OH. (September 1999)

"Effects of the V1a and V2 vasopressin receptor antagonist YM087 in hyponatremic patients with chronic heart failure." Presented at The Third Annual Scientific Meeting of the Heart Failure Society of America, San Francisco, CA. (September 1999)

"Clinical studies in heart failure." Presented at Cardiology Research Conference, Cincinnati, OH. (September 1999)

"Newer and future therapies for heart failure." Presented at Division of General Internal Medicine Conference, Cincinnati, OH. (October 1999)

"Abstract Session - Emerging Pharmacological Therapies for Heart Failure." Presented at The 72th Annual Scientific Sessions of the American Heart Association, Atlanta, GA. (November 1999)

"Pharmacotherapy for hyponatremia in heart failure: effects of a new dual V1a/V2 vasopressin antagonist YM087.." Presented at The 72th Annual Scientific Sessions of the American Heart Association, Atlanta, GA. (November 1999)

"Anti-adrenergic treatment of hypertension in the prevention of heart failure: focus on patients with concomitant disease.." Presented at Anti-Adrenergic Therapy in the Prevention of Disease Progression within the Cardiovascular Continuum, Satellite Symposium preceding the 72th Annual Scientific Sessions of the American Heart Association, Atlanta, GA. (November 1999)

"Novel drugs and devices for the management of heart failure." Presented at Department of Medicine Staff Meeting and Research Conference, Cincinnati, OH. (February 1999)

"Disease management for heart failure." Presented at Medical Grand Rounds, Lexington, KY. (July 2000)

"Satellite Symposium: B-Type Natriuretic Peptide for CHF: From Pathophysiology to Therapeutic Tool, “Algorithms and treatment options: present and future.�." Presented at The Fourth Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2000)

"Satellite Mini-Symposium: Cardiac Resynchronization in Heart Failure: An Emerging Management Strategy, “Ventricular dysynchrony: epidemiology and insights into patient selection for cardiac resynchronization." Presented at The Fourth Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2000)

"Satellite Mini-Symposium: Cardiac Resynchronization in Heart Failure: An Emerging Management Strategy, “The MIRACLE trial: patient characteristics and observations regarding pacemaker and lead implantation success and complications.�." Presented at The Fourth Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2000)

"Satellite Mini-Symposium: Cardiac Resynchronization in Heart Failure: An Emerging Management Strategy, “Chairman’s Welcome and Introduction.�." Presented at The Fourth Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2000)

"How-To Session: “How to Obtain Research Funding.�." Presented at The Fourth Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2000)

"Landmark Symposium: Resynchronization of the Failing Heart: A New Therapeutic Option?, "Principles of cardiac resynchronization and results of initial studies." Presented at Heart Failure 2000, The third International meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Venice, IT|ITA. (June 2000)

"Chronic management of hemodynamics in heart failure: a new technology." Presented at Heart Failure 2000, The third International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Venice, IT|ITA. (June 2000)

"Evolving principles in beta-blocker management of heart failure." Presented at The 52rd Annual Meeting of the Canadian Cardiovascular Society, Vancouver, BC, CA|CAN. (October 2000)

"Heart failure and neurohormonal factors: implications for contemporary therapy." Presented at The XXIth Annual Central American Congress of Cardiology, San Salvador, SV|SLV. (November 2000)

"Plenary Session XIII: Adjunctive and Alternative Therapeutic Approaches for Heart Failure, “Cardiac resynchronization.�." Presented at The 73rd Annual Scientific Sessions of the American Heart Association, New Orleans, LA. (November 2000)

"The cardiovascular disease continuum and the role of adrenergic blockade." Presented at Comprehensive Adrenergic Blockade: Can We Improve Outcomes Across the Cardiovascular Disease Continuum, Satellite Symposium preceding the 49th Annual Scientific Session of the American College of Cardiology, Anaheim, CA. (March 2000)

"Role of vasopressin and the use of vasopressin receptor antagonists in heart failure." Presented at Division of Nephrology Research Conference, Cincinnati, OH. (April 2000)

"Special Symposium: Adrenergic Blockade in the Management of Cardiovascular Diseases: Can We Improve Outcomes?, Beta-blockers in the management of heart failure and post-myocardial infarction: newer approaches to therapy.�." Presented at Fifteenth Annual Scientific Meeting of the American Society of Hypertension, New York, NY. (May 2000)

"Arrhythmias in heart failure." Presented at Annual Meeting of the Swiss Cardiovascular Society, Lausanne, CH|CHE. (May 2000)

"Disease management for heart failure." Presented at Cardiology Grand Rounds, Cincinnati, OH. (May 2000)

"Treatment of hyponatremia in patients with SIADH or CHF with intravenous conivaptan (YM087), a new combined vasopressin V1a/V2 receptor antagonist." Presented at The XXIInd Congress of the European Society of Cardiology, Amsterdam. (August 2000)

"Satellite Symposium: Carvedilol- A Comprehensive Agent for a Comprehensive Treatment Strategy, "Carvedilol: a comprehensive treatment for hypertension in patients with concomitant diseases."." Presented at The XXIInd Congress of the European Society of Cardiology, Amsterdam. (August 2000)

"Pharmacotherapy for hyponatremia in heart failure: effects of a new combined vasopressin V1a/V2 receptor antagonist, conivaptan (YM087) administered orally." Presented at The XXIInd Congress of the European Society of Cardiology, Amsterdam. (August 2000)

"Evidence based approaches to heart failure." Presented at 13th Annual Dr. Walter M. Booker, Sr. Memorial Symposium, Association of Black Cardiologists, Washington, DC. (August 2000)

"The role of anti-adrenergic therapy in cardiovascular diseases." Presented at The 61st National Congress of the Italian Society of Cardiology, Rome, IT|ITA. (December 2000)

"Meet the Experts Session: “How to treat acutely decompensated heart failure.�." Presented at The 50th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2001)

"Luncheon Panel: “Common errors in the management of heart failure.�." Presented at The 50th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2001)

"Late-Breaking Clinical Trials Session: “Multicenter InSync Randomized Clinical Evaluation (MIRACLE): Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients.�." Presented at The 50th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2001)

"Late-Breaking Clinical Trials Session: “Effects of enrasentan, a nonselective endothelin receptor antagonist, in class II-III heart failure: results of the Enrasentan Cooperative Randomized (ENCOR) Evaluation.�." Presented at The 50th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2001)

"The efficacy of cardiac resynchronization therapy is independent of baseline QRS duration.." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Satellite Symposium: Beyond Promise: The Emerging Role of Cardiac Resynchronization Therapy for Heart Failure, “Welcome and Introduction.�." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Satellite Symposium: Beyond Promise: The Emerging Role of Cardiac Resynchronization Therapy for Heart Failure, “Cardiac resynchronization: a review of recent clinical trials data.�." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Prevalence and associated risk factors for intraventricular conduction delay in patients with chronic heart failure." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Impact of cardiac resynchronization on health-related quality of life in heart failure patients.." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Effects of nesiritide (B-type natriuretic peptide) in decompensated heart failure patients receiving beta-blockers." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Debate: Multisite Pacing is an Effective Modality for Treating Heart Failure, “Protagonist.�." Presented at The 5th Scientific Meeting of the Heart Failure Society of America, Washington, DC. (September 2001)

"Vasopressin antagonism in hyponatremia." Presented at Heart Failure 2001, The Fourth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Barcelona, ES|ESP. (June 2001)

"Multicenter InSync Randomized Clinical Evaluation (MIRACLE): Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients.." Presented at Heart Failure 2001, The Fourth International Meeting Organized by the Working Group on heart Failure of the European Society of Cardiology, Barcelona, ES|ESP. (June 2001)

"Loop diuretics in heart failure: Is there an impact on prognosis?." Presented at Heart Failure 2001, The Fourth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Barcelona, ES|ESP. (June 2001)

"Invited Symposium- Treatment of Hypertension in Heart Failure: Impact on Recent Trials." Presented at Heart Failure 2001, The Fourth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Barcelona, ES|ESP. (June 2001)

"Avoiding fluid overload: diuretic therapy before the start of anti-adrenergic treatment in chronic heart failure patients.." Presented at Heart Failure 2001, The Fourth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Barcelona, ES|ESP. (June 2001)

"Seminar: End of Life Care for Cardiovascular Patients and Families, “Prognostic indicators, clinical, and patient/family perspectives.�." Presented at 74th Annual Scientific Sessions of the American Heart Association, Anaheim, CA. (November 2001)

"Multicenter InSync Randomized Clinical Evaluation (MIRACLE): results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients." Presented at The 74th Annual Scientific Sessions of the American Heart Association, Anaheim, CA. (November 2001)

"Effects of nesiritide (B-type natriuretic peptide) in decompensated heart failure patients receiving beta-blockers." Presented at The 74th Annual Scientific Sessions of the American Heart Association, Anaheim, CA. (November 2001)

"Evaluation and management of primary pulmonary hypertension." Presented at Cardiology Core Curriculum, Lexington, KY. (January 2001)

"The epidemic of heart failure in the new millenium." Presented at Cardiology Update 2001, The 14th International Postgraduate Course on Myocardial Infarction and Angina Pectoris, Davos, CH|CHE. (February 2001)

"Meet the Experts Session: "Diagnosing chronic heart failure"." Presented at Cardiology Update 2001, The 14th International Postgraduate Course on Myocardial Infarction and Angina Pectoris, Davos, CH|CHE. (February 2001)

"Consequences of current clinical trial results for the therapy of heart failure." Presented at Cardiology Update 2001, The 14th International Postgraduate Course on Myocardial Infarction and Angina Pectoris, Davos, CH|CHE. (February 2001)

"Cardiac resynchronization for heart failure.." Presented at The 2nd International Congress on Heart Disease: New Trends in Research, Diagnosis, and Treatment, Washington DC. (July 2001)

"Newer and future therapies for heart failure." Presented at Medical Grand Rounds, Lexington, KY. (July 2001)

"Update on clinical trials: ENCOR and MIRACLE." Presented at Cardiology Core Curriculum, Lexington, KY. (April 2001)

"Cardiac resynchronization therapy for heart failure." Presented at Gill Heart Institute Cardiovascular Seminars Series, Lexington, KY. (April 2001)

"Multicenter InSync Randomized Clinical Evaluation (MIRACLE): Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients." Presented at The 22nd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, Boston, MA. (May 2001)

"Anti-adrenergic therapy in hypertensive patients with concomitant disease." Presented at The 2nd Congress of the Asian-Pacific Society of Hypertension, Pattaya, TH|THA. (August 2001)

"Evaluation and management of heart failure." Presented at Cardiology Core Curriculum, Lexington, KY. (August 2001)

"Overview Session: Highlights of the 23rd Annual Scientific Sessions (Roundtable Discussion), “Devices: ventricular function/resynchronization therapy.�." Presented at The 23rd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, San Diego, CA. (May 2002)

"NASPE Expert Consensus Conference: Resynchronization Therapy for Heart Failure, “Cost and reimbursement issues.�." Presented at The 23rd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, San Diego, CA. (May 2002)

"Core Curriculum: Device Therapy in Heart Failure: Collaboration Between the Heart Failure Specialist and the Electrophysiologist, “ Heart failure and the need for device therapy.�." Presented at The 23rd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, San Diego, CA. (May 2002)

"Cardiac resynchronization therapy benefits patients: combined results of the MIRACLE and MIRACLE ICD trials." Presented at The 23rd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, San Diego, CA. (May 2002)

"What are the long-term effects of cardiac resynchronization therapy? The MIRACLE Trial experience." Presented at Cardiostim 2002, The 13th International Congress, Nice, FR|FRA. (June 2002)

"Does the use of beta-blockers influence the effect of cardiac resynchronization on reverse remodeling in heart failure?." Presented at Cardiostim 2002, The 13th International Congress, Nice, FR|FRA. (June 2002)

"Does cardiac resynchronization therapy result in reverse remodeling in both ischemic and non-ischemic heart failure patients?." Presented at Cardiostim 2002, The 13th International Congress, Nice, FR|FRA. (June 2002)

"Resynchronization therapy: trial results and implications for patient selection." Presented at The 75th Annual Scientific Sessions of the American Heart Association, Chicago, IL. (November 2002)

"Joint AHA/ESC Symposium: How to Manage Co-morbidities in Heart Failure Patients, “Co-morbidities in heart failure patients.�." Presented at The 75th Annual Scientific Sessions of the American Heart Association, Chicago, IL. (November 2002)

"Cardiac resynchronization therapy clinical trials." Presented at Cardiac Resynchronization Therapy, Satellite Symposium preceding the 75th Annual Scientific Sessions of the American Heart Association, Chicago, IL. (November 2002)

"Biventricular Pacing- Satellite Symposium, "Over-view of ongoing clinical trials concerning CRT."." Presented at The HDZ-Symposuim, Bad Oeynhausen, DE|DEU. (December 2002)

"Symposium: Cardiac Resynchronization for Patients with Heart Failure, “Chairman’s Introduction.�." Presented at The 51st Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2002)

"Original Contributions Session - Mechanisms of Biventricular Pacing for the Treatment of Congestive Heart Failure." Presented at The 51st Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2002)

"Long-term improvement in functional status, quality of life and exercise capacity with cardiac resynchronization therapy: the MIRACLE trial experience." Presented at The 51st Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2002)

"Cardiac resynchronization therapy reduces morbidity in patients with moderate to severe systolic heart failure and intraventricular conduction delays." Presented at The 51st Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2002)

"Ultrafiltration for Congestive Heart Failure." Presented at The 8th World Congress on Heart Failure: Mechanisms and management, Washington DC. (July 2002)

"Heart Failure Awareness Week 2002: the growing epidemic of heart failure." Presented at Medical Grand Rounds, Lexington, KY. (February 2002)

"Vasopressin antagonists: interest and limitations." Presented at The XXIVth Congress of the European Society of Cardiology, Berlin, DE|DEU. (September 2002)

"Satellite Symposium: Novel Therapeutic Options for Heart Failure: Strategies for Today and Tomorrow, "Recent completed clinical trials: what have we learned."." Presented at The XXIVth Congress of the European Society of Cardiology, Berlin, DE|DEU. (September 2002)

"Cardiac resynchronization therapy reduces the risk of hospitalization for heart failure and length of stay: results from the MIRACLE trial." Presented at The XXIVth Congress of the European Society of Cardiology, Berlin, DE|DEU. (September 2002)

"Benefits of cardiac resynchronization therapy: results of the InSync and InSync ICD trials." Presented at The XXIVth Congress of the European Society of Cardiology, Berlin, DE|DEU. (September 2002)

"Sleep disordered breathing in heart failure patients: first night treatment response from a multicenter international study." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"Sleep disordered breathing in heart failure patients: a multicenter international trial.." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"Sequential biventricular pacing provides significant hemodynamic benefit for heart failure patients with ventricular dysynchrony." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"Satellite Symposium: Noninvasive hemodynamic monitoring in heart failure: Utilization of Impedance Cardiography (ICG), “Heart failure as a hemodynamic disease: review of literature and clinical practice." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"How-To Session: How to Recognize, Evaluate, and Treat Sleep." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"Does sequential biventricular pacing contribute incremental benefit to patient well-being? Results from the InSync III study." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"Biventricular pacing trials: how do we determine who will benefit?." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"A prevalence study of sleep disordered breathing in consecutive patients from a heart failure clinic." Presented at The 6th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2002)

"Newer pharmacological and non-pharmacological approaches to the management of heart failure." Presented at Medical Grand Rounds, Columbus, OH. (January 2003)

"Update on clinical trials [cardiac resynchronization therapy]." Presented at The XII World Congress on Cardiac Pacing and Electrophysiology, Hong Kong, CN|CHN. (February 2003)

"Integrating Cardiac Resynchronization Therapy into Management of Heart Failure, "Eras in heart failure therapy"." Presented at The XII World Congress on Cardiac Pacing and Electrophysiology, Hong Kong, CN|CHN. (February 2003)

"Impact of cardiac resynchronization on renal function." Presented at The XII World Congress on Cardiac Pacing and Electrophysiology, Hong Kong, CN|CHN. (February 2003)

"Device therapy in heart failure." Presented at The XII World Congress on Pacing and Electrophysiology, Hong Kong, CN|CHN. (February 2003)

"Mini-Course: Resynchronization Therapy: From Identifying the Appropriate Patient to Optimal Follow-Up, “Currently available results of CRT.." Presented at The 24th Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, Washington, DC. (May 2003)

"Featured Symposium: Bench-to-Bedside: Cardiac Resynchronization Therapy, “Results of clinical trials and directions for the future.�." Presented at The 24th Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, Washington, DC. (May 2003)

"The effect of cardiac resynchronization on disease progression in patients with mild heart failure and an indication for an ICD-Results of a randomized double blind study." Presented at Heart Failure 2003, The Sixth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Strasbourg, FR|FRA. (June 2003)

"Satellite Symposium: Cardiac resynchronization therapy for heart failure: an alternative choice or preferred therapy? "Drugs and devices: A happily married couple?"." Presented at Heart Failure 2003, The Sixth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Strasbourg, FR|FRA. (June 2003)

"Satellite Symposium: Brain Natriuretic Peptide: a novel approach for the treatment of acute heart failure, "Clinical experience with recombinant human brain natriuretic peptide in acute heart failure."." Presented at Heart Failure 2003, The Sixth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Strasbourg, FR|FRA. (June 2003)

"Determining the risk of heart failure decompensation: use of CRT device diagnostics." Presented at Heart Failure 2003, The Sixth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Strasbourg, FR|FRA. (June 2003)

"A multivariate assessment of cardiac resynchronization therapy on morbidity and mortality." Presented at Heart Failure 2003, The Sixth International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Strasbourg, FR|FRA. (June 2003)

"Device therapies for the management of heart failure patients." Presented at International Cardiac Symposium, Zadar, HR|HRV. (August 2003)

"Clinical experience with nesiritide in the treatment of acute decompensated heart failure." Presented at The XXVth Congress of the European Society of Cardiology, Vienna, AT|AUT. (August 2003)

"Session 44: Heart Failure, “Panel discussion member.�." Presented at The 52nd Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2003)

"Chairman’s welcome and introduction." Presented at Sleep Disordered Breathing and Cardiovascular Diseases/Disorders, Satellite Symposium preceding the 52nd Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2003)

"Cardiac resynchronization and defibrillator devices should be implanted in all patients with left ventricular ejection fractions less than 30% – Protagonist." Presented at The 52nd Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2003)

"Satellite Symposium: The Expanding Role of Human Natriuretic Peptide Treatment in the Management of Heart Failure, “Chairman’s welcome and introduction.�." Presented at The 7th Annual Scientific Meeting of the Heart Failure Society of America, Las Vegas, NV. (September 2003)

"Satellite Symposium: “The expanding role of human natriuretic peptide treatment in the management of heart failure.�." Presented at The 7th Annual Scientific Meeting of the Heart Failure Society of America, Las Vegas, NV. (September 2003)

"Device therapy as management for heart failure: what is state-of-the art?." Presented at The 7th Annual Scientific Meeting of the Heart Failure Society of America, Las Vegas, NV. (September 2003)

"Debate: “Getting the heart failure patient to lose weight is detrimental for the patient – Protagonist.�." Presented at The 7th Annual Scientific Meeting of the Heart Failure Society of America, Las Vegas, NV. (September 2003)

"Conduction and Resynchronization: “New insights from clinical trials.�." Presented at The 7th Annual Scientific Meeting of the Heart Failure Society of America, Las Vegas, NV. (September 2003)

"Opening Plenary Session: “Heart failure and the need for device therapy.�." Presented at The International Academy of Cardiology, 3rd World Congress on Heart Disease, Washington, DC. (July 2003)

"Neurohormonal strategies in patients with LV dysfunction." Presented at Post MI and Heart Failure Patients with LV Dysfunction: Evidence-based clinical practice, Satellite Symposium preceding the 76th Annual Scientific Sessions of the American Heart Association, Orlando, FL. (November 2003)

"Management of heart failure: a condition for all ages, “Overview of heart failure: from cradle to grave.�." Presented at The 76th Annual Scientific Sessions of the American Heart Association, Orlando, FL. (November 2003)

"How to choose the appropriate patient and type of resynchronization therapy." Presented at The 76th Annual Scientific Sessions of the American Heart Association, Orlando, FL. (November 2003)

"Chairman’s welcome and introduction." Presented at Post MI and Heart Failure Patients with LV Dysfunction: Evidence-based clinical practice, Satellite Symposium preceding the 76th Annual Scientific Sessions of the American Heart Association, Orlando, FL. (November 2003)

"Benefits of cardiac resynchronization therapy sustained for 18 months: Results from the MIRACLE program." Presented at The 76th Annual Scientific Sessions of the American Heart Association, Orlando, FL. (November 2003)

"The 8th Annual Scientific Meeting of the Heart Failure Society of America." Presented at Continuous hemodynamic monitoring reduces hospitalizations and health care utilization costs, Toronto, ON, CA|CAN. (September 2004)

"Satellite Symposium: Novel Therapies for Heart Failure: Expanding the Role of Natriuretic Peptides, “How is mortality impacted by parenteral therapy for ADHF: insights from the ADHERE Registry.�." Presented at The 8th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2004)

"Satellite Symposium: Sleep Apnea and Heart Failure: Practical Approaches to Diagnosis and Treatment, “Welcome and introductions.�." Presented at The 8th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, CA|CAN. (September 2004)

"Satellite Symposium: Sleep Apnea and Heart Failure: Practical Approaches to Diagnosis and Treatment, “Overview of sleep apnea for the heart failure cardiologist.�." Presented at The 8th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2004)

"Acute decompensated heart failure: lessons learned from registries." Presented at The 8th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2004)

"Re-focus on cardiac resynchronization therapy." Presented at CardioStim 2004, The 14th World Congress in Cardiac pacing and Electrophysiology and Cardiac Techniques, Nice, FR|FRA. (June 2004)

"Writing Clinical Papers." Presented at Tools of the Trade: The Art of Scientific Writing, Columbus, OH. (June 2004)

"Satellite Symposium: Optimal Medical Management, CRT, and ICD for Patients with Left Ventricular Dysfunction or Heart Failure, “Medical management of patients with left ventricular dysfunction or heart failure.�." Presented at Heart Rhythm 2004, The 25th Annual Scientific Sessions of the Heart Rhythm Society, San Francisco, CA. (May 2004)

"Overview Session: Highlights of Heart Rhythm 2004, “Ventricular Function/Resynchronization Therapy�." Presented at Heart Rhythm 2004, The 25th Annual Scientific Sessions of the Heart Rhythm Society, San Francisco, CA. (May 2004)

"Does CRT-reverse remodeling in HF patients reduce VT/VF frequency? A retrospective analysis." Presented at Heart Rhythm 2004, The 25th Annual Scientific Sessions of the Heart Rhythm Society, San Francisco, CA. (May 2004)

"Controversies in Ventricular Function/Resynchronization Therapy: More Trials Are Needed to Determine Who Benefits from CRT." Presented at Heart Rhythm 2004, The 25th Annual Scientific Sessions of the Heart Rhythm Society, San Francisco, CA. (May 2004)

"Original Contributions Session - Heart Failure: Impact of Established and Novel Therapy on Clinical Outcomes." Presented at The 77th Annual Scientific Session of the American Heart Association, New Orleans, LA. (November 2004)

"What the Clinician Needs to Know About Resynchronization." Presented at The 53rd Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2004)

"Tolerability, safety and efficacy of beta-blockers in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry." Presented at The 53rd Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2004)

"The expanding role of natriuretic peptides in the management of heart failure." Presented at The Evolving Use of Natriuretic Peptide Therapy, Satellite Symposium preceding the 53rd Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2004)

"Sleep disordered breathing and cardiovascular disease: epidemiology and major consequences." Presented at Cardiovascular Disease and Sleep Apnea, Satellite Symposium preceding the 53rd Annual Scientific Session of the American College of Cardiology, New Orleans, Louisisana. (March 2004)

"Optimizing Device Therapy for Heart Failure, “Patient selection.�." Presented at The 53rd Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2004)

"Chairman’s welcome and introduction." Presented at The Evolving Use of Natriuretic Peptide Therapy, Satellite Symposium preceding the 53rd Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2004)

"Device therapy for heart failure." Presented at The 6th Pan-Hellenic Conference on Heart Failure, Athens, GR|GRC. (February 2005)

"Devices for the management of heart failure." Presented at Cardiovascular Medicine Weekly Conference, Columbus, OH. (February 2005)

"Managing the heart failure patient with an implanted device." Presented at Role of Heart Failure Clinics in the Management of Patients with Implanted Cardiac Devices, Satellite Symposium held during the 9th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2005)

"Introduction." Presented at Alumni Weekend CME Program: Innovations in Cardiovascular Care, Columbus, OH. (September 2005)

"Innovations in medical approaches to congestive heart failure." Presented at Alumni Weekend CME Program: Innovations in Cardiovascular Care, Columbus, OH. (September 2005)

"Improving outcomes in heart failure: its all about remodeling." Presented at The Role of Cardiac support Devices for the Treatment of Chronic Heart Failure, Satellite Symposium held during the 9th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2005)

"How-To Session, “How to get started in clinical trials in heart failure.�." Presented at The 9th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2005)

"Economic implications of continuous hemodynamic monitoring on heart failure care.." Presented at The 9th Annual Scientific Meeting of the Heart Failure Society of America, Boca Raton, FL. (September 2005)

"When to admit." Presented at Contemporary Management of Acute Decompensated Heart Failure, Satellite Symposium preceding the 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Therapeutic application of cardiac resynchronization." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Special Session: Clinical Practice 2005 – Applying the New Guideline for Heart Failure: Practical Considerations, “Stage C symptomatic heart failure.�." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Serum creatinine elevations in patients receiving nesiritide are related to starting dose." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Predictors of in-hospital mortality in patients hospitalized with heart failure: an analysis of 48,152 hospitalizations from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Nesiritide does not increase 30-day or 6-month mortality risk." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Management of atrial fibrillation in the management of heart failure." Presented at New Approaches to Complex Issues in Heart Failure, Satellite Symposium held during the 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Heart failure treatment strategy based on continuous hemodynamic monitoring decreases the number of extended hospital admission in NYHA Class III patients." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Heart failure in the diabetic: treatment strategies." Presented at Merging Information on Three Critical Challenges: Hypertension, Diabetes Mellitus, and Heart Failure, Satellite Symposium held during the 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"Effect of baseline covariates on mortality risk in the Vasodilation in the Management of Acute Decompensated Heart Failure (VMAC) trial." Presented at The 78th Annual Scientific Sessions of the American Heart Association, Dallas, TX. (November 2005)

"The Problem of Congestion in Heart Failure." Presented at A New Paradigm in Volume Management for Heart Failure, Satellite Symposium preceding the 54th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2005)

"Clinical value in measuring intra-thoracic impedance in patients with chronic heart failure: Fluid Accumulation Status Trial (FAST)." Presented at The 54th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2005)

"Background and findings from the ADHERE National Registry." Presented at Emergency Medicine Cardiac Research and Education Group – International Symposium: Emergency Diagnosis and treatment of Acute Decompensated Heart Failure, Orlando, FL. (March 2005)

"Acute decompensated heart failure: patient characteristics, practice patterns, and outcomes." Presented at Heart Failure Management 2005 and Beyond: Current Status, Emerging Guidelines, and Future Trends, Satellite Symposium preceding the 54th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2005)

"Integrating Implantable Diagnostics into the Management of CHF." Presented at Heart Rhythm 2005, The 26th Annual Scientific Sessions of the Heart Rhythm Society, New Orleans, LA. (May 2005)

"Results of the InSync III Marquis trial." Presented at Heart Rhythm 2005, The 26th Annual Scientific Sessions of the Heart Rhythm Society, New Orleans, LA. (May 2005)

"Fluid Accumulation Status Trial (FAST)." Presented at Heart Rhythm 2005, The 26th Annual Scientific Sessions of the Heart Rhythm Society, New Orleans, LA. (May 2005)

"Clinical Tutorial – CRT: Pacemakers Versus ICDs, “Overview of cardiac resynchronization therapy." Presented at Heart Rhythm 2005, The 26th Annual Scientific Sessions of the Heart Rhythm Society, New Orleans, LA. (May 2005)

"2005 ACC/AHA Heart Failure Guideline." Presented at Medical Grand Rounds, Columbus, OH. (July 2005)

"Congestive heart failure." Presented at Family Medicine Resident Conference, Columbus, OH. (August 2005)

"A cardiologist's perspective on the role of sleep apnea treatment in the overall management of heart failure." Presented at Heart and Sleep Apnea Conference, Columbus, OH. (April 2005)

"Reversing heart failure: making weak hearts stronger." Presented at The Ohio State University Medical Center, Unique Healthcare, . (January 2006)

"Reversing heart failure: making weak hearts stronger." Presented at Ohio State University, . (February 2006)

"Remote monitoring to enhance outcomes." Presented at Heart Rhythm 2006, The 27th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2006)

"Left atrial pressure sensing for heart failure management." Presented at Vision of the Future for EP and Heart Failure, Satellite Symposium held during Heart Rhythm 2006, The 27th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2006)

"Implantable Monitoring for Heart Failure." Presented at Heart Rhythm 2006, The 27th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2006)

"Effects of cardiac resynchronization therapy on the autonomic nervous system: mechanisms and implications." Presented at Heart Rhythm 2006, The 27th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2006)

"New devices in heart failure." Presented at American Heart Association/Middletown Regional Hospital Fundraiser, . (June 2006)

"The 54th Annual Scientific meeting of the Cardiac Society of Australia and New Zealand." Presented at The 54th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Canberra, AU|AUS. (August 2006)

"Implantable 'medical' devices for monitoring and treating heart failure." Presented at The 54th Annual Scientific Meeting of the Cardiac Society of Australia and new Zealand, Canberra, AU|AUS. (August 2006)

"Bradyarrhythmias and pacing in heart failure." Presented at The 54th Annual Scientific meeting of the Cardiac Society of Australia and New Zealand, Canberra, AU|AUS. (August 2006)

"Present and future considerations for the utility of devices in heart failure." Presented at The 11th Congress on Treatment of Cardiovascular Disease, sponsored by the Association of Black cardiologists, held immediately prior to the 79th Annual Scientific Sessions of the American Heart Association, Chicago, IL. (November 2006)

"Drugs, devices, and dysynchrony: integrating care for the heart failure patient." Presented at Recent Advances in Device and Drug Therapy for Heart Failure, Satellite Symposium held during the 79th Annual Scientific Sessions of the American Heart Association, Chicago, IL. (November 2006)

"Clinical Controversies 2006: All implantable devices in left ventricular dysfunction should have defibrillation capability: pro." Presented at The 79th Annual Scientific Sessions of the American Heart Association, Chicago, IL. (November 2006)

"Cardiovascular Seminar: Device Thearpy in Heart Failure: "Which device, which patient?"." Presented at The 79th Annual Scientific Sessions of the American heart Association, Chicago, IL. (November 2006)

"Anemia correction in heart failure patients: what do we know?." Presented at Managing the Heart Failure Patient: New Perspectives and Emerging Evidence, Satellite Symposium held during the 79th Annual Scientific Sessions of the American heart Association, Chicago, IL. (November 2006)

"New heart failure guidelines." Presented at Family Medicine Faculty Grand Rounds, Columbus, OH. (April 2006)

"Welcome and introductions." Presented at Bridging the Management Gap: A Practical Approach to Sleep Apnea and Heart Failure, Satellite Symposium held during the 10th Annual Scientific meeting of the Heart Failure Society of America, Seattle, WA. (September 2006)

"Symposium- New Heart Failure Devices." Presented at The 10th Annual Scientific meeting of the Heart Failure Society of America, Seattle, WA. (September 2006)

"Scanning the horizon: cardiac resynchronization therapy for treating heart failure." Presented at World Congress of Cardiology 2006, a joing meeting of the European Society of Cardiology 2006 and the World Heart Federation's XVth World Congress of Cardiology, Barcelona, ES|ESP. (September 2006)

"Safety and efficacy of darbepoetin alpha treatment in anemic patients with symptomatic heart failure: a pooled analysis of two randomized, double-blind, placebe-controlled trials." Presented at World Congress of Cardiology 2006, a joint meeting of the European Society of Cardiology 2006 and the World Heart Federation's XVth World Congress of Cardiology, Barcelona, ES|ESP. (September 2006)

"Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HF." Presented at World Congress of Cardiology 2006, a joint meeting of the European Society of Cardiology 2006 and the World Heart Federation's XVth World Congress of Cardiology, Barcelona, ES|ESP. (September 2006)

"Proactive monitoring and management of heart failure: role of technology." Presented at Improving Heart Failure Management: Evidence-Based Medications, Device Therapy, and Monitoring, Satellite Symposium held during the 10th Annual Scientific Meeting of the heart Failure Society of America, Seattle, WA. (September 2006)

"Intravenous therapies for acute heart failure: what we know and what we don't know." Presented at World Congress of Cardiology 2006, a joint meeting of the European Society of Cardiology 2006 and thw World Heart Federation's XVthe World Congress of Cardiology, Barcelona, ES|ESP. (September 2006)

"Integrating heart failure and sleep medicine programs to optimize care." Presented at Bridging the Gap: A Practical Approach to Sleep Apnea and Heart Failure, Satellite Symposium held during the 10th Annual Scientific Meeting of the Heart Failure Society of America, Seattle, WA. (September 2006)

"Extending the Indications for cardiac resynchronization therapy: patients with New York Heart Association class II heart failure." Presented at World Congress of Cardiology 2006, a joint meeting of the European Society of Cardiology 2006 and the World Heart Federation's XVth World Congress of Cardiology, Barcelona, ES|ESP. (September 2006)

"Echocardiographically optimized interventricular pacing delay improves CRT clinical response." Presented at The 10th Annual Scientific Meeting of the heart Failure Society of America, Seattle, WA. (September 2006)

"Acute heart failure in the critical care setting: renal replacement therapy." Presented at World Congress of Cardiology 2006, a joint meeting of the European Society of Cardiology 2006 and the World Heart Federation's XVth World Congress of Cardiology, Barcelona, ES|ESP. (September 2006)

"Modern management of acute heart failure syndromes." Presented at Heart Failure: Comprehensive Management, Chennai, IN|IND. (February 2006)

"Heart failure clinical assessment and risk stratification." Presented at Heart Failure: Comprehensive Management, Chennai, IN|IND. (February 2006)

"Advances in heart disease and cardiology." Presented at Upper Arlington Rotary, . (May 2006)

"The ABCDs of heart failure: stages A and B." Presented at AAHFN 2006, The 2nd Annual Meeting of the American Association of Heart Failure Nurses, Miami, FL. (June 2006)

"Case studies – Putting it all together: the right device for the right patient.." Presented at AAHFN 2006, The 2nd Annual Meeting of the American Association of Heart Failure Nurses, Miami, FL. (June 2006)

"Pathological remodeling and reversal of remodeling in heart failure: effects of cardiac resynchronization therapy." Presented at Association of University Cardiologists Forty-Fifth Annual Meeting, Carmel, CA. (January 2006)

"Update on recent clinical trials." Presented at Anemia and Heart Failure: New Concepts, New Data, Satellite Symposium held during the 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"Special Session – Cardiac Resynchronization Therapy: What to do with Non-responders." Presented at The 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"Intravenous vasoactive medications in acute decompensated heart failure." Presented at Fine-Tuning Heart Failure Management, Satellite Symposium held during the 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"From research to real world: integrating the implantable hemodynamic monitor into clinical practice." Presented at Implantable Hemodynamic Monitoring: The Next Gold Standard in Assessing and Managing Heart Failure Patients, Satellite Symposium held during the 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"ClinCard 2006 – Heart Failure: ACCSAP 6 Questions." Presented at The 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"Cardiac Resynchronization Therapy: All You Need to Know, “Overview of the latest clinical trials." Presented at The 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"Cardiac resynchronization therapy placement during hospitalization for heart failure is associated with a significant improvement in early clinical outcomes." Presented at The 55th Annual Scientific Session of the American College of Cardiology, Atlanta, GA. (March 2006)

"Clinical development of new devices for heart failure." Presented at Translational Biomedical Research IBGP-792, Columbus, OH. (October 2006)

"Spotlight session: Cardiac Resynchronization Therapy." Presented at The 56th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2007)

"Physiological basis and potential of device-based diagnostics in heart failure." Presented at Beyond Symptoms: The Use of Heart Failure Diagnostics in Clinical Practice, Satellite Symposium held during the 56th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2007)

"Clinical Monitoring of Heart Failure." Presented at The 56th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2007)

"Class IV patients are appropriate candidates for cardiac resynchronization therapy: antagonist." Presented at The 56th Annual Scientific Session of the American College of Cardiology, New Orleans, LA. (March 2007)

"Status of current ongoing clinical trials: the REVERSE study." Presented at Heart Rhythm 2007, The 28th Annual Scientific Sessions of the Heart Rhythm Society, Denver, CO. (May 2007)

"Mechanisms and clinical implications of cardiac resynchronization in patients." Presented at Heart Rhythm 2007, The 28th Annual Scientific Sessions of the heart Rhythm Society, Denver, CO. (May 2007)

"Long-term performance of a left ventricular lead." Presented at Heart Rhythm 2007, The 28th Annual Scientific Sessions of the Heart Rhythm Society, Denver, CO. (May 2007)

"How to optimally exploit device remote follow-up for disease management programs." Presented at Heart Rhythm 2007, The 28th Annual Scientific Sessions of the Heart Rhythm Society, Denver, CO. (May 2007)

"Dysynchrony, drugs, and devices: the need for a multidisciplinary approach." Presented at Advances in Drug, Device, and imaging Strategies for the heart Failure Patient, Satellite Symposium held during heart Rhythm 2007, The 28th Annual Scientific Sessions of the Heart Rhythm Society, Denver, CO. (May 2007)

"Case-Based Tutorial: I Can't Place the LV Lead on the Lateral Wall: What are my Options?." Presented at Heart Rhythm 2007, The 28th Annual Scientific Sessions of the Heart Rhythm Society, Denver, CO. (May 2007)

"Symposium-Devices for Arrhythmias, Resynchronization, and Heart Failure Remodeling." Presented at The 11th Annual Scientific Meeting of the Heart Failure Society of America, Washington DC. (September 2007)

"managing ADHF: don't forget the hemodynamic goals." Presented at Meeting the Challenges of Heart Failure: Insights into Critical issues, Satellite Symposium held during the 11th Annual Scientific meeting of the Heart Failure Society of America, Washington DC. (September 2007)

"FREEDOM (a Frequent Optimization Study Using the QuickOpt TM Method) study design." Presented at The 11th Annual Scientific Meeting of the Heart Failure Society of America, Washington DC. (September 2007)

"Emerging strategies to reduce congestion in decompensated heart failure: new drugs and devices." Presented at Return to Balance: Current and Future Strategies to Reduce Congestion in Decompensated heart Failure Syndromes, Satellite Symposium held during the 11th Annual Scientific meeting of the Heart Failure Society of America, Washington DC. (September 2007)

"Comparison of all-cause mortality in a randomized controlled trial (MIRACLE) and "real-world" (InSync Registry) use of cardiac resynchronization threapy (CRT)." Presented at The 11th Annual Scientific Meeting of the Heart Failure Society of America, Washington DC. (September 2007)

"A cardiac support device produces incremental clinical benefits in heart failure patients treated with cardiac resynchronization therapy." Presented at The 11th Annual Scientific Meeting of the heart Failure Society of America, Washington DC. (September 2007)

"Congestive heart failure." Presented at OSU Center for EMS Conference, Columbus, OH. (September 2007)

"The future of heart failure management." Presented at Klassen Research Day, Columbus, OH. (April 2007)

"Symposium-Interventional Heart Failure I: Recent Developments and new Directions Session II: Device-Based Management of Worsening Chronic Heart Failure." Presented at Transcatheter Cardiovascular Therapeutics 2007, Washington DC. (October 2007)

"Clinical studies with a pulmonary artery pressure sensor II: Cardiomems." Presented at Transcatheter Cardiovascular Therapeutics 2007, Washington DC. (October 2007)

"Cardiac resynchronization therapy: How efficacious is it? Are the indications expanding?." Presented at Transcatheter Cardiovascular Therapeutics 2007, Washington DC. (October 2007)

"Clinical development of new devices for heart failure." Presented at Translational Biomedical Research IBGP-792, Columbus, OH. (October 2007)

"State of the art: devices for the management of heart failure." Presented at The 55th Annual Scientific meeting of the Cardiac Society of Australia and new Zealand, Christchurch, NZ|NZL. (August 2007)

"Heart failure: monitoring devices." Presented at The 55th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Christchurch, NZ|NZL. (August 2007)

"Erythropoietin for the management of anemia in heart failure." Presented at The 55th Annual Scientific meeting of the Cardiac Society of Australia and New Zealand, Christchurch, NZ|NZL. (August 2007)

"Devices for monitoring heart failure." Presented at The 55th Annual Scientific Meeting of the Cardiac Society of Australia and new Zealand, Christchurch, NZ|NZL. (August 2007)

"We will know the answers - the FREEDOM study." Presented at Echo Optimization for CRT Patients-Still Needed or Obsolete by Now?, Satellite Symposium held at EUROPACE 2007, Lisbon, PT|PRT. (June 2007)

"Ultra Filtration: Who? When? How?." Presented at AAHFN 2007, The 3rd Annual Meeting of the American Association of Heart Failure Nurses, San Diego, CA. (June 2007)

"State of the state of heart failure management." Presented at Proactive Heart Failure Management: The Future is Here!, Satellite Symposium held during AAHFN 2007, The 3rd Annual Meeting of the American Association of Heart Failure Nurses, San Diego, CA. (June 2007)

"Select Topics in HF: Hypertrophic Obstructive Cardiomyopathy; Rigth Sided Heart Failure; Congenital Heart Disease." Presented at AAHFN 2007, The 3rd Annual Meeting of the American Association of Heart Failure Nurses, San Diego, CA. (June 2007)

"Pulmonary pressures and the risk of worsening heart failure." Presented at Innovative Device Technologies for Optimizing the Management of Heart Failure by Continual Pulmonary Pressure Monitoring, Satellite Symposium held during heart Failure 2007, the Annual Congress of the Heart Failure Association oftheEuropeanSocietyofCardio, Hamburg, DE|DEU. (June 2007)

"International perspectives and individual approaches to anemia research." Presented at America as a Novel Cellular Target for Heart Failure Therapy, Satellite Symposium held during Heart Failure 2007, the Annual Congress of the Heart Failure Association of the European Society of Cardiology, Hamburg, DE|DEU. (June 2007)

"Evaluation of clinical studies on anemia in patients with heart failure." Presented at America as a Novel Cellular Target for Heart Failure Therapy, Satellite Symposium held during European Society of Cardiology, Hamburg, DE|DEU. (June 2007)

"Plenary Session- Joint AHA/ESC Session: Reversing Heart Failure, "Electrical device therapy"." Presented at The 80th Annual Scientific Sessions of the American heart Association, Orlando, FL. (November 2007)

"Clinical Controversies, "CON: Echocardiographic evidence of dysynchrony is necessary prior to CRT." Presented at The 80th Annual Scientific Sessions of the American heart Association, Orlando, FL. (November 2007)

"Interpreting pacemakers diagnostics during follow-up." Presented at The XIIIth World Congress on Cardiac Pacing & Electrophysiology, Rome, IT|ITA. (December 2007)

"Fifty years of electrical therapy for the heart: ICD and CRT therapy." Presented at The XIIIth World Congress on Cardiac pacing & Electrophysiology, Rome, IT|ITA. (December 2007)

"Debates on Heart Failure Electrical Therapy, "All patients receiving CRT therapy should receive a CRT-D"." Presented at The XIIIth World Congress on Cardiac Pacing & Electrophysiology, Rome, IT|ITA. (December 2007)

"Novel Devices for monitoring and for treating heart failure." Presented at The 4th Asian Pacific Congress of Heart Failure, Melbourne, AU|AUS. (January 2008)

"Left atrial pressure monitoring for the management of heart failure." Presented at The 4th Asian pacific Congress of Heart Failure, Melbourne, AU|AUS. (January 2008)

"Current device therapy for heart failure." Presented at The 4th Asian Pacific Congress of Heart Failure, Melbourne, AU|AUS. (January 2008)

"Cardiac resynchronization therapy: current weight of evidence and future directions." Presented at The 4th Asian Pacific Congress of Heart Failure, Melbourne, AU|AUS. (January 2008)

"Novel drugs and devices for heart failure." Presented at Cardiovascular Medicine Weekly Conference, Columbus, OH. (February 2008)

"The heart failure clinical composite score at six months predicts subsequent morbidity and mortality." Presented at The 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"Optimizing the Role of Vasodilating Beta-Blockeres in the Management of Complicated Hypertension." Presented at Satellite Symposium held during the 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"Optimal Medical Therapy 2008: BiV-ICD for all, for a few?." Presented at The 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"Meet the Experts Session, Implantable Devices: Regulatory and Quality Issues, "Panelist"." Presented at The 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"Long-term results of cardiac resynchronization therapy: does cardiac resynchronization therapy arrest the natural history of CHF?." Presented at The 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"Late breaking Clinical Trail Presentation, "Multicenter randomized controlled trial of cardiac contractility modulation in patients with advanced heart failure." Presented at The 58th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2008)

"Cardiac resynchronization and defibrillator therapy (CRT-D) improves survival compred to CRT alone (CRT-P) in heart failure patients." Presented at The 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"A novel ventricular elastic support system reverses remodeling in heart failure patients." Presented at The 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL. (March 2008)

"Evaluation and management of acutely decompensated heart failure." Presented at Family Medicine Resident Conference, Columbus, OH. (March 2008)

"Unconventional Applications of CRT." Presented at Heart Rhythm 2008, The 29th Annual Scientific Sessions of the Heart Rhythm Society, San Francisco, CA. (May 2008)

"Targeting Mechanical Dysynchrony: Is it Worth the Extra Effort?." Presented at How to Manage Heart Failure Patients with CRT Devices, Satellite Symposium held during Heart Rhythm 2008, The 29th Annual Scientific Sessions of the Heart Rhythm Society, San Francisco, CA. (May 2008)

"Should CRT Ever Be Considered for Narrow QRS Patients?." Presented at Heart Rhythm 2008, The 29th Annual Scientific Sessions of the heart Rhythm Society, San Francisco, CA. (May 2008)

"What can resynchronization therapy add?." Presented at The XXXth Congress of the European Society of Cardiology, Munich, DE|DEU. (August 2008)

"How to Improve the Rate of Responders with Cardiac Resynchronization Therapy?." Presented at The XXXth Congress of the European Society of Cardiology, Munich, DE|DEU. (August 2008)

"CRT: A Potpourri." Presented at CardioStim 2008, The 16th World Congress in Cardiac Pacing and Electrophysiology and Cardiac Techniques, Nice, FR|FRA. (June 2008)

"Wild card cases VII: the challenging CRT non-responder." Presented at Arrhythmias in the Real World 2008, Washington DC. (September 2008)

"Pharmacologic Versus Device Therapy: To Implant or Not to Implant,." Presented at Satellite Symposium held during the 12th Annual Scientific meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Non-arryhythmic syncope in CHF: work-up and management." Presented at Arrhythmias in the Real World 2008, Washington DC. (September 2008)

"Left atrial pressure monitoring." Presented at The 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Genetic influences on disease severity and treatment resistance in heart failure." Presented at Personalized Healthcare: Application of Pharmacogenetics to the Treatment of Cardiovascular Disease, Satellite Symposium held during the 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Exercise for health and recreation in patients with CHF." Presented at Arrhythmias in the Real World 2008, Washington DC. (September 2008)

"Electrical therapies for heart failure: CRT and CCM." Presented at The 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Electrical therapies for heart failure: CRT and CCM." Presented at The 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Effects of lixivaptan, a novel vasopressin V2 receptor antagonist, in chronic heart failure: results from a double-blind, placebo-controlled, multiple-dose study." Presented at The 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Comparison of sudden cardiac death in heart failure patients with cardiac resynchronization and defibrillator therapy (CRT-D) versus CRT alone (CRT-P).." Presented at The 12th Annual Scientific meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Charman's Introduction: Application of pharmacogenetics to the treatment of cardiovascular disease." Presented at Personalized Healthcare: Application of Pharmacogenetics to the Treatment of Cardiovascular disease, Satellite Symposium held during the 12th Annual Scientific Meetings of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Cardiac resynchronization therapy: current trends and new frontiers." Presented at Medtronic In-Booth Presentation, held during the 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2008)

"Implantable devices in heart failure." Presented at OSU College of Engineering-College of Medicine Collaborative Research Symposium, Columbus, OH. (September 2008)

"Resynchronization Therapy: Choosing the Right Device for the Right Patient." Presented at The 81st Annual Scientific Sessions of the American heart Association, New Orleans, LA. (November 2008)

"How to manage CRT non-responders." Presented at The 81st Annual Scientific Sessions of the American Heart Association, New Orleans, LA. (November 2008)

"Cardiac resynchronization therapy is a class I indication: why are only 1/3 being treated?." Presented at Medtronic In-Booth Presentation, held during the 81st Annual Scientific Sessions of the American Heart Association, New Orleans, LA. (November 2008)

"Using genetic information to select treatment for patients with heart failure." Presented at Personalized Medicine: Genetic Considerations in the Treatment of Cardiovascular Disease, Satellite Symposium held during the 58th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2009)

"Update in Cardiac Resynchronization Therapy." Presented at The 58th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2009)

"Sleep apnea incidence and outcomes in heart failure patients: a retrospective study of Medicare beneficiaries." Presented at The 58th Annual Scientific Session of the American College of cardiology, Orlando, FL. (March 2009)

"Reverse remodeling through CRT." Presented at The 58th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2009)

"Chair's Welcome and introduction." Presented at Personalized Medicince: Genetic Considerations in the Treatment of Cardiovascular Disease, Satellite Symposium held during the 58th Annual Scientific Session of the American College of Cardiology, Orlando, FL. (March 2009)

"Guideline recommended approach to the management of heart failure." Presented at Family Medicine Resident Conference, Columbus, OH. (March 2009)

"Lecture 2." Presented at HDL South Symposia, Langkawi, MY|MYS. (July 2009)

"Lecture 1." Presented at HDL South Symposia, Langkawi, MY|MYS. (July 2009)

"Late Breaking Clinical Trials Session, "REsynchronizatin reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) trial: effect of CRT on 18 month outcomes." Presented at The 12th Annual Scientific Meeting of the Heart Failure Society of America, Toronto, ON, CA|CAN. (September 2009)

"How to Optimize Bi-Ventricular Pacers." Presented at HFSA 2009 13th Annual Scientific Meeting, Boston, MA, US|USA. (September 2009)

"Cardiac Resynchronization Therapy to Improve Outcomes in Heart Failure: Eveidence, Guidelines, Challenges, and New Opportunities." Presented at HFSA 2009 13th Annual Scientific Meeting, Boston, MA, US|USA. (September 2009)

"Telecardiology: Advantages and Disadvantages." Presented at Latin America Course, Buenos Aires, AR|ARG. (November 2009)

"Sleep Apnea and Heart Failure." Presented at Latin America Course, Buenos Aires, AR|ARG. (November 2009)

"Impact of Device Therapy on Sleep Apnea in Heart Failure." Presented at AHA Conference 2009, Orlando, FL, US|USA. (November 2009)

"Imaging Patients with Heart Failure: Expectations of the Clinician." Presented at AHA Conference 2009, Orlando, FL, US|USA. (November 2009)

"Drug Therapy for Heart Failure." Presented at Latin America Course, Buenos Aires, AR|ARG. (November 2009)

"Device Therapies for Heart Failure." Presented at Latin America Course, Buenos Aires, AR|ARG. (November 2009)

"Controversy: Ecocardiography predicts CRT responders - WTA says Yes." Presented at Latin America Course, Buenos Aires, AR|ARG. (November 2009)

"Neurohormonal Modulators: Relaxin and Others Device Therapies." Presented at Emergency Department Management of Acute Heart Failure: Research Challenges and Opportunities, Bethesda, MD, US|USA. (August 2009)

"Collaborative Team Roundtable." Presented at Sleep Heart Observation Program, Columbus, OH, US|USA. (August 2009)

"Overall Management of Fluid Overload." Presented at ESC Congress 2009, Barcelona, ES|ESP. (August 2009)

"M4, randomized/registry comparison." Presented at STICH Investigator Meeting, Barcelona, ES|ESP. (August 2009)

"Landmark Trials in Arrhythmia Management." Presented at Barcelona EP Fellows Program, Barcelona, ES|ESP. (August 2009)

"Personalized Treatment of Heart Failure: Moving Away From One Size Fits All." Presented at Contemporary Multi-Disciplinary Cardiovascular Medicine Conference, Orlando, FL, US|USA. (October 2009)

"Pathophysiology in Normal and Reduced EF." Presented at Contemporary Multi-Disciplinary Cardiovascular Medicine Conference, Orlando, FL, US|USA. (October 2009)

"Case 9 - Implantable Hemodynamic Monitoring Device in HF." Presented at Contemporary Multi-Disciplinary Cardiovascular Medicine Conference, Orlando, FL, US|USA. (October 2009)

"Afternoon Keynote - Genetics and Heart Failure." Presented at BREATHE Conference, Cincinnati, OH, US|USA. (October 2009)

""What is it?" and Case Studies." Presented at Contemporary Multi-Disciplinary Cardiovascular Medicine Conference, Orlando, FL, US|USA. (October 2009)

"Symposium on: "Heart Failure� on the topic: “Sleep Disordered Breathing and Heart Failure"." Presented at 25th. URUGUAYAN CONGRESS OF CARDIOLOGY, Montevideo, UY|URY. (December 2009)

"Round Table on: “Heart Failure�, on the topic: "Newer strategies for monitoring heart failure patients"." Presented at 25th. URUGUAYAN CONGRESS OF CARDIOLOGY, Montevideo, UY|URY. (December 2009)

"Relevant aspects of the new 2009 Guidelines for the Management of Heart Failure." Presented at 25th. URUGUAYAN CONGRESS OF CARDIOLOGY, Montevideo, UY|URY. (December 2009)

"Newer and Future Approaches to Monitoring Heart Failure Patients." Presented at 21st Annual Cardiovascular Disease Symposium, Toledo, OH, US|USA. (December 2009)

"Devices for Heart Failure." Presented at 25th. URUGUAYAN CONGRESS OF CARDIOLOGY, Montevideo, UY|URY. (December 2009)

"Ongoing trials: what comes next?." Presented at New Clinical Evidence for Home Monitoring: Towards Safe, Need based Patient Follow-up and Beyond, Satellite Symposium held during Heart Rhythm 2009, The 30th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2009)

"Ideas on Trial (Debate), Echocardiography is Useful to Predict CRT Responders: Prosecuter (Antagonist)." Presented at Heart Rhythm 2009, The 30th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2009)

"Electrophysiological effects of restoring cardiac synchrony: clinical evidence for benefit of cardiac resynchronization." Presented at Heart Rhythm 2009, The 30th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2009)

"CRT myths and facts." Presented at Medtronic In-Booth Presentation, held during Heart Rhythm 2009, The 30th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2009)

"Case Based Tutorial, What is the Best Device Derived Measure of Heart Failure Clinical Status." Presented at Heart Rhythm 2009, The 30th Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA. (May 2009)

"Cardiovascular effects of central sleep apnea." Presented at Heart Failure 2009, The Eleventh International Meeting Organized by the Working Group on Heart Failure of the European Society of Cardiology, Nice, FR|FRA. (May 2009)

"Assessment of patient's response to cardiac resynchronization therapy varies between different clinical practices." Presented at Heart Rhythm 2009, The 30th Annual Scientific Sessions of the heart Rhythm Society, Boston, MA. (May 2009)

"Integration of home monitoring in modern heart failure therapy." Presented at Cardiolgoy Update 2009, 18th International Postgraduate Course on Cardiovascular Disease, Davos, CH|CHE. (February 2009)

"Devices in Heart Failure." Presented at Cardiology Update 2009, 18th International Postgraduate Course on Cardiovascular Disease, Davos, CH|CHE. (February 2009)

"Clinical Decision Seminar: Optimal patient Selection for Biventricular Pacing." Presented at Cardiology Update 2009, 18th International Postgraduate Course on Cardiovascular Disease, Davos, CH|CHE. (February 2009)

"Gender difference in Cardiovascular Medicine." Presented at AHA Annual Fundraiser, Middletown, OH, US|USA. (June 2009)

"Panel Discussion." Presented at 2nd Annual Women's Cardiovascular Conference, Columbus, OH, US|USA. (May 2010)

"Guideline Approach to Heart Failure." Presented at 2010 Mercy Health Partner's Visiting Professor, Toledo, OH, US|USA. (May 2010)

"Extra systolic monitoring devices." Presented at Heart Failure 2010 (ESC), Berlin, DE|DEU. (May 2010)

"Devices for Managing & Monitoring Heart Failure." Presented at Grand Rounds, NY. (February 2010)

"Patients with Mild Symptoms of Heart Failure?." Presented at Heart Failure 2010 (ESC), Berlin, DE|DEU. (May 2010)

"What do we need to monitor? Defining the right signals which would prompt action. A review of the existing moniorting devices." Presented at Heart Failure 2010 (ESC), Berlin, DE|DEU. (May 2010)

"Unresolved Issues." Presented at Heart Rhythm Society 31st Scientific Sessions (NASPE), Denver, CO, US|USA. (May 2010)

"TRIDENT-1." Presented at Heart Failure 2010 (ESC), Berlin, DE|DEU. (May 2010)

"Results From The Freedom Trial - Assess The Safety and Efficacy of Frequent Optimization of Cardiac Resynchronization Therapy." Presented at Heart Rhythm Society 31st Scientific Sessions (NASPE), Denver, CO, US|USA. (May 2010)

"Sleep Apnea and Heart Failure - Who should be screened and how?." Presented at Heart Failure 2010, Los Angeles, CA, US|USA. (January 2010)

"Cardiac resynchronization therapy for Heart Failure - A decade in perspective." Presented at Heart Failure 2010, Los Angeles, CA, US|USA. (January 2010)

"Percutaneous Left Ventricular Partitioning for Ischemic Heart Failure: Results of the US-PARACHUTE Feasibility Study." Presented at HFSA, San Diego, CA, US|USA. (September 2010)

"Management of LV Dsyfunction and Advanced Heart Failure after STEMI: A Role for Long-term Invasive Monitoring-Results of the Champion Trial." Presented at 2nd Annual Acute Myocardial Infarction Update: Big 10 Topics In STEMI Management, . (September 2010)

"Intravascular Pressure Sensors: Can monitoring pulmonary artery pressure improve clinical outcomes in CHF?." Presented at TCT 2010, Washington, D.C., US|USA. (September 2010)

"Implantable Monitoring Devices: Can We Throw Away the Stethescope?." Presented at HFSA, San Diego, CA, US|USA. (September 2010)

"Ventricular Elastic Support Therapy (VEST) in Stage C Heart Failure: Analysis from the PEERLESS-HF Study." Presented at HFSA, San Diego, CA, US|USA. (September 2010)

"CRT clinical trials: What we know and why." Presented at ADVANCE CRT Summit, Philadelphia, PA. (October 2010)

"What Do the Clinical Trials Tell Us About Imaging and CRT?." Presented at American Heart Association Annual Scientific Sessions, Chicago, IL. (November 2010)

"Epidemiology of Diuretic Resistance in Cardiovascular Disease." Presented at American Heart Association Annual Scientific Sessions, Chicago, IL. (November 2010)

""Why treating CSA will improve the outcomes of HF"." Presented at Board Meeting - Cardiac Concepts, Minneapolis, MN, US|USA. (February 2010)

"Cardiorenal Syndrome." Presented at OSU Cath Conference, Columbus, OH, US|USA. (April 2010)

"Devices for Monitoring and Managing Heart Failure." Presented at 2010 Mercy Health Partner's Visiting Professor, Toledo, OH, US|USA. (May 2010)

"Devices - Case based interactive session." Presented at Heart Failure 2010 (ESC), Berlin, DE|DEU. (May 2010)

"Debate the benefits and risks of providing patients with hemodynamic and implanted device data for improving outcomes." Presented at Heart Rhythm Society 31st Scientific Sessions (NASPE), Denver, CO, US|USA. (May 2010)

"CHAMPION." Presented at Heart Failure 2010 (ESC), Berlin, DE|DEU. (May 2010)

"Biotronik Satellite Symposium - “Evolving Fields of Cardiac Resynchronization Therapy"." Presented at Heart Rhythm Society 31st Scientific Sessions (NASPE), Denver, CO, US|USA. (May 2010)

"Trials in Progress that could Alter CRT Selection & Management." Presented at Cardiostim Congress, Nice, FR|FRA. (June 2010)

"The Heart — Genetics and Treatments of the Future." Presented at Heart Golf Outing About Prevention, Not Score Card, Middletown, OH, US|USA. (June 2010)

"The FIX-HF-5 US Clinical Study of CCM: Overall Results and Implications for Different Patient Populations." Presented at Cardiostim Congress, Nice, FR|FRA. (June 2010)

"Electrical Therapy of the Heart Failure Patient: Evolving New Concepts." Presented at Cardiostim Congress, Nice, FR|FRA. (June 2010)

"CRT in mildly symptomatic heart failure." Presented at Cardiostim Congress, Nice, FR|FRA. (June 2010)

"Arrhythmia & sudden cardiac death epidemiology." Presented at Cardiostim Congress, Nice, FR|FRA. (June 2010)

"Results of Randomized Clinical Trials on CCM." Presented at ESC, Stockholm, SE|SWE. (August 2010)

"Pharmacologic therapy - Emerging therapies for heart failure." Presented at ESC, Stockholm, SE|SWE. (August 2010)

"Ongoing clinical trials." Presented at ESC, Stockholm, SE|SWE. (August 2010)

"Implantable monitoring devices." Presented at ESC, Stockholm, SE|SWE. (August 2010)

"Clinical Trial Update session following the presentation entitled "PACE"." Presented at ESC, Stockholm, SE|SWE. (August 2010)

"Heart Sensors: A new technology for heart failure patients to reduce readmissions and increase life span (as published in Lancet)." . (July 2011)

"Implantable Pacing/Defibrillation Devices." Presented at Heart Failure Society of America, Boston, MA. (September 2011)

"Future Physiologic Heart Failure Monitoring." Presented at Heart Failure Society of America, Boston, MA. (September 2011)

"Confronting the Challenge of Central Sleep Apnea in Heart Failure." Presented at Satellite Symposium for Respicardia, . (September 2011)

"Heart failure management: Integration of device sensor data into clinical practice." Presented at Cardiology Update 2011, Davos, CH|CHE. (February 2011)

"Clinical Decision Seminar 2: CRT and ICD - Experts and Cases." Presented at Cardiology Update 2011, Davos, CH|CHE. (February 2011)

"Devices for Managing and Monitoring Heart Failure." Presented at Grand Rounds for University of Rochester Medical Center, Rochester, NY. (February 2011)

"Monitoring heart failure: Implantable devices to guide management." Presented at Cardiology Update 2011, Davos, CH|CHE. (February 2011)

"Cardiac resynchronization therapy in heart failure - Meet the Experts." Presented at Cardiology Update 2011, Davos, CH|CHE. (February 2011)

"Do Our Treatments Used to Manage the Cardiorenal Syndrome Precipitate Sudden Death?." Presented at Eleventh International Symposium Heart Failure & Co., Caserta, IT|ITA. (April 2011)

"Myocardial Ischemia: an Under Rated Cause for Sudden Death." Presented at Eleventh International Symposium Heart Failure & Co., Caserta, IT|ITA. (April 2011)

"Home-Based management of Heart Failure with Implantable Devices." Presented at American College of Cardiology, New Orleans, LA. (April 2011)

"Hands on Lab - Chronic HF." Presented at American College of Cardiolgy, . (April 2011)

"Functional Mitral Regurgitation." Presented at American College of Cardiology, New Orleans, LA. (April 2011)

"Functional Mitral Regurgitation." Presented at American College of Cardiology, New Orleans, LA. (April 2011)

"Expanding Indications for Cardiac Resynchronization Therapy in Heart Failure." Charlotte, NC. (April 2011)

"AV and VV Optimization in CRT." Presented at American College of Cardiology, New Orleans, LA. (April 2011)

"Evidence Based management of Diastolic congestive Heart Failure and the Promise of Implanted Hemodynamic Monitoring Devices." Presented at 3rd Annual Cardiovascular Disease in African Americans, Columbus, OH. (April 2011)

"Devices for Monitoring Heart Failure to Reduce Hospital Admissions." Detroit, MI. (August 2011)

"Which patients should receive a CRT defifibrillator?." Presented at ESC Congress 2011, Paris, FR|FRA. (August 2011)

"Novel Devices for Heart Failure." Presented at ESC Congress 2011, Paris, FR|FRA. (August 2011)

"What is the clinical value of these pathologies." Presented at 19th Annual Echocardiography Conference presented by University Hospital Luzern, Luzern, CH|CHE. (January 2011)

"Safety & Endpoint Reporting Process (SAE's, Hospitalizations, Deaths, DSMB & CEC REview, FDA requirements)." Presented at EchoCRT Investigator Meeting, Zurich, CH|CHE. (January 2011)

"Echochardiography Guided Cardiac Resynchronization Therapy (EchoCRT) Protocol Review." Presented at EchoCRT Investigator Meeting, Zurich, CH|CHE. (January 2011)

"Echocardiography Guided Cardiac Resynchronization Therapy." Presented at 19th Annual Echocardiography Conference presented by University Hospital Luzern, Luzern, CH|CHE. (January 2011)

"Monitoring Heart Failure Patients to Reduce Hospitalization." Presented at National Arab American Medical Association Conference, . (March 2011)

"New Physician/Patient Paradigms in the treatment of heart failure." Presented at Fourth Annual Personalized Health Care National Conference, Orlando, FL. (October 2011)

"Medical management of acute decompensated heart failure." Presented at 3rd Annual Contemporary Multi-Disciplinary Cardiovascular Medicine Conference, Orlando, FL. (October 2011)

"What can CMR tell me about dyssynchrony?." Presented at 2011 CMR/CT CME Update, . (May 2011)

"New-Onset Heart Failure - Echo/Catherization/CMR." Presented at 2011 Cardiovascular MR/CT Update, Columbus, OH. (May 2011)

"New Perspectives in Acute Decompensated Heart Failure." Presented at Israel Heart Society Annual Meeting, Tel Aviv, IL|ISR. (May 2011)

"New Approaches for Monitoring Heart Failure Patients." Presented at Israel Heart Society Annual Meeting, Tel Aviv, IL|ISR. (May 2011)

"Implantable Hemodynamic Monitoring in Heart Failure." Presented at 2011 ACVIM Forum, Denver, CO. (June 2011)

"Evaluation and Management of Acutely Decompensated Heart Failure." Presented at 2011 ACVIM Forum, Denver, CO. (June 2011)

"Resynchronization in narrow QRS: getting closer to the truth?." Presented at Europace 2011, Madrid, ES|ESP. (June 2011)

"Future perspectives in basic research in CRT." Presented at Europace 2011, Madrid, ES|ESP. (June 2011)

"Clinical implications of the cardiorenal syndrome in heart failure." . (June 2011)

"Besides the ICD: The future of implant technology." Presented at Europace 2011, Madrid, ES|ESP. (June 2011)

"CRT - patient selection and follow-up." Presented at 25th Annual Echocardiography Conference, . (January 2012)

 

Professional Activities

1996 - present Visiting Professorship.
1997 - present Visiting Professorship. Louisville, KY.
1997 - present Visiting Professorship. Lexington, KY.
1998 - present Visiting Professorship. Houston, TX.
1998 - present Visiting Professorship. Little Rock, AR.
1998 - present Visiting Professorship. Philadelphia, Pennsylavania.
1999 - present Visiting Professorship. Pittsburgh, PA.
1999 - present Visiting Professorship. Lexington, KY.
1999 - present Primary Physician Presenter on behalf of Scios, Inc. NDA for Natrecor (nesiritide) to the Cardiovascular and Renal Drugs Advisory Panel of the U.S. Food and Drug Administration.
2000 - present Visiting Professorship. Madison, WI.
2001 - present Primary Physician Presenter on behalf of Medtronic, Inc. PMA for InSync (cardiac resynchronization therapy) to the Circulatory System Devices Panel of the U.S. Food and Drug Administration.
2001 - present Visiting Professorship. Knoxville, TN.
2001 - present Visiting Professorship. Boston, MA.
2001 - present Visiting Professorship. Huntington, WV.
2001 - present Physician Presenter on behalf of Scios, Inc. NDA for Natrecor (nesiritide) to the Cardiovascular and Renal Drugs Advisory Panel of the U.S. Food and Drug Administration.
2002 - present Physician Presenter on behalf of Otsuka Maryland Research Institute, Inc. for OPC-41061 (tolvaptan) to the Division of Metabolic and Endocrine Drug Products of the U.S. Food and Drug Administration, End of Phase 2 Meeting.
2002 - present Visiting Professorship. Nashville, TN.
2002 - present Principal Investigator on behalf of CHF Solutions, Inc. 510(k) marketing clearance for the System 100 Fluid Removal System..
2002 - present Visiting Professorship. Atlanta, GA.
2002 - present Physician Presenter on behalf of Medtronic, Inc. PMA for InSync ICD (cardiac resynchronization therapy plus implantable cardioverter defibrillator) to the Circulatory System Devices Panel of the U.S. Food and Drug Administration.
2003 - present Invited Professorship. Boston, MA.
2003 - present Co-Principal Investigator on behalf of Medtronic, Inc. PMA for InSync III (cardiac resynchronization therapy with independent ventricular-ventricular programming)..
2004 - present Invited Professorship.
2004 - present Invited Professorship.
2004 - present Invited Professorship. Basle, Switzerland.
2004 - present Invited Professorship. Indianapolis, IN.
2004 - present Physician Presenter on behalf of Cardiac Resynchronization Therapy. Baltimore, MD.
2005 - present Principal Investigator on behalf of Medtronic, Inc. PMA-S for InSync III Marquis Model 7279 Clinical Study submitted to FDA.
2005 - present Invited Professorship. New York, NY.
2005 - present Physician Presenter on behalf of Cardiokine, Inc. for Lixivaptan to the Division of Metabolic and Endocrine Drug Products of the U.S. Food and Drug Administration, End of Phase 2 Meeting.
2005 - present Invited Professorship. Jacksonville, FL.
2005 - present Invited Professorship. Hershey, PA.
2005 - present Invited Professorship. New York, NY.
2005 - present Invited Professorship.
2006 - present Invited Professorship. Cleveland, OH.
2006 - present Invited Professorship. Pittsburgh, PA.
2008 - present Visiting Professorship. Boston, MA.
2008 - present Visiting Professorship.
2008 - present Visiting Professorship.
2008 - present Visiting Professorship. Ann Arbor, MI.
1995 Visiting Professorship. Montreal, QC.
1996 Visiting Professorship.
1998 Visiting Professorship. Rochester, MN.
1998 Visiting Professorship. Wichita, KS.
1999 Visiting Professorship. New Orleans, LA.
1999 Visiting Professorship. Dallas, TX.
2002 Invited Professorship. Birmingham, AL.
2003 Invited Professorship. Little Rock, AR.
2003 Invited Professorship. Ann Arbor, MI.
2004 Invited Professorship. Seattle, WA.
2005 Invited Professorship. Youngstown, OH.
2006 Invited Professorship. Boston, MA.
2008 Visiting Professorship. Cleveland, OH.